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ABSTRACT 
 
Among the frontier challenges in chemistry in the 21st century are the 
interconnected goals of increasing synthetic efficiency and diversity in the construction 
of complex molecules. Oxidation reactions of C–H bonds, particularly when applied at 
late-stages of complex molecule syntheses, hold special promise for achieving both these 
goals by minimizing the use of functional group manipulations typically required to 
synthesize these molecules. Traditionally, C–H oxidation reactions install oxidized 
functionality onto a preformed molecular skeleton, resulting in a local molecular change. 
However, the use of C–H activation chemistry to construct complex molecular scaffolds 
is a new area with tremendous potential in synthesis. This work showcases a late-stage 
C–H oxidation strategy in the total synthesis of 6-deoxyerythronolide B (6-dEB), the 
aglycone precursor to the erythromycin antibiotics. An advanced intermediate is cyclized 
to the 14-membered macrocyclic core of 6-dEB using a late-stage (step 19 of 22) C–H 
oxidative macrolactonization reaction that proceeds with high regio-, chemo-, and 
diastereoselectivity (>40:1). A chelate-controlled model for macrolactonization predicted 
the stereochemical outcome of C–O bond formation and guided the discovery of 
conditions for synthesizing the first diastereomeric 13-epi-6-dEB precursor. Overall, this 
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C–H oxidation strategy affords a highly efficient and stereochemically versatile synthesis 
of the erythromycin core.  
Throughout the erythromycin’s rich synthetic history, no concept has been 
entrenched as deeply as the perceived need for biasing elements in order to effect 14-
membered macrocyclization. This work showcases the cyclizations of completely 
unbiased 6-deoxyerythronolide B precursors, using either C–H oxidative or Yamaguchi 
macrolactonization reactions. Late-stage and stereodivergent C–H oxidation reactions 
enabled seco acid formation with both configurations at C13. Consequently, it is shown 
that both the natural and unnatural C13 configurations can be formed in the 
macrocyclization of the 6-dEB core in the absence of preorganizational elements. Overall 
these findings require revision of the 30-year-old dogma that preorganization is 
mandatory for achieving macrocyclization of the erythromycins. 
Sequential transformations in a single reaction have the potential to dramatically 
increase synthetic efficiency by rapidly building molecular complexity while lowering 
step count and intermediate isolations. Catalytic dehydrogenation reactions of 
hydrocarbons represent a powerful reaction class capable of activating an otherwise non-
reactive substrate through sequential C–H bond activations. As a result, coupling a 
dehydrogenation transformation to a complexity generating reaction would lead to 
complex molecular architectures from topologically simple starting materials in a rapid 
fashion. We report a Pd(II)/bis-sulfoxide catalyzed dehydrogenative Diels-Alder reaction 
that converts simple terminal olefins into complex cyclohexenyl adducts in good yields 
and selectivities. Based on the high functional group tolerance, this method enables 
expedient access to a wide variety of biologically and medicinally relevant heterocycles, 
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such as hydroisoindolines, cis-decalins, hydroisoquinolines, and isoindoloquinolines. 
Mechanistic studies indicate the reaction proceeds through a sequential allylic C–H 
cleavage and homoallylic β-hydride elimination to produce a mixture of E and Z terminal 
1,3-dienes, which isomerize to the Diels-Alder capable (E)-isomer via Pd(II)-catalysis, 
followed by a thermal Diels-Alder cycloaddition. 
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CHAPTER 1 
 
TOTAL SYNTHESIS AND STUDY OF 6-DEOXYERYTHRONOLIDE B 
BY LATE-STAGE C–H OXIDATION 
 
1.1 INTRODUCTION 
Many biologically important small molecules consist of a hydrocarbon skeleton decorated 
with oxygen functionality. Synthetic chemists have typically synthesized these compounds by 
incrementally adding oxygenation throughout a synthetic route using a combination of three 
reaction classes: 1) C–C bond forming reactions between two preoxidized coupling fragments, 2) 
functional group interconversions (i.e. substitution reactions), and 3) olefin oxidations. While 
this strategy has enabled the synthesis of seemingly any complex molecule,1 it often requires the 
heavy use of functional group manipulations (FGMs), such as protection-deprotection sequences 
and oxidation state changes. As a consequence, the routes to these polyoxidized molecules often 
require more synthetic manipulations than the complexity of the target dictates, resulting in 
lower synthetic efficiencies. Late-stage oxidative tailoring of hydrocarbons, enabled by C–H 
oxidation methodology, provides an alternative approach to complex molecule synthesis.2 This 
late-stage C–H oxidation strategy enables reactive functional groups to be masked as inert C–H 
bonds until the final stages of a synthesis, and in theory reduces FGMs and improves synthetic 
efficiencies. However, applications of C–H oxidation reactions in target-oriented synthesis are 
scarce3 due to the requirement that oxidation occur at one C–H bond amid scores of others, with 
predictably high levels of regio-, chemo- and stereoselectivity. Approaches for predicting and 
influencing the stereochemical course of C–H oxidations, in particular, are not well developed.  
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Figure 1. Macrolide Antibiotics 
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The polyketide macrolide antibiotics are a large family of compounds all possessing a 
signature macrocyclic lactone (or “macrolide”) structure of various sizes (12, 14 or 16 membered 
lactones), and most possess an amino sugar and/or neutral sugar moieties (Figure 1).4 These 
compounds are of great interest due to their antibacterial activity, particularly against gram-
positive bacteria and mycoplasmas. The macrolide aglycones found in this class of compounds 
are nearly structurally homologous and tend to differ only in degree of oxygenation and 
glycosylation. Furthermore, many of these natural products share a striking stereochemical 
homology at all comparable stereocenters (Celmer’s Rules).5 Based on their interesting 
macrocyclic structures and dense array of stereochemistry, the polyketide macrolide antibiotics 
have inspired tremendous conceptual advances in total synthesis, including novel strategies for 
acyclic stereocontrol and macrocyclization methodologies. The erythromycins have served as 
vital members of this antibacterial fleet since their isolation in the 1950’s, owing to their broad-
spectrum antibacterial activity and lack of activity against eukaryotes.4 This sub-class of 
macrolide compounds (including, but not limited to: erythronolide A, erythronolide B, and 6-
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deoxyerythronolide B) all share a 14-membered macrolactone aglycone, an ethyl side chain at 
C13, as well as 10 asymmetric centers. 6-Deoxyerythronolide B (6-dEB) is the biogenic 
precursor to the erythromycins, and therefore serves as the archetypical core of these polyketide 
macrolides.6  
Figure 2. General Synthetic Approaches Towards the Erythromycins. From reference 14 
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Synthetic studies of the erythromycins, spanning more than a quarter of a century,7 have 
relied on internal esterification of a stereochemically defined linear hydroxyacid for macrocycle 
construction. Of these, 6-dEB has been synthesized three times previously using an acylation-
based macrocyclization event.8,9,10,11 We questioned whether this same core structure could be 
accessed through a late-stage C–H oxidative macrolactonization reaction where oxygen is 
installed directly into the hydrocarbon framework late in the synthesis (Figure 2). This C–H 
oxidation strategy offers several potential advantages. First, the amount of reactive oxygen 
functionality is minimized, thereby reducing side reactions that erode synthetic yields over the 
course of multi-step sequences.1a,12 In addition, installing this ‘ester’ functionality directly from a 
C–H bond obviates the need to selectively expose the desired free hydroxyl group needed for 
acylation-based cyclizations, which often necessitates the use of delicate FGMs.13 Second, this 
strategy can furnish diastereomeric macrolactones at the site of oxidation from a 
stereochemically versatile oxidation precursor.  
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Figure 3. Retrosynthetic Analysis of 6-deoxyerythronolide B 
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Our retrosynthetic approach to 6-dEB focused on C13 oxidation/macrocyclization to forge 
the macrolide core, which when fully saturated, presents a formidable chemoselectivity 
challenge. We therefore envisioned selective oxidation at C13, in preference to multiple tertiary 
and ethereal C–H bonds, through use of a C14-C15 vinyl moiety (Figure 3).14 Towards this goal, 
we recently developed a palladium(II)/bis-sulfoxide catalyzed allylic C–H macrolactonization 
reaction that converts simple linear alkenoic acids directly into 14- to 19-membered 
macrolactones with excellent levels of chemo- and regioselectivity (Figure 4).15 While this C–H 
oxidative macrolactonization reaction did proceed with high levels of chemo- and 
regioselectivity on simple alkenoic acid substrates, it led to low levels of diastereocontrol (<3:1 
d.r.) at the site of oxidation on all substrates examined. Strategic application of this reaction at a 
late stage of a target-oriented synthesis hinges on a stereochemically predictive model for C–O 
bond formation during a global topological change (i.e. macrocyclization). Elegant examples of 
diastereoselective C–H oxidations in complex molecular settings have relied on the local 
topology of rigid, cyclic architectures to predict and control diastereomeric outcomes.16 Albeit 
effective in these contexts, this conceptual framework cannot be used for predicting 
Figure 4. C–H Oxidative Macrolactonization Methodology 
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stereochemical outcomes with flexible, acyclic compounds, thus necessitating an alternative 
approach. 
 
Oxidative C–H macrolactonization is thought to proceed via an initial PdII/phenylbis-
sulfoxide (1) promoted allylic C–H cleavage event to generate a π-allylPd(carboxylate) 
intermediate (II, Figure 5A). Based on previous mechanistic studies, the palladium is thought to 
coordinate both the π-allyl and carboxylate functionality of the same molecule (i.e. chelated).15,17 
Furthermore, deuterium isomerization studies reveal that an alkenoic acid substrate labelled with 
a (Z)-deuterium is isomerized over the course of macrocyclization, giving rise to a 1:1 E:Z 
deuterium product ratio (Figure 5B).14 This isomerization event indicates that the π-
allylPd(carboxylate) species rapidly interconverts via a π−σ−π isomerization mechanism, 
allowing palladium to survey both faces of the π-allyl regardless of which diastereotopic allylic 
hydrogen is initially cleaved. Subsequent association of the π-acid 1,4-benzoquinone (BQ) 
promotes a stereodetermining C–O bond-forming event within the coordination sphere of the 
metal (III) to provide the branched allylic macrolide product.18 BQ then reoxidizes the resulting 
Pd(0) species (IV) back to Pd(II), regenerating the C–H cleavage catalyst and closing the 
catalytic cycle. 
Figure 5. Proposed Mechanism of C–H Oxidative Macrolactonization 
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Figure 6. Molecular Modeling Studies 
 
Figure adapted from reference 14 
 
Assuming the π-allylPd(carboxylate) intermediates closely resemble the products, we 
anticipated that such palladium chelation would lead to transition structures with product-like 
transannular character, and thus the stereochemical outcome of macrolactonization could be 
predicted using the relative ground state product energies. Based on molecular modeling studies, 
macrolide 4 was found to be 3 kcal/mol more stable than 5 (MMFF94 force fields) due, in part, 
to a pseudo-equatorial disposed exocyclic vinyl moiety (Figure 6).14 We anticipated that chelate-
controlled C–H macrolactonization would therefore strongly favor formation of the natural 
epimer. Furthermore, disrupting the chelation event could provide a different stereochemical 
outcome by generating an earlier transition state with very little transannular character.  
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1.2 RESULTS AND DISCUSSION 
1.2.1 Synthesis of the Alkenoic Acid Cyclization Precursor 
Figure 7. Synthesis of Aldol Adduct 11 
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NH3BH3 (4.0 equiv.), LDA (4.0 equiv.), 0°C, 98% (c) oxalyl chloride (1.3 equiv.), NEt3 (5.0 equiv.), DMSO 
(1.6 equiv.), -78°C (d) 8 (1.0 equiv.), Bu2BOTf (1.2 equiv.), i-Pr2NEt (1.4 equiv.), -78°C, >20:1 d.r., 55% 
over 2-steps (e) AlMe3 (5.0 equiv.), (MeO)NHMe-HCl (5.0 equiv.), -10°C, 86% (f) PMBBr (1.8 equiv.), 
NaH (1.8 equiv.), 0°C, 96% (g) Dibal-H (2.0 equiv.), -78°C, 91% (h) 10 (1.0 equiv.), Bu2BOTf (1.2 equiv.), 
NEt3 (1.2 equiv.), -78°C, >20:1 d.r., 96%. 
 
Our study commenced with construction of a versatile, linear C–H oxidation precursor 
using a series of powerful polyketide synthase (PKS)-inspired, stereoselective aldol- and 
alkylation reactions in a linear, iterative fashion.14 Towards the goal of minimizing the total 
oxygen content, a relatively inert allyl moiety, acting as a latent allylic alcohol, was installed 
during the first step of the synthetic route via Myers’ diastereoselective alkylation19 (6 → 7, 
>20:1 d.r.), and carried through the entire linear polypropionate synthesis without manipulation 
(Figure 7). Conversion of the pseudoephedrine-based amide 7 to an aldehyde, followed by a syn 
Evans’ aldol reaction20 with norephedrine-based auxiliary 8 provided aldol product 9 in good 
yield and selectivity (>20:1 d.r.). A Weinreb amide was next installed so as to prevent a retro-
aldol reaction under the basic (NaH) p-methoxybenzylidene (PMB) protection conditions. After 
mono-reduction of the Weinreb amide with DIBAL-H to give an aldehyde, a subsequent syn 
Evans’ aldol reaction with auxiliary 10 secured adduct 11 with good yield and >20:1 d.r. With 
assistance from the C9 hydroxyl group, reductive cleavage of the oxazolidinone auxiliary 
proceeded smoothly with LiBH4 (11 →  12, Figure 8). However, in the presence of the free 
 8 
primary alcohol, DDQ promoted oxidative cyclization provided a 1:1 mixture of the desired 
PMB-acetal product (13) along with rearranged pyran byproduct (14), resulting from 
displacement of the C11 oxygen with the primary hydroxyl group. After unsuccessful attempts to 
alter this product selectivity, aldol adduct 11 was first subjected to DDQ promoted ketalization  
Figure 8. Unexpected Rearrangement for Pyran Formation 
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conditions,21 securing the PMB acetal product (15) cleanly in >20:1 d.r. (Figure 9). Reductive 
cleavage of the auxiliary could then be effected with LAH at -60°C (15 →  13). Without 
assistance from the free C9 hydroxyl group, the low reaction temperature proved to be critical for 
selective hydride addition to the desired imide carbonyl over opening of the oxazolidinone. 
Straightforward conversion to the primary iodide, followed by a Myers’ alkylation reaction to set  
Figure 9. Alkenoic Acid 20 Synthesis: β-Keto Imide Aldol Coupling 
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(1.2 equiv.), I2 (1.4 equiv.), imidazole (1.5 equiv.), 94% (d) 6 (2.1 equiv.), LDA (4.0 equiv.), LiCl (12.7 equiv.), 
0°C, >20:1 d.r., 94% (e) NH3BH3 (4.0 equiv.), LDA (4.0 equiv.), 0°C, 99% (f) DMP (1.6 equiv.), 96% (g) 18 (1.5 
equiv.), TiCl4 (1.6 equiv.), NEt3 (1.6 equiv.), -78°C, 7:1 d.r., 49%. 
 
 9 
the C6 stereogenic center (16), and a reduction-oxidation sequence provided 17 as a sole 
diastereomer. At this juncture, a β-keto imide (18) derived enolate would provide the 
dipropionate unit needed to complete the alkenoic acid synthesis. Standard generation of a 
titanium(IV) enolate using TiCl4 led to modest coupling yields and selectivities (49%, 7:1 d.r.), 
with significant epimerization at C2 along with competitive removal of the PMB acetal. 
Gratifyingly, we found that the use of Ti(Oi-Pr)Cl3 Lewis acid, thought to generate a more  
Figure 10. Completion of Alkenoic Acid 20 Synthesis 
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d.r., 88% (b) Zn(BH4)2 (1.6 equiv.), -78°C, >20:1 d.r., 75-86% (c) CSA (cat.), 2,2-dimethoxypropane (9.8 
equiv.), 84% (d) LiOOH(aq) (2.0 equiv.), 0°C, 99%. 
 
nucleophilic enolate,22 provided the necessary syn-syn aldol adduct 19 in good yield (88%) and 
selectivity (95:5 d.r.), with no epimerization at C2 and minimal PMB acetal cleavage (Figure 
10). Chelate-controlled reduction with Zn(BH4)2 (>20:1 d.r.), followed by ketalization and chiral 
auxiliary hydrolysis, completed the synthesis of alkenoic acid 20 in 18 steps and 18% overall 
yield. Furthermore, all but the last step (steps 1-17) were performed on a gram-scale, providing 
ample quantities of material to test the C–H oxidative macrolactonization reaction.14  
 
1.2.2 C–H Oxidative Macrolactonization Reactions 
With the linear oxidation precursor (20) in hand, we were poised to investigate whether 
late-stage C–H macrolactonization would proceed with the predicted levels of selectivity. Initial 
macrolactonization attempts, under the previously reported conditions, led to sluggish conversion  
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Table 1. Optimization of the C–H Oxidative Macrolactonization Reactiona 
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O O
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additivefconcentration
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6
7e
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8e 0.005
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S S PhPh
OO
Pd(OAc)2
(mol %)
AcOH
<10
22
55
92
64
23
9
15
<5
11
34
56
21
1
 
a Reaction conditions: 20 (1.0 equiv.), BQ (2.0 equiv.), CH2Cl2, 45°C, 72 hr  b 
Formed using in situ protocol c Calculated based on recovered starting material d 
Isolated yield e BQ (2.0 equiv.) added after 36 hr and allowed to stir for an 
additional 24 hr. f 80 mol% g Recovered starting material recycled through the 
reaction twice under conditions found in entry 3. 
 
with only trace product formation (entry 1, Table 1). Stoichiometric palladium studies indicated 
that the C–H cleavage step proceeded to generate the desired π-allylPd complex, albeit at a slow 
rate, while functionalization occurred as expected. In order to improve the reactivity of the C–H 
cleavage step, the oxidative lactonization was optimized around catalyst loadings and reaction 
concentration, as well as adding Brønsted acid additives. Increased catalyst loadings led to 
higher starting material conversions (entries 2-6), but loadings above 30mol% resulted in 
significant intermolecular functionalization and thus low product yields (entries 7,8). Similarly, 
increasing the reaction concentration greatly improved reactivity (entries 3-7), but also 
diminished product formation above 0.02 M (entries 5,7). Interestingly, the addition of Brønsted 
acids, such as AcOH, thought to increase the rate of C–H cleavage, actually diminished 
reactivity (entry 6). In the end, increasing the catalyst loading (10 to 30 mol %) and 
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concentration (0.01 M to 0.02 M) provided the best results, affording the 14-membered 
macrolide in 34% yield (45% rSM, entry 3). Consistent with predictions made using the chelate-
controlled model, only the desired C13 diastereomer (4) was detectable by 1H NMR of the crude 
reaction mixture (>20:1 d.r.). Furthermore, formation of 5 (vide infra) enabled determination of 
the diastereoselectivity by HPLC analysis (>40:1 d.r.). The mass balance of this reaction 
indicates that the reaction is highly selective for C13 oxidation. By recycling this valuable 
starting material through the reaction twice, we obtained diastereomerically pure macrolide 4 in 
56% isolated yield (8% rSM, entry 4). The macrocyclization event presented here constitutes a 
rare example of a highly regio-, chemo-, and stereoselective C–H oxidation at a late-stage of a 
complex molecule synthesis.14 
Figure 11. Non-chelated C–H Oxidative Macrolactonization Reaction 
O O
PMP
OOO
HO 13 TBAF (30 mol%)
BQ, 45!C
(44% + 36% rSM
2x recycles)
O
O
O
O
O
O
PMP H
13
+O
O
O
O
O
O
PMP H
13
1.3:1 d.r.
S S PhPh
OO
Pd(OAc)2
(30 mol%)
20
1
4 5  
Conditions: 1 (30 mol%), BQ (2.0 equiv.), TBAF (0.3 equiv.), CH2Cl2 (0.02 M), 45°C, 72 h, 
1.3:1 d.r., 20% + 75% rSM (44% + 36% rSM, 2x recycle). 
 
In attempts to alter the stereochemical outcome of C–H macrolactonization, we aimed to 
disrupt the palladium chelation event believed to be responsible for the diastereoselectivity.23 
Addition of fluoride anion to π-allylPd complexes has been shown previously to enhance the rate 
of π-σ-π isomerization, presumably by interacting with a coordination site on palladium.24 We 
anticipated that such an additive would disrupt the π-allylPd(carboxylate) chelate to favor an 
outer-sphere C–O bond forming event. Consistent with this hypothesis, the addition of tetra-n-
butylammonium fluoride (TBAF)25 to the oxidative C–H macrolactonization reaction 
dramatically altered the stereoselectivity to furnish a separable mixture of C13 diastereomers 4 
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and 5 in useful quantities (20% + 75% rSM; 44% + 36% rSM, recycled 2X, 1.3:1 d.r., Figure 
11). Although the diastereoselectivity was not overturned, we were able to obviate the 3 kcal/mol 
energy preference for the natural epimer by switching the functionalization mechanism. Despite 
the potential for stereochemical analogues of erythromycin to display novel chemical and 
antibacterial properties, this is the first time that a stereochemical modification at the critical 
macrolide linkage has been reported.14 
 
1.2.3 Intermolecular C13 C–H Oxidation and Yamaguchi Macrolactonizations 
Figure 12. Intermolecular C–H Oxidation Reaction 
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OOO
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O
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O
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+
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R = p-NO2Bz
73%
(10 mol%)
S S PhPh
OO
Pd(OAc)2 1
21
22
23  
Conditions: 1 (10 mol%), BQ (2.0 equiv.), p-NO2BzOH (1.5 equiv.), 45°C, 72 h, 1:1 d.r., 
73% (combined) 
 
In order to probe the loss of stereocontrol upon addition of fluoride, we aimed to determine 
the intrinsic diastereoselectivity of C–H oxidation near the allyl moiety in the absence of 
transannular interactions. Performing our intermolecular (non-chelated) allylic C–H 
esterification18 reaction on imide 21 provided C13 p-nitrobenzoates 22 and 23 in 73% yield as a 
1:1 separable mixture of diastereomers (Figure 12). Notably, in the absence of transannular 
effects, no chiral information found in the polypropionate backbone was relayed to the site of 
oxidation. This result supports our hypothesis that C–O bond formation in the fluoride-controlled 
C–H macrolactonization protocol occurs through a non-chelated process.14 
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Figure 13. Yamaguchi Macrolactonization Studies 
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 (over 2 steps)
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O O
PMP
OOO
HO 13
OH
O O
PMP
OOO
HO 13
OH
22
23
a,b
a,b
c
c
97%
 (over 2 steps)
24
25
4
5  
Conditions: (a) LiOOH(aq) (2.0 equiv.), 0°C (b) K2CO3 (3.0 equiv.), MeOH, 97% 
over 2-steps (c) Cl3C6H2COCl (15.0 equiv.), i-Pr2NEt (20.0 equiv.), DMAP (40.0 
equiv.), Benzene (0.005 M), r.t., 87% (for 4). Figure adapted from reference 14. 
 
To further probe the origin of diastereoselectivity in the chelate-controlled C–H 
macrolactonization, we attempted to synthesize 4 and 5 through a classical acylation-based 
(Yamaguchi) macrolactonization,26 that, like the chelate-controlled C–H macrolactonization, is 
thought to proceed via a product-like transition state. Toward this end, late-stage intermolecular 
C13 C–H oxidation (vide supra) was critical for circumventing lengthy parallel de novo 
syntheses of each epimeric seco acid (24 and 25, Figure 13). As anticipated, Yamaguchi 
macrolactonization of hydroxyacid 24 led to an 87% yield of the natural epimer (macrolide 4).  
In contrast, attempted cyclization of 25 yielded oligomer as the exclusive reaction product.14 
These empirical cyclization results support our hypothesis that the origin of diastereoselectivity 
in the chelate-controlled C–H macrolactonization derives from product-like transition states 
where a greater kinetic barrier of cyclization prevents formation of the less stable epimer 
(macrolide 5).  
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1.2.4 Completion of 6-Deoxyerythronolide B and Attempted Synthesis of 13-epi-6-
Deoxyerythronolide B 
With the C13 stereocenter in place, concurrent hydrogenation of the PMB acetal and α-
olefin with Pearlman’s catalyst (Pd(OH)2/C), site-selective oxidation of the C9 alcohol,7 and 
acetonide removal completed the synthesis of 6-deoxyerythronolide B (Figure 14).14 Following 
peracetylation of 6-dEB, X-ray quality crystals of triacetate 26 were obtained, which confirmed 
the relative stereochemical assignments. In total, 6-dEB was synthesized in 22 steps and 7.8% 
overall yield, representing a highly efficient route to this classic target. This efficiency can be 
attributed, at least in part, to a C–H oxidative macrolactonization strategy that minimizes the 
number of reactive functional groups carried through the synthetic sequence. Instead, the final 
oxygen species was installed at a late-stage from an allylic C–H bond in the proper oxidation 
state, with the correct stereochemical configuration, all while forming the desired macrolide 
core. 
Figure 14. Completion of 6-deoxyerythronolide B 
OH
O
O
O
OH
OH
6-deoxyerythronolide B
a-c
96%
22 steps 
(7.8% overall yield, 85% avg. yield/step)
13
6
O
O
O
O
O
O
PMP H
13
9
79%
(over 3 steps)
d
4 26
 
Conditions: (a) Pd(OH)2/C (cat.), H2 (1 atm), i-PrOH, 96% (b) TPAP (cat.), NMO (5.0 equiv.), 0°C, 84% (c) 1M 
HCl(aq) (11.0 equiv.), 98% (d) Ac2O (93.0 equiv.), DMAP (cat.), Pyridine, 96%. Figure adapted from reference 14. 
 
Efforts to convert 5 into 13-epi-6-deoxyerythronolide B following the same protocol used 
to construct 6-dEB failed due to acid-catalyzed decomposition during the acetonide removal step 
involving hemiketal formation at C9 and subsequent dehydration to form an enol ether product. 
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Interestingly, while the uniform arrangement of catalytic domains in the polyketide synthases 
(PKSs) accounts for the substitution patterns found in the macrolide antibiotics, the evolutionary 
basis for “Celmer’s Rules” has not yet been elucidated.27,28 While it is generally considered that 
evolution of the structure of erythromycin was driven by its shape complementarity to the 
ribosome,29 the results presented here, along with the accepted low energy conformational 
models (i.e. “diamond-lattice”) for the erythromycin aglycones,5 raise the interesting question of 
a contributing chemical basis for the observed stereochemistry that is conserved throughout the 
polyketide macrolides. 
 
1.3 CONCLUSIONS 
In conclusion, C–H oxidative macrolactonization is demonstrated to be a novel approach 
for complex macrolide synthesis, as well as a rapid means of achieving stereochemical diversity 
at the key lactone position. Predictably high levels of substrate-based diastereocontrol are 
possible from advanced linear intermediates under cyclization conditions that proceed via 
palladium-induced templation. Moreover, conditions that break chelation remove this element of 
stereocontrol and enable access to an alternate diastereomer. This work highlights that 
predictably selective C–H oxidation methods can be strategically utilized at late-stages to 
increase the overall efficiency of target-oriented synthesis. Additionally, methods subject to 
reagent modulation can rapidly generate stereochemical divergency and may find use in 
diversity-oriented synthesis.30 
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1.4 EXPERIMENTAL SECTION 
General Information: Unless otherwise noted, all reactions were conducted in flame-dried 
glassware with magnetic stirring under an inert atmosphere of dry nitrogen. Solvents 
tetrahydrofuran (THF), diethyl ether (Et2O), N,N-dimethylformamide (DMF), methanol 
(MeOH), Dimethyl Sulfoxide (DMSO), 1,4-dioxane, benzene, and methylene chloride (CH2Cl2) 
were purified prior to use by passage through a bed of activated alumina (Glass Contour, Laguna 
Beach, California). Deuterochloroform was stored over 3 Å molecular sieves. 
Diisopropylethylamine (DIPEA), triethylamine (TEA), diisopropylamine (DIPA), and pyridine 
were distilled from calcium hydride. The following commercially obtained reagents were used as 
received: propionyl chloride (Sigma-Aldrich), Bu2BOTf (Fluka, 1M in CH2Cl2), Borane-
ammonia complex (Sigma-Aldrich, 90%), H2O2 (Fisher Scientific, 30% wt solution), 1,4-
benzoquinone (Sigma-Aldrich), Pd(OH)2/C (Sigma-Aldrich, 20 wt %, lot # - PZ 14221JZ). 
 Propionaldehyde was purified using a Kugelrohr distillation apparatus prior to use. n-
butyllithium in hexanes (Sigma-Aldrich, 2.5M) was titered using No-D NMR spectroscopy with 
1,5-cyclooctadiene (Sigma-Aldrich) as the internal standard.31 LiCl (Sigma-Aldrich) was stored 
under an inert atmosphere of Argon and flame dried immediately prior to use. Allyl iodide 
(Sigma-Aldrich) was passed through a plug of basic alumina prior to use. Oxalyl Chloride 
(Sigma-Aldrich), titanium tetraisopropoxide (Sigma-Aldrich), and titanium tetrachloride (Sigma-
Aldrich) were distilled prior to use. Triphenylphosphine was recrystallized from ethanol and 
stored under Ar. Pd(OAc)2 (Johnson-Matthey Chemicals) was recrystallized prior to use [see 
‘Pd(OAc)2 Recrystallization’ section]. 
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 Optical rotations were measured using a 1 mL cell with a 1dm path length on a Perkin-
Elmer 341 polarimeter. Optical rotations were obtained with a sodium lamp and are reported as 
follows: [α]λ
T°C (c = g/100 mL, solvent). Infrared spectra were recorded as thin films on NaCl 
plates on a Mattson Galaxy Series FTIR 5000 and are reported in frequency of absorption (cm-1). 
High-resolution mass spectra were obtained through the Mass Spectrometry Laboratory, School 
of Chemical Sciences, University of Illinois. Electrospray ioniztion (ESI) spectra were 
performed on a Waters Q-Tof Ultima spectrometer. 1H NMR spectra were recorded on a Varian 
Unity-400 (400 MHz) or Varian Unity-500 (500 MHz) spectrometer and are reported in ppm 
using solvent as an internal standard (CDCl3 at 7.26 ppm).  Data reported as: s = singlet, d = 
doublet, t = triplet, q = quartet, quint = quintet, oct = octet, m = multiplet, br = broad, app = 
apparent; coupling constant(s) in Hz; integration. Proton-decoupled 13C-NMR spectra were 
recorded on a Varian Unity-400 (100 MHz) or Varian Unity-500 (125 MHz) spectrometer and 
are reported in ppm using solvent as an internal standard (CDCl3 at 77.0 ppm). HPLC analysis 
was performed on an Agilent 1100 Series instrument. Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized with UV, 
potassium permanganate, and ceric ammonium molybdate staining.  Flash column 
chromatography was performed as described by Still et al.32 using EM reagent silica gel 60 (230-
400 mesh). 
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Synthesis of Palladium Catalysts for C–H Oxidation Reactions 
 
Figure 15. Synthesis of Catalyst 1 
S S PhPh
OO
S S PhPh
H2O2
AcOH Pd(OAc)2
S S PhPh
OO
Pd(OAc)2
1  
 
Pd(OAc)2 Recrystallization: Pd(OAc)2 (Johnson-Matthey Chemicals) was dissolved in minimal 
refluxing benzene (~0.5 g Pd(OAc)2/8.0 mL benene).  A black precipitate was removed from the 
refluxing solution by Acrodisc® filtration.  The resulting solution was cooled to room 
temperature.  Amber crystals began to form after 15 min.  After 1 hr the solution was filtered to 
give the recrystallized Pd(OAc)2 as gold plates. The recrystallized Pd(OAc)2 was stored for 
months under an Ar atmosphere with no deleterious effects. A difference in NMR purity was 
noted between “old” and recrystallized Pd(OAc)2 samples.  Reported hydrogen values are 
normalized ratios of the smallest peak in the acetate region.  “Old” Pd(OAc)2: 1H NMR (500 
MHz, CDCl3) δ 2.17 (s, 1H), 2.10 (s, 3.6H), 2.07 (s, 6.1H), 2.06 (s, 6.1H), 2.03 (m, 15.3H), 2.00 
(m, 95.7H), 1.97 (s, 5.7H), 1.95 (s, 6.3), 1.89 (s, 9.4H). 
Recrystalized Pd(OAc)2: 1H NMR (500 MHz, CDCl3) δ 2.10 (s, 1H), 2.03 (s, 2.8H), 2.00 (s, 
40.1H), 1.97 (s, 1.2H), 1.90 (s, 2.3H).  
 
1,2-bis(phenylsulfinyl)ethane: A 50 mL round bottom flask was charged with a 
stir bar, 2 g (8.12 mmol, 1.0 equiv.) of 1,2-bis(phenylthio)ethane (Oakwood Products Inc.), and 
12.2 mL of glacial acetic acid.  A solution of H2O2 (Sigma-Aldrich, 50 wt%, 31.08 mmol, 2.114 
mL, 2.0 equiv.) in acetic acid (6.7 mL) was added dropwise at rt.  After approximately 15 min 
the solution became homogeneous and turned a pale yellow.  An additional 8 mL of acetic acid 
S S PhPh
OO
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was then added and the solution allowed to stir for 24 hrs at room temperature.  The acetic acid 
was removed with mild heating (45°C) under high vacuum. The pale yellow solid was emulsified 
in cold ethanol and cold filtered to yield a mixture of the meso and racemic 1,2-
bis(phenylsulfinyl)ethane in 92% yield (2.088 g). 
Recrystalization:  To a solution of refluxing acetone (~100 ml) was added the crude ligand 
mixture (~2 g).  Acetone was then added slowly to the mixture with reflux until all the powder 
dissolved.  The mixture was then allowed to cool to room temperature.  The solution was left at 
room temperature for an hour then cooled to 4°C overnight.  (IMPORTANT:  The meso 
recrystalizes out first as small white clumps and extended time is needed to allow the racemic 
long white needles to crystallize out.  The crystals were filtered off with a buchner funnel and 
rinsed with cold acetone.  For all reactions and catalyst preparations performed during this study, 
only the meso-1,2-bis(phenylsulfinyl)ethane ligand was used.) 
Meso-1,2-bis(phenylsulfinyl)ethane: 1H NMR (500 MHz, CDCl3) δ 7.56-7.52 (m, 10H), 3.05 (s, 
4H).  13C NMR (500 MHz, CDCl3) δ 142.29, 131.55, 129.63, 124.10, 47.06.  IR (neat) 3048.84, 
2970.01, 2922.41, 1442.10, 1036.34, 745.45, 695.70 cm-1  
Racemic-1,2-bis(phenylsulfinyl)ethane: 1H NMR (500 MHz, CDCl3) δ 7.51-7.48 (m, 10H), 3.40 
(m, 2H), 2.74 (m, 2H).  13C NMR (125 MHz, CDCl3) δ 142.55, 131.53, 129.64, 124.08, 47.94.  
IR (neat, cm-1) 3053.16, 2911.39, 1443.77, 1084.88, 1042.50, 748.52.  HRMS (ESI) m/z 
calculated for C14H14O2S2Na [M+Na]+: 301.0333, found 301.0320. 
 
Pd(II)/bis-sulfoxide Catalyst [1]: In-Situ Pd(II)/bis-sulfoxide Catalyst (1) 
Preparation for C–H Oxidative Macrolactonization: An oven dried 1 dram 
borosilicate vial (topped with a Teflon-lined cap) was charged sequentially with recrystallized 
S S PhPh
OO
Pd(OAc)2
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Pd(OAc)2 (2.9 mg, 0.0127 mmol, 0.3 equiv.), meso-1,2-bis(phenylsulfinyl)ethane (3.6 mg, 
0.0127 mmol, 0.3 equiv.), CH2Cl2 (142 µL), and a teflon stir bar. The 1 dram vial was then 
stirred for 12 hours in 40°C bath, at which time a clear bright red solution resulted. Note: The 
following precautions were taken to avoid moisture: recrystallized Pd(OAc)2 was stored under an 
atmosphere of Ar (glove box), and meso-1,2-bis(phenylsulfinyl)ethane and the stir bar were 
stored in a dessicator. The reagents were added quickly to the 1 dram vial on a benchtop balance. 
 Pre-complexed Pd(II)/bis-sulfoxide Catalyst (1) Preparation for Intermolecular C–H Oxidation: 
A flame dried 250 mL flask was charged with meso-1,2-bis(phenylsulfinyl)ethane (2.53 g, 9.1 
mmol, 1.0 equiv.), CH2Cl2 (101 mL, 0.09 M), and recrystallized Pd(OAc)2 (2.04 g, 9.1 mmol, 
1.0 equiv.).  The mixture was stirred at 40°C for 24h.  The reaction becomes a dark red 
homogenous solution.  The solution was concentrated in vacuo to incomplete dryness, and then 
fully dried under a stream of N2 for 24 hours to give a dark red solid used without further 
purification.  Note: The catalyst must be stored at below 4oC.  The catalyst very slowly 
decomposes at ambient temperature; however, may be stored for prolonged periods (months) at 
reduced temperatures.  1H NMR and IR data of this catalyst looks like meso-1,2-
bis(phenylsulfinyl)ethane ligand and Pd(OAc)2.  
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Deuterium Isomerization Study for Figure 5 
 
Figure 16. Deuterium Isomerization Study 
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dec-9-yn-1-ol: The title compound was prepared using a known 
procedure: A flame-dried 100 mL round bottom flask was charged 
with NaH (0.408 g, 17.0 mmol, 8.0 equiv.) and diaminopropane (15 mL). The solution was 
topped with a reflux condenser and stirred at 70°C for 1 hr, or until the evolution of gas ceased 
and a cloudy tan solution resulted. The reaction was cooled to r.t. and a solution of dec-2-yn-1-ol 
(0.388 mL, 2.15 mmol, 1.0 equiv.) in diaminopropane (8 mL) was added via syringe. The brown 
reaction mixture was then placed in a 55°C bath and stirred for 17 hrs. At this time the reaction 
was cooled, diluted with Et2O (10 mL) and quenched slowly with H2O (10 mL). The layers were 
separated, and the aqueous was extracted with Et2O (4 x 10 mL). The combined organic layers 
were washed with H2O (1 x 10 mL), 1 M HCl (1 x 10 mL), and satd brine (1 x 10 mL), then 
dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. This crude oil was 
passed through a short Si plug to remove any residual H2O with 20% EtOAc/Hex, and 
concentrated in vacuo to afford the clean title compound (0.2985 g, 1.935 mmol, 90%). 
 1H NMR (500 MHz, CDCl3) δ 3.64 (app q, J = 5.7 Hz, 2H), 2.18 (dt, J = 2.5, 7.0 Hz, 2H), 
1.94 (t, J = 2.5 Hz, 1H), 1.49-1.59 (m, 4H), 1.31-1.43 (m, 8H), 1.19-1.25 (m, 1H). 
 
HO
H
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10-D-dec-9-yn-1-ol: A flame-dried 25 mL round bottom flask was 
charged with dec-9-yn-1-ol (0.2985 g, 1.935 mmol, 1.0 equiv.) and 
THF (3.87 mL, 0.5 M) and cooled to -78°C. At this time, nBuLi (2.5 M, 1.93 mL, 4.84 mmol, 
2.5 equiv.) was syringed into reaction dropwise, resulting in an orange solid. The reaction was 
allowed to warm to 0°C and the heterogenous orange solution was stirred for 1 hr, at which time 
D2O (5 mL) was added dropwise. The resulting clear orange solution was stirred for 2 hrs, then 
poured into a separatory funnel containing satd NH4Cl (20 mL) and Et2O (20 mL). The layers 
were separated, and the aqueous was extracted with Et2O (2 x 10 mL). The combined organic 
layers were dried over MgSO4, filtered through a silica plug, and concentrated in vacuo to afford 
a clear oil (0.2922 g, 1.87 mmol, 97%, >20:1 D:H incorporation by 1H NMR analysis). 
 1H NMR (400 MHz, CDCl3) δ 3.64 (app q, J = 6.0 Hz, 2H), 2.18 (t, J = 7.2 Hz, 2H),1.50-
1.58 (m, 4H), 1.33-1.43 (m, 9H). 
 
10-(Z)-D-9-decen-1-ol: A flame-dried 50 mL round bottom flask was 
charged with Cp2Zr(H)Cl (0.868 g, 3.366 mmol, 1.8 equiv.) and THF 
(7.56 mL) to produce a gray slurry. A solution of 10-D-dec-9-yn-1-ol (0.2922 g, 1.870 mmol, 1.0 
equiv.) in THF (4.1 mL) was cannulated into the slurry, resulting in a yellow bubbling solution. 
After 35 min, the brown reaction solution was quenched with satd NH4Cl (10 mL) and diluted 
with Et2O (10 mL). The layers were separated, and the aqueous was extracted with Et2O (1 x 10 
mL). The combined organic layers were washed with satd NaHCO3 (1 x 10 mL), H2O (1 x 10 
mL), dried over MgSO4, filtered, and concentrated in vacuo to afford a yellow oil with insoluble 
white solids. This crude reaction product was passed through a short silica plug with 20% 
HO
D
HO
D
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EtOAc/Hex, and concentrated in vacuo to afford the clean title compound as a yellow oil (0.2774 
g, 1.76 mmol, 94%, >20:1 Z:E by 1H NMR analysis). 
 1H NMR (500 MHz, CDCl3) δ 5.80 (m, 1H), 4.92 (d, J = 10.0 Hz, 1H), 3.64 (app q, J = 6.3 
Hz, 2H), 2.04 (m, 2H),1.54-1.59 (m, 2H), 1.26-1.39 (m, 10H). 
 
D-(Z)-alkenoic acid [2]: A 50 mL round bottom flask was charged with 10-
(Z)-D-9-decen-1-ol (0.2774 g, 1.76 mmol, 1.0 equiv.), DCM (8.39 mL, 0.21 
M), phthalic anhydride (0.274 g, 1.85 mmol, 1.05 equiv.), NEt3 (0.368 mL, 
2.65 mmol, 1.5 equiv.), and DMAP (53.8 mg, 0.44 mmol, 0.25 equiv.) and let stir for 12 hrs. The 
reaction was then poured into a separatory funnel containing 1 M HCl (10 mL) and DCM (10 
mL). The organic layer was washed with 1 M HCl (3 x 10 mL), H2O (1 x 10 mL), dried over 
MgSO4, filtered, and concentrated in vacuo to afford a yellow oil. Purification by flash 
chromatography (20% EtOAc/hexanes + 1% AcOH) furnished D-(Z)-alkenoic acid 2 as a yellow 
oil (0.457 g, 1.497 mmol, 85%). 
 1H NMR (500 MHz, CDCl3) δ 7.94 (m, 1H), 7.73 (m, 1H), 7.60 (m, 2H), 5.78 (m, 1H), 
4.90 (d, J = 10.5 Hz, 1H), 4.33 (t, J = 7.0 Hz, 2H), 2.01 (m, 2H), 1.71-1.77 (m, 2H), 1.23-1.43 
(m, 10H). 
 
D-(E+Z)-Macrolides [3]: In-Situ Pd(II)/bis-sulfoxide Catalyst (1) Preparation 
for C–H Oxidative Macrolactonization: An oven dried 1 dram borosilicate vial 
(topped with a Teflon-lined cap) was charged sequentially with recrystallized 
Pd(OAc)2 (4.48 mg, 0.02 mmol, 0.1 equiv.), meso-1,2-bis(phenylsulfinyl)ethane 
O
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O
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(5.56 mg, 0.02 mmol, 0.1 equiv.), CH2Cl2 (0.22 mL), and a teflon stir bar. The 1 dram vial was 
then stirred for 12 hours in 40°C bath, at which time a clear bright red solution resulted. 
C–H Oxidative Macrolactonization: The freshly prepared catalyst (1) batch in a 1 dram vial was 
transferred to a 40 mL scintillation vial via pipette using DCM (5 mL). This vial was charged 
with 1,4-benzoquinone (43.2 mg, 0.4 mmol, 2.0 equiv.). D-(Z)-alkenoic acid 2 (60.9 mg, 0.2 
mmol, 1.0 equiv.) was then dissolved/transferred (via pipette) to the 40 mL scintillation vial 
using CH2Cl2 (14.78 mL) and the reaction was topped with a Teflon-lined cap. This orange 
solution was stirred in a 45°C bath 72 hrs. The resulting dark brown reaction was cooled to r.t. 
and transferred to a separatory funnel with CH2Cl2, where it was quenched with satd NH4Cl (20 
mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 20 mL). 
The combined organic layers were then dried over MgSO4, filtered, and concentrated in vacuo to 
afford a yellow oil. 1H NMR analysis of the crude product showed a 1:1 E:Z ratio. Purification 
by flash chromatography (10% EtOAc/hexanes) furnished D-(E+Z)-macrolides 3 as an 
inseparable equal mixture of E:Z isomers as a clear oil (33.7 mg, 0.111 mmol, 56%).  
 1H NMR (500 MHz, CDCl3) δ 7.73-7.75 (m, 4H), 7.51-7.56 (m, 4H), 5.90-5.94 (m, 2H), 
5.66-5.69 (m, 2H), 5.33 (d, J = 17.0 Hz, 1H), 5.19 (d, J = 10.5 Hz, 1H), 4.72-4.76 (m, 2H), 3.99-
4.03 (m, 2H),  1.70-1.83 (m, 6H), 1.44-1.64 (m, 11H), 1.30-1.39 (m, 7H). 
 
 
This same procedure was performed using the “C–H Oxidative Macrolactonization +TBAF” 
protocol, where TBAF (9.4 mg, 0.03 mmol, 0.15 equiv.) was also added to the reaction, and gave 
similar results (27.9 mg, 0.092 mmol, 46%, 1:1 E:Z ratio). 
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Synthesis of the Linear Macrocyclization Precursor for Figures 7-10 
 
N-((1-R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpropionamide [6]: A 
flame-dried 250 mL round bottom flask was sequentially charged with (1R, 2R)-
(-)-Pseudoephedrine (Sigma-Aldrich, 10 g,  60.5 mmol, 1.0 equiv.), CH2Cl2 (110 mL,  0.55 M),  
NEt3 (9.26 mL, 66.57 mmol, 1.1 equiv.), propionic anhydride (Sigma-Aldrich, 8.34 mL, 64.75 
mmol, 1.07 equiv.). The reaction mixture was allowed to stir for 1.5 hours. The reaction was 
quenched with a saturated aqueous solution of NaHCO3 (75 mL). The layers were separated and 
the organic layer was washed sequentially with saturated NaHCO3 (1 x 50 mL), 1M HCl (2 x 30 
mL), brine (1 x 50 mL). Organic layer was dried over MgSO4, filtered, and concentrated in 
vacuo. The crude white solid was dissolved in refluxing toluene (18 mL), and allowed to cool 
overnight in a -20°C refrigerator. Upon recrystallization of a white solid, the supernatant was 
removed by decantation. The white crystals were dried under vacuum to yield the Myers’ 
auxiliary 6 (12.67 g, 57.25 mmol, 95%). 
 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3) δ 
7.27-7.39 (m, 5H), 4.56-4.61 (m, 1H), 4.43 (m, 1H), 4.31 (br s, 1H), 4.01* (m, 1H), 2.93* (s, 
3H), 2.81 (s, 3H), 2.54* (m, 2H), 2.40* (m, 2H), 2.31 (m, 2H), 1.17* (t, J = 7.0 Hz, 3H), 1.13 (t, 
J = 7.5 Hz, 3H), 1.12 (d, J = 7.5 Hz, 3H), 0.98* (d, J = 6.5 Hz, 3H). [α]D23 = -100o (c = 0.57, 
methanol). Note that this spectroscopic data is in full agreement with a previous literature 
report.33 
 
(S)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N,2-dimethylpent-4-
enamide [7]: A flame dried 500 mL round bottom flask under Ar was 
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charged with LiCl (11.49 g, 271.12 mmol, 6.0 equiv.) and flame-dried vigorously. The reaction 
flask was then charged sequentially with THF (54 mL) and diisopropylamine (14.25 mL, 101.67 
mmol, 2.25 equiv.). The resulting suspension was cooled to -78°C, and a solution of n-
butyllithium in hexanes (2.56 M, 36.6 mL, 93.99 mmol, 2.08 equiv.) was added via syringe. The 
suspension was warmed to 0°C briefly then cooled to -78°C. An ice-cooled solution of Myers’ 
auxiliary 6 (10.0 g, 45.18 mmol, 1.0 equiv.) in THF (141 mL) was added to the reaction flask via 
cannula. The reaction mixture was stirred at -78°C for 1 h, 0°C for 15 min, room temperature for 
5 min, and finally cooled to -78°C, whereupon allyl iodide (98%, 6.3 mL, 67.78 mmol, 1.5 
equiv.) was added to reaction via syringe. The reaction was allowed to stir at -78°C for 2 h, 0°C 
for 30 min, and then quenched by the addition of saturated aqueous ammonium chloride solution 
(150 mL). The layers were partitioned and the aqueous layer was extracted with ethyl acetate (3 
x 200 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated in 
vacuo to afford an orange oil. 1H NMR analysis of the crude product showed a d.r. > 20:1. 
Purification by flash chromatography (35% EtOAc/hexanes) furnished amide 7 as a yellow oil 
(11.31g, 43.28 mmol, 96%). 
 1H NMR (4:1 rotamer ratio, asterisk denotes minor rotamer peaks, 400 MHz, CDCl3) δ 
7.24-7.38 (m, 5H), 5.78* (m, 1H), 5.69 (dddd, J = 17.2, 14.0, 10.0, 6.8 Hz, 1H), 5.10* (d, J = 
17.2 Hz, 1H), 5.02 (d, J = 17.2 Hz, 1H), 4.99 (d, J = 10.4 Hz, 1H), 4.60 (m, 1H), 4.42 (br s, 1H), 
4.07* (m, 1H), 2.91* (s, 3H), 2.86 (s, 3H), 2.68 (m, 1H), 2.51* (m, 1H), 2.35 (m, 1H), 2.16* (m, 
1H), 2.08 (m, 1H), 1.01-1.12 (m, 6H). Note that this spectroscopic data is in full agreement with 
a previous literature report.34 
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 (4R,5S)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one [8]: A flame dried 
500 mL round bottom flask under Ar was charged with (4R,5S)-(+)-4-Methyl-5-
phenyl-2-oxazolidinone (Sigma-Aldrich, 15.183 g, 85.68 mmol, 1.0 equiv.) and 
THF (248 mL, 0.346 M). The reaction was cooled to -78°C and a solution of n-butyllithium in 
hexanes (2.45 M, 34.97 mL, 85.68 mmol, 1.0 equiv.) was added via syringe over 30 min. The 
resulting dark red solution was stirred for 15 min at -78°C. The reaction was then charged with 
propionyl chloride (8.4 mL, 95.96 mmol, 1.12 equiv.) and stirred for 1.5 hr. The reaction was 
quenched with satd K2CO3 (80 mL) and diluted with satd NaCl (40 mL) and EtOAc (100 mL) to 
achieve a homogenous solution. The layers were separated and the aqueous layer was extracted 
with EtOAc (3 x 60 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo to afford an orange oil. Purification by flash chromatography (linear 
gradient 15-20% EtOAc/hexanes) furnished N-propionyloxazolidinone 8 as a clear oil (18.91 g, 
81.05 mmol, 95%). 
 1H NMR (400 MHz, CDCl3) δ 7.29-7.44 (m, 5H), 5.67 (d, J = 7.2 Hz, 1H), 4.77 (app pent, 
J = 6.7 Hz, 1H), 2.96 (m, 2H), 1.18 (t, J = 7.6 Hz, 3H), 0.90 (d, J = 6.4 Hz, 3H). [α]D23 = +44.8o 
(c = 2.47, CH2Cl2). Note that this spectroscopic data is in full agreement with a previous 
literature report.35 
 
 (S)-2-methylpent-4-en-1-ol: A flame-dried 100 mL round bottom flask under Ar 
was charged with THF (17 mL) and diisopropylamine (2.82 mL, 20.15 mmol, 4.2 
equiv.). The reaction flask was cooled to -78°C and a solution of n-butyllithium in hexanes (2.56 
M, 7.49 mL, 19.19 mmol, 4.0 equiv.) was added via syringe. The reaction temperature was 
maintained at -78°C for 10 min and then 0°C for 10 min. Solid Borane-ammonia complex (90%, 
O
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0.658 g, 19.19 mmol, 4.0 equiv.) was then added to the reaction mixture, and a vigorous 
evolution of gas ensued. After stirring for 15 min at 0°C, the reaction was warmed to room 
temperature for 15 min, then finally recooled to 0°C, where a solution of amide 7 (1.25 g, 4.79 
mmol, 1.0 equiv.) in THF (15 mL) was cannulated in the reaction mixture using THF (3 mL) to 
quantitate the transfer. The reaction was warmed to room temperature, let stir for 1 hr, and then 
quenched by the cautious addition of 1M HCl (50 mL) and allowed to stir for 30 min. The layers 
were separated and the aqueous layer was extracted with Et2O (4 x 20 mL). The combined 
organic layers were washed successively with 1M HCl (1 x 20 mL), 1M NaOH (1 x 20 mL), and 
brine (1 x 40 mL). The organic layer was then dried over MgSO4, and concentrated in vacuo 
(cold, under reduced vacuum) to afford a clear oil. Purification by flash chromatography (40% 
Et2O/pentane) furnished the alcohol product as a clear oil (0.470 g, 4.694 mmol, 98%). 
 1H NMR (400 MHz, CDCl3) δ 5.81 (ddt, J = 17.2, 10.0, 7.2 Hz, 1H), 5.02 (m, 2H), 3.50 
(m, 2H), 2.17 (m, 1H), 1.94 (m, 1H), 1.73 (octet, J = 6.8 Hz, 1H), 1.37 (t, J = 6.0 Hz, 1H), 0.92 
(d, J = 6.8 Hz, 3H). [α]D23 = -2.2o (c = 1.5, CHCl3). Note that this spectroscopic data is in full 
agreement with a previous literature report.36 
 
 (4R,5S)-3-((2R,3S,4S)-3-hydroxy-2,4-dimethylhept-6-enoyl)-4-methyl-5-
phenyloxazolidin-2-one [9]:  A flame-dried 500 mL round bottom flask under 
Ar was charged with CH2Cl2 (48.0 mL) and oxalyl chloride (3.91 mL, 44.80 
mmol, 1.27 equiv.) and cooled to -78°C. A solution of DMSO (4.01 mL, 56.50 
mmol, 1.60 equiv.) in CH2Cl2 (9.7 mL) pre-cooled to -78°C was cannulated into oxalyl chloride 
solution and evolution of gas occurred. Reaction was stirred stir for 1 hr at -78°C, then a solution 
of (S)-2-methylpent-4-en-1-ol (3.537 g, 35.31 mmol, 1.0 equiv.) in CH2Cl2 (8.7 mL) was 
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cannulated into the reaction flask using CH2Cl2 (1 mL) to quantitate the transfer. The reaction 
was stirred for 2.5 hr at -78°C when NEt3 (24.6 mL, 176.5 mmol, 5.0 equiv.) was syringed into 
reaction flask, which was subsequently allowed to warm to room temperature. The reaction was 
quenched upon the addition of 1M KH2PO4 solution (60 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (1 x 15 mL). The combined organic layers were 
washed with brine (1 x 40 mL) and the organic layer was dried over Na2SO4 and filtered into a 
flame-dried 250 mL round bottom flask containing activated 4Å molecular sieves. The crude 
aldehyde solution was used directly without further concentration or purification. 
 A flame-dried 1 L round bottom flask under Ar was charged sequentially with N-
propionyloxazolidinone 8 (8.23 g, 35.31 mmol, 1.0 equiv.), CH2Cl2 (100 mL), and iPr2NEt (8.30 
mL, 47.7 mmol, 1.35 equiv.) and cooled to 0°C. The reaction flask was then charged with 
Bu2BOTf (1 M in CH2Cl2, 42.3 mL, 42.3 mmol, 1.2 equiv.) and let stir at 0°C for 1 hr, then 
cooled to -78°C. The crude aldehyde solution, pre-cooled to -78°C, was cannulated into the 
reaction flask using CH2Cl2 (17 mL) to quantitate the transfer and let stir at -78°C for 1.5 hr, then 
warmed to room temperature and stirred for 1 hr. The reaction was then quenched with the 
addition of 1M KH2PO4 solution (60 mL). The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 x 60 mL). The combined organic layers were concentrated in vacuo to 
incomplete dryness and the slurry was dissolved in MeOH (65 mL), put in a 0°C bath, and 
charged cautiously with H2O2 (30% wt solution, 98 mL). The product mixture was allowed to 
stir at room temperature for 1 hr and then diluted with brine (100 mL). The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (3 x 60 mL), the organic layers were then 
combined and dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. 1H 
NMR analysis of the crude product showed a d.r. > 20:1. Purification by flash chromatography 
 30 
(22% EtOAc/hexanes) followed by recrystallization in refluxing 22% EtOAc/cyclohexane (15 
mL) furnished aldol adduct 9 as white needles (6.4835 g, 19.564 mmol, 55% over 2 steps). 
 1H NMR (400 MHz, CDCl3) δ 7.36-7.45 (m, 3H), 7.29-7.32 (m, 2H), 5.83 (dddd, J = 17.0, 
10.0, 8.0, 6.0 Hz, 1H), 5.69 (d, J = 7.2 Hz, 1H), 5.07 (d, J = 17.0 Hz, 1H), 5.04 (d, J = 8.8 Hz, 
1H), 4.79 (quint, J = 6.8 Hz, 1H), 3.96 (dq, J = 7.0, 2.0 Hz, 1H), 3.65 (app dt, J = 9.3, 2.6 Hz, 
1H), 3.07 (d, J = 3.2 Hz, 1H), 2.51-2.57 (m, 1H), 1.93-2.00 (m, 1H), 1.65-1.73 (m, 1H), 1.22 (d, 
J = 6.8 Hz, 3H), 0.90 (d, J = 6.4 Hz, 6H). [α]D23 = +47o (c = 0.25, CHCl3). Note that this 
spectroscopic data is in full agreement with a previous literature report.37 
 
 (4S,5R)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one [10]: A flame dried 
500 mL round bottom flask under Ar was charged with (4S,5R)-(-)-4-Methyl-5-
phenyl-2-oxazolidinone (Sigma-Aldrich, 10.688 g, 60.32 mmol, 1.0 equiv.) and THF (174.3 mL, 
0.346 M). The reaction was cooled to -78°C and a solution of n-butyllithium in hexanes (2.5 M, 
24.13 mL, 60.32 mmol, 1.0 equiv.) was added via syringe over 30 min. The resulting dark red 
solution was stirred for 15 min at -78°C. The reaction was then charged with propionyl chloride 
(5.90 mL, 67.55 mmol, 1.12 equiv.) and stirred for 1.5 hr. The reaction was quenched with satd 
K2CO3 (60 mL) and diluted with satd NaCl (30 mL) and EtOAc (80 mL) to achieve a 
homogenous solution. The layers were separated and the aqueous layer was extracted with 
EtOAc (3 x 60 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo to afford a clear oil. Purification by flash chromatography (linear gradient 
15-20% EtOAc/hexanes) furnished N-propionyloxazolidinone 10 as a clear oil (13.367 g, 57.30 
mmol, 95%). 
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 1H NMR (500 MHz, CDCl3) δ 7.30-7.43 (m, 5H), 5.67 (d, J = 7.5 Hz, 1H), 4.77 (app pent, 
J = 6.8 Hz, 1H), 2.96 (m, 2H), 1.19 (t, J = 7.3 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H). [α]D23 = -55.0 o 
(c = 2.23, CH2Cl2). Note that this spectroscopic data is in full agreement with a previous 
literature report.38 
 
 (2R,3S,4S)-3-hydroxy-N-methoxy-N,2,4-trimethylhept-6-enamide: A flame 
dried 500 mL round bottom flask was charged with N,O-dimethylhydroxylamine 
hydrochloride (Sigma-Aldrich, 7.36 g, 73.96 mmol, 5.0 equiv.) and THF (74 
mL). The reaction flask was cooled to -10°C, and charged with AlMe3 (Sigma-Aldrich, 2 M in 
toluene, 37.1 mL, 74.11 mmol, 5.01 equiv.). An evolution of gas ensued and the reaction was 
stirred at -10°C for 15 min, room temperature 15 min, and then finally cooled to -10°C. Aldol 
adduct 9 (4.9027 g, 14.79 mmol, 1.0 equiv.) dissolved in THF (74 mL) was cannulated into 
reaction flask and allowed to warm to room temperature slowly while stirring for 12 hr. The 
reaction was quenched at -10°C with the cautious addition of saturated Rochelle’s salt (100 mL) 
and the resulting mixture was stirred vigorously for 4 hr. The layers were then separated and the 
aqueous layer was extracted with EtOAc (3 x 100 mL). The combined organic layers were 
washed with saturated NaHCO3 (1 x 50 mL), dried over MgSO4, filtered, and concentrated in 
vacuo to afford a yellow oil. Purification by flash chromatography (35% EtOAc/hexanes) 
furnished the 3-hydroxyheptenamide product as a yellow oil (2.732 g, 12.69 mmol, 86%).  
 1H NMR (500 MHz, CDCl3) δ 5.81 (dddd, J = 16.5, 10.0, 8.4, 6.0 Hz, 1H), 5.03 (d, J = 
18.3 Hz, 1H), 5.00 (d, J = 11.0 Hz, 1H), 4.07 (br, s, 1H), 3.69 (s, 3H), 3.50 (d, J = 9.5 Hz, 1H), 
3.19 (s, 3H), 3.08 (m, 1H), 2.55 (m, 1H), 1.92 (app dt, J = 13.7, 8.6 Hz, 1H), 1.66 (m, 1H), 1.13 
(d, J = 7.0 Hz, 3H), 0.82 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 178.6, 137.1, 116.2, 
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74.8, 61.5, 37.1, 35.4, 35.0, 31.8, 15.0, 9.4; IR (film, cm-1): 3453, 3075, 2970, 2936, 1640, 1460, 
994; HRMS (ESI) m/z calc’d for C11H21NO3Na [M + Na]+: 238.1419, found 238.1416; [α]D23 = 
+2.2o (c = 0.56, CHCl3). 
 
 (2R,3S,4S)-3-(4-methoxybenzyloxy)-N-methoxy-N,2,4-trimethylhept-6-
enamide: A flame-dried 25 mL round bottom flask was charged sequentially 
with the 3-hydroxyheptenamide (0.156 g, 0.725 mmol, 1.0 equiv.), DMF (0.3 M, 
2.42 mL), and 4-methoxybenzyl bromide (Sigma-Aldrich, 0.183 mL, 1.27 mmol, 1.75 equiv.). 
Reaction flask cooled to 0°C and charged with NaH (Sigma-Aldrich, 60 wt% dispersion in 
mineral oil, 48.1 mg, 1.203 mmol, 1.66 equiv.).  The reaction stirred for 1.5 hr and was then 
poured into a separatory funnel containing H2O (20 mL) and 50% Et2O/Pentane (20 mL). The 
layers were separated and the organic layer was washed with H2O (1 x 20 mL) and brine (1 x 20 
mL). The organic layer was dried over MgSO4, filtered, and concentrated in vacuo to afford a 
yellow oil. Purification by flash chromatography (20% EtOAc/hexanes) furnished the 3-(4-
methoxybenzoyloxy)heptenamide product as a yellow oil (0.2322 g, 0.6926 mmol, 96%). 
 1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 5.75 
(dddd, J = 16.8, 10.0, 8.0, 6.3 Hz, 1H), 5.00 (d, J = 17.0, 1H), 4.98 (d, J = 9.0 Hz, 1H) 4.54 (d, J 
= 10.5 Hz, 1H), 4.49 (d, J = 11.0 Hz, 1H), 3.80 (s, 3H), 3.68 (s, 3H), 3.60 (dd, J = 7.3, 4.3 Hz, 
1H), 3.19 (br, s, 4H), 2.37 (m, 1H), 1.87 (m, 1H), 1.67 (m, 1H), 1.24 (d, J = 7.0 Hz, 3H), 0.96 (d, 
J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 176.8, 159.1, 137.9, 130.9, 129.5, 115.7, 113.7, 
84.5, 74.7, 61.4, 55.2, 38.3, 36.7, 36.0, 32.3, 16.9, 13.8; IR (film, cm-1): 3075, 2964, 2935, 1661, 
1613, 1514, 1461, 1248; HRMS (ESI) m/z calc’d for C19H30NO4 [M + H]+: 336.2175, found 
336.2185; [α]D23 = -9.7o (c = 0.43, CHCl3). 
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 (2R,3S,4S)-3-(4-methoxybenzyloxy)-2,4-dimethylhept-6-enal: A flame-dried 
250 mL round bottom flask under Ar was charged with 3-(4-
methoxybenzoyloxy)heptenamide (3.6875 g, 10.99 mmol, 1.0 equiv.) and THF 
(0.26 M, 41.6 mL). The reaction flask was cooled to -78°C and charged with Dibal-H (Sigma-
Aldrich, 1 M in hexanes, 22.0 mL, 22.0 mmol, 2.0 equiv.) and let stir at -78°C for 2 hr. The 
reaction was then cannulated into a solution of 1M HCl and stirred vigorously for 1 hr at which 
time the layers were separated. The organic layer was washed with H2O (1 x 50 mL) and brine (1 
x 50 mL). The combined aqueous layers were extracted with CH2Cl2 (3 x 60 mL) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo to afford a 
clear oil. Purification by flash chromatography (10% EtOAc/hexanes) furnished the heptenal 
product as a clear oil (2.751 g, 9.953 mmol, 91%). 
 1H NMR (500 MHz, CDCl3) δ 9.86 (d, J = <1 Hz, 1H), 7.27 (d, J = 8.5 Hz, 2H), 6.91 (d, J 
= 8.5 Hz, 2H), 5.82 (dddd, J = 17.5, 10.5, 8.0, 6.0 Hz, 1H), 5.06 (m, 2H), 4.42 (app s, 2H), 3.85 
(s, 3H), 3.76 (dd, J = 8.0, 3.0 Hz, 1H), 2.65 (dq, J = 7.0, 3.0 Hz, 1H), 2.50 (m, 1H), 2.02 (m, 1H), 
1.92 (m, 1H), 1.17 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
204.7, 159.2, 136.9, 130.2, 129.3, 116.5, 113.8, 81.5, 73.3, 55.3, 49.1, 37.2, 35.9, 15.9, 7.8; IR 
(film, cm-1): 3074, 2969, 2935, 2878, 2712, 1723, 1613, 1514, 1463, 1249; HRMS (ESI) m/z 
calc’d for C17H24O3Na [M + Na]+: 299.1623, found 299.1616; [α]D23 = -40.9o (c = 2.26, CHCl3). 
 
 (4S,5R)-3-((2S,3R,4S,5S,6S)-5-(4-methoxybenzyloxy)-3-hydroxy-
2,4,6-trimethylnon-8-enoyl)-4-methyl-5-phenyloxazolidin-2-one [11]: 
A flame-dried 100 mL round bottom flask under Ar was charged with N-
propionyloxazolidinone 10 (2.208 g, 9.47 mmol, 1.04 equiv.) and CH2Cl2 (8.6 mL) and cooled to 
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-78°C. The reaction was then charged with Bu2BOTf (1 M in CH2Cl2, 10.7 mL, 10.74 mmol, 
1.18 equiv.) and the reaction solution turned dark orange. NEt3 (1.51 mL, 10.83 mmol, 1.19 
equiv.) was added to the reaction, followed by stirring at -78°C for 5 min, 0°C for 10 min, and 
finally re-cooled to -78°C. A solution of the heptenal (2.516 g, 9.104 mmol, 1.0 equiv.) in 
CH2Cl2 (8.6 mL) was cooled to -78°C, cannulated into reaction flask at -78°C, and stirred for 1.5 
hr. The reaction was then warmed to 0°C and stirred for 1.5 hr. The reaction was quenched 
consecutively with H2O (9 mL), MeOH (25 mL), and H2O2 (30% wt solution, 9 mL), and stirred 
for 3 hr at room temperature. The reaction was then concentrated in vacuo to give a slurry, which 
was partitioned between H2O (20 mL) and EtOAc (20 mL). After separating the layers, the 
aqueous layer was extracted with EtOAc (4 x 20 mL) and the combined organic layers were 
washed with satd NaHCO3 (1 x 20 mL) and brine (1 x 30 mL). The organic layer was dried over 
MgSO4, filtered, and concentrated in vacuo to afford a yellow oil. 1H NMR analysis of the crude 
product showed a d.r. > 20:1. Purification by flash chromatography (20% EtOAc/hexanes) 
furnished aldol adduct 11 as a clear oil (4.472 g, 8.774 mmol, 96%). 
 1H NMR (500 MHz, CDCl3) δ 7.37-7.45 (m, 3H), 7.28-7.32 (m, 4H), 6.87 (d, J = 8.0 Hz, 
2H), 5.81 (m, 1H), 5.66 (d, J = 7.0 Hz, 1H), 5.04 (d, J = 16.0 Hz, 1H), 5.02 (d, J = 8.5 Hz, 1H), 
4.77 (quint, J = 6.8 Hz, 1H), 4.63 (app. q, J = 11 Hz, 2H), 3.89-3.96 (m, 2H), 3.78 (s, 3H), 3.64 
(d, J = 9.0 Hz, 1H), 3.52 (d, J = 2.5 Hz, 1H), 2.54-2.56 (m, 1H), 1.83-1.94 (m, 3H), 1.22 (d, J = 
7.0 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H). 13C 
NMR (125 MHz, CDCl3) δ 178.1, 158.9, 152.4, 137.7, 133.1, 131.5, 128.9 (2 peaks), 128.8, 
125.6, 116.0, 113.7, 82.6, 78.9, 74.2, 72.2, 55.3, 54.7, 39.3, 38.0, 37.2, 36.0, 15.9, 14.3, 9.8, 9.2; 
IR (film, cm-1): 3522, 3073, 2973, 2934, 1783, 1687, 1613, 1514, 1456, 1367; HRMS (ESI) m/z 
calc’d for C30H40NO6 [M + H]+: 510.2856, found 510.2868; [α]D23 = -3.3o (c = 0.83, CHCl3). 
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 (4S,5R)-3-((S)-2-((2S,4R,5R,6S)-2-(4-methoxyphenyl)-5-methyl-6-
((S)-pent-4-en-2-yl)-1,3-dioxan-4-yl)propanoyl)-4-methyl-5-
phenyloxazolidin-2-one [15]: A flame-dried 500 mL round bottom 
flask was charged with aldol adduct 11 (4.3297 g, 8.49 mmol, 1.0 equiv.), CH2Cl2 (100 mL), and 
MgSO4 (8.0 g). A suspension of DDQ (Sigma-Aldrich, 2.314 g, 10.12 mmol, 1.2 equiv.) and 
MgSO4 (4.6 g) in CH2Cl2 (100 mL) was cannulated in reaction flask, causing an instantaneous 
color change to green, which then gradually turned brown. The suspension was stirred for 15 min 
at which time the reaction was quenched with satd NaHCO3 (300 mL). The resulting orange 
solution was stirred for 5 min at which time the layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 x 80 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo to afford a clear oil. 1H NMR analysis of the crude product 
showed a d.r. > 20:1. Purification by flash chromatography (15% EtOAc/hexanes) furnished 
PMB acetal 15 as a clear oil (3.9887 g, 7.857 mmol, 93%). 
 1H NMR (500 MHz, CDCl3) δ 7.38-7.47 (m, 5H), 7.31-7.33 (d, J = 7.0 Hz, 2H), 6.91 (d, J 
= 8.5 Hz, 2H), 5.78 (dddd, J = 18.0, 14.8, 9.0, 6.3 Hz, 1H), 5.63 (s, 1H), 5.63 (d, J = 8.0 Hz, 1H), 
5.03 (app d, J = 12.5 Hz, 2H), 4.78- 4.87 (m, 2H), 4.14 (d, J = 11.0 Hz,  1H), 3.81 (s, 3H), 3.73 
(dd, J = 10.0, 2.0 Hz, 1H), 2.53-2.57 (m, 1H), 1.90 (dt, J = 13.5, 8.5 Hz,  1H), 1.75-1.79 (m, 1H), 
1.48 (dq, J = 6.8, 1.0 Hz, 1H), 1.35 (d, J = 6.5 Hz, 3H), 1.24 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 6.5 
Hz, 3H), 0.79 (d, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 175.2, 159.9, 152.6, 136.8, 
133.0, 131.5, 128.9, 128.8, 127.3, 125.6, 116.4, 113.6, 95.6, 81.1, 78.9 (2 peaks), 55.3, 54.9, 
37.0, 36.8, 33.8, 31.6, 14.9, 14.3, 13.7, 13.0; IR (film, cm-1): 3073, 2974, 2936, 2879, 1783, 
1698, 1615, 1517, 1455, 1347; HRMS (ESI) m/z calc’d for C30H38NO6 [M + H]+: 508.2699, 
found 508.2705; [α]D23 = -5.8o (c = 1.05, CHCl3). 
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 (R)-2-((2S,4S,5R,6S)-2-(4-methoxyphenyl)-5-methyl-6-((S)-pent-4-en-2-
yl)-1,3-dioxan-4-yl)propan-1-ol [13]: A flame-dried 250 mL round bottom 
flask under Ar was charged with PMB acetal 15 (3.9887 g, 7.857 mmol, 1.0 
equiv.) and THF (0.25 M, 31.4 mL) and cooled to -78°C. The reaction flask was then charged 
with LAH (Sigma-Aldrich, 1 M in THF, 23.6 mL, 23.6 mmol, 3.0 equiv.) via syringe over the 
course of 10 min, and the reaction flask was allowed to warm up to room temperature on its own 
accord over 12 hrs. The reaction was then cooled to 0°C and quenched with the cautious addition 
of 1 M NaOH (15 mL), followed by celite and MgSO4 and allowed to stir vigorously at room 
temperature for 1.5 hr. The reaction mixture was filtered through a celite plug washing with THF 
(400 mL) and concentrated in vacuo to afford a clear oil. Purification by flash chromatography 
(30% EtOAc/hexanes) furnished alcohol 13 as a white solid (2.522 g, 7.541 mmol, 96%). 
 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 5.79 
(dddd, J = 18, 15.2, 8.8, 6.4 Hz, 1H), 5.63 (s, 1H), 5.03 (m, 2H), 3.80 (s, 3H), 3.54-3.68 (m, 4H), 
2.47-2.54 (m, 2H), 1.88-1.97 (m, 2H), 1.80 (m, 1H), 1.43 (br s, 1H), 1.19 (d, J = 7.2 Hz, 3H), 
1.11 (d, J = 6.8 Hz, 3H), 0.82 (d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 159.7, 136.8, 
131.9, 127.2, 116.4, 113.6, 95.4, 81.9, 78.5, 65.9, 55.3, 37.2, 34.3, 33.8, 30.1, 13.8 (2 peaks), 
13.1; IR (film, cm-1): 3317, 3074, 2968, 2933, 2877, 1615, 1515, 1248; HRMS (ESI) m/z calc’d 
for C20H31O4 [M + H]+: 335.2222, found 335.2215; [α]D23 = -41.8o (c = 0.35, CHCl3). 
 
 (2S,4R,5R,6S)-4-((S)-1-iodopropan-2-yl)-2-(4-methoxyphenyl)-5-methyl-
6-((S)-pent-4-en-2-yl)-1,3-dioxane: A flame dried 25 mL round bottom flask 
was charged sequentially with PPh3 (0.513 g, 1.961 mmol, 1.2 equiv.), CH2Cl2 
(5.5 mL), imidazole (Sigma-Aldrich, 0.166 g, 2.452 mmol, 1.5 equiv.), and I2 (Sigma-Aldrich, 
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0.560 g, 2.207 mmol, 1.35 equiv.). An exotherm ensued upon the addition of I2 and resulted in a 
brown suspension. The reaction flask was charged with alcohol 13 (0.5468 g, 1.635 mmol, 1 
equiv.) in CH2Cl2 (1.1 mL) via cannula and let stir for 3 hr, at which time the reaction was 
concentrated in vacuo and purified by flash chromatography (5% EtOAc/hexanes) to furnish the 
iodide product as a white solid (0.6837 g, 1.538 mmol, 94%). 
 1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 8.5 Hz, 2H), 6.90 (d, J = 8.5 Hz, 2H), 5.78 
(dddd, J = 17.5, 14.5, 8.5, 6.0 Hz, 1H), 5.57 (s, 1H), 5.03 (m, 2H), 3.80 (s, 3H), 3.55 (dd, J = 
10.0, 2.5 Hz, 2H), 3.32 (dd, J = 10.3, 2.8 Hz, 1H), 3.12 (dd, J = 10.0, 5.5 Hz, 1H), 2.51 (m, 1H), 
2.21 (m, 1H), 1.92 (dt, J = 14.0, 8.5 Hz, 1H), 1.80 (m, 1H), 1.74 (q, J = 6.5 Hz, 1H), 1.22 (d, J = 
7.0 Hz, 3H), 1.13 (d, J = 6.5 Hz, 3H), 0.84 (d, J = 6.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
159.8, 136.7, 131.6, 127.2, 116.5, 113.6, 96.0, 84.0, 78.5, 55.3, 37.1, 33.8, 31.8, 29.2, 17.7, 13.9, 
13.0, -7.9; IR (film, cm-1): 3073, 2968, 2932, 2876, 2836, 1615, 1516, 1460, 1378, 1301, 1249; 
HRMS (ESI) m/z calc’d for C20H30O3I [M + H]+: 445.1240, found 445.1221; [α]D23 = -37.0o (c = 
0.21, CHCl3). 
 
 (2S,4R)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-4-
((2S,4S,5R,6S)-2-(4-methoxyphenyl)-5-methyl-6-((S)-pent-4-en-2-
yl)-1,3-dioxan-4-yl)-N,2-dimethylpentanamide [16]: A 250 mL round 
bottom flask under Ar was charged with LiCl (3.13 g, 73.98 mmol, 12.7 
equiv.) and flame-dried vigorously 5 times. The reaction flask was then 
charged sequentially with THF (16.7 mL) and diisopropylamine (3.51 mL, 25.1 mmol, 4.31 
equiv.). The resulting suspension was cooled to -78°C, and a solution of n-butyllithium in 
hexanes (2.48 M, 9.39 mL, 23.3 mmol, 4.0 equiv.) was added via syringe. The suspension was 
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warmed to 0°C briefly then cooled to -78°C. An ice-cooled solution of Myers’ auxiliary 6 (2.707 
g, 12.23 mmol, 2.1 equiv.) in THF (38 mL) was added to the reaction flask via cannula. The 
reaction mixture was stirred at -78°C for 1 h, 0°C for 15 min, room temperature for 5 min, and 
finally cooled to 0°C, whereupon a 0°C solution of freshly prepared iodide compound (2.5885 g, 
5.825 mmol, 1.0 equiv.) in THF (12 mL) was added to the reaction via cannula. The reaction was 
allowed to warm up to room temperature on it’s own accord over 12 hr. The reaction was then 
quenched by the addition of saturated aqueous ammonium chloride solution (100 mL). The 
layers were partitioned and the aqueous layer was extracted with ethyl acetate (4 x 80 mL). The 
organic layers were combined, dried over MgSO4, filtered, and concentrated in vacuo to afford a 
clear oil. 1H NMR analysis of the crude product showed a d.r. > 20:1. Purification by flash 
chromatography (linear gradient 25% to 30% EtOAc/hexanes) furnished amide 16 as a white 
amorphous solid (2.937 g, 5.462 mmol, 94%). 
 1H NMR (3:1 rotamer ratio, asterisk denotes minor rotamer peaks, 500 MHz, CDCl3) δ 
7.25-7.39 (m, 6H), 7.17-7.20 (m, 1H), 6.83 (d, J = 8.5 Hz, 2H), 6.80* (d, J = 8.5 Hz, 2H), 5.70-
5.81 (m, 1H), 5.47 (s, 1H), 5.44* (s, 1H), 4.88-4.98 (m, 2H), 4.61 (app t, J = 7.3 Hz, 1H), 4.54* 
(dd, J = 9.0, 1.5 Hz, 1H), 4.24 (br, s, 1H), 4.07* (app quint, J = 7.4 Hz, 1H), 3.73 (s, 3H), 3.71* 
(s, 3H), 3.56 (m, 1H), 3.53* (m, 1H), 3.26* (d, J = 9.0 Hz, 1H), 3.23 (d, J = 10.5 Hz, 1H), 3.06* 
(m, 1H), 2.87* (s, 3H), 2.80 (s, 3H), 2.69 (m, 1H), 2.47 (m, 1H), 1.98 (m, 2H), 1.82-1.92 (m, 
2H), 1.71-1.76 (m, 1H), 1.16 (d, J = 7.0 Hz, 3H), 1.13 (d, J = 7.0 Hz, 3H), 1.02 (d, J = 6.5 Hz, 
3H), 0.97 (dd, J = 11.5, 7.0 Hz, 1H), 0.90 (d, J = 7.0 Hz, 3H), 0.82 (d, J = 6.5 Hz, 3H), 0.80-0.85 
(m, 1H). 13C NMR (125 MHz, CDCl3) δ 178.1, 176.6*, 159.7, 142.7, 141.4*, 137.5*, 137.0, 
132.3*, 132.1, 128.8, 128.5*, 128.2, 127.5, 127.1, 126.8*, 126.0, 116.2, 115.9*, 113.6, 113.5*, 
95.2, 94.9*, 84.9*, 84.7, 78.9, 78.7*, 76.3, 75.4*, 57.7*, 55.3, 38.9*, 38.4, 37.4*, 37.2, 34.4, 
 39 
34.0*, 34.0, 33.7*, 30.0*, 29.8, 28.7, 28.4*, 27.1, 19.4*, 18.4, 16.7*, 15.9, 15.6*, 14.4, 13.8, 
13.7*, 13.3; IR (film, cm-1): 3401, 3072, 2969, 2932, 2873, 1621, 1516, 1463, 1377, 1301, 1249; 
HRMS (ESI) m/z calc’d for C33H48NO5 [M + H]+: 538.3532, found 538.3521; [α]D23 = -31.7o (c 
= 0.62, CHCl3). 
 
 (2S,4R)-4-((2S,4S,5R,6S)-2-(4-methoxyphenyl)-5-methyl-6-((S)-pent-4-
en-2-yl)-1,3-dioxan-4-yl)-2-methylpentan-1-ol: A flame-dried 25 mL 
round bottom flask under Ar was charged with  THF (1.58 mL) and 
diisopropylamine (0.25 mL, 1.814 mmol, 4.2 equiv.). The reaction flask was 
cooled to -78°C and a solution of n-butyllithium in hexanes (2.45 M, 0.71 mL, 1.728 mmol, 4.0 
equiv.) was added via syringe. The reaction temperature was maintained at -78°C for 10 min and 
then 0°C for 10 min. Solid Borane-ammonia complex (90%, 59.2 mg, 1.728 mmol, 4.0 equiv.) 
was then added to the reaction mixture, and a vigorous evolution of gas ensued. After stirring for 
15 min at 0°C, the reaction was warmed to room temperature for 15 min, then finally recooled to 
0°C, where a solution of amide 16 (0.2322 g, 0.4319 mmol, 1.0 equiv.) in THF (1.0 mL) was 
cannulated in the reaction mixture using THF (0.5 mL) to quantitate the transfer. The reaction 
was warmed to room temperature, let stir for 1 hr 45 min, and then quenched by the precautious 
addition of H2O (3 mL) followed by satd NH4Cl (5 mL) and Et2O (5 mL). The layers were 
separated and the organic layers were washed successively with satd NH4Cl (1 x 10 mL) and 1M 
NaOH (1 x 10 mL). The organic layer was then dried over MgSO4, filtered, and concentrated in 
vacuo to afford a yellow oil. Purification by flash chromatography (20% EtOAc/hexanes) 
furnished the primary alcohol product as a yellow oil (160.9 mg, 0.4273 mmol, 99%). 
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 1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.8 Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 5.78 
(dddd, J = 17.8, 14.8, 8.6, 6.0 Hz, 1H), 5.60 (s, 1H), 5.04 (m, 2H), 3.79 (s, 3H), 3.60 (dd, J = 
10.0, 2.2 Hz, 1H), 3.56 (dd, J = 10.4, 4.4 Hz, 1H), 3.39 (dd, J = 10.6, 6.6 Hz, 1H), 3.33 (d, J = 
10.8 Hz, 1H), 2.53-2.57 (m, 1H), 2.28-2.52 (m, 1H), 1.71-1.94 (m, 4H), 1.61 (br s, 1H), 1.35 
(ddd, J = 14.0, 9.2, 2.8 Hz, 1H), 1.19 (d, J = 7.2 Hz, 3H), 1.04 (d, J = 6.4 Hz, 3H), 0.99 (d, J = 
6.8 Hz, 3H), 0.92 (ddd, J = 14.0, 9.4, 5.0 Hz, 1H), 0.82 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ 159.6, 136.9, 131.8, 127.1, 116.3, 113.5, 95.2, 84.7, 78.6, 67.1, 55.2, 37.7, 37.1, 33.7, 
33.3, 29.3, 29.1, 18.4, 16.6, 13.7, 13.2; IR (film, cm-1): 3453 (br), 2966, 2929, 2879, 1617, 1518, 
1462, 1379, 1302, 1249; HRMS (ESI) m/z calc’d for C23H37O4 [M + H]+: 377.2692, found 
377.2709; [α]D23 = -11.6o (c = 0.44, CH2Cl2). 
 
 (2S,4R)-4-((2S,4S,5R,6S)-2-(4-methoxyphenyl)-5-methyl-6-((S)-pent-4-
en-2-yl)-1,3-dioxan-4-yl)-2-methylpentanal [17]: A 50 mL round bottom 
flask was charged sequentially with primary alcohol (294.8 mg, 0.7829 
mmol, 1.0 equiv.), CH2Cl2 (0.063 M, 12.4 mL), H2O (3 drops), and Dess-
Martin periodinane (Sigma-Aldrich, 0.531 g, 1.253 mmol, 1.6 equiv.). The white suspension was 
stirred at room temperature for 1 hr, at which time it was quenched with the addition of a 5:1 
solution of Na2S2O3: NaHCO3 (33 mL). The resulting solution was stirred until homogeneity was 
reached, at which time the layers were separated, and the aqueous layer was washed with CH2Cl2 
(3 x 20 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated in 
vacuo to afford a white solid. Purification by flash chromatography (10% EtOAc/hexanes) 
furnished aldehyde 17 as a white amorphous solid (281.1 mg, 0.7506 mmol, 96%). 
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 1H NMR (400 MHz, CDCl3) δ 9.63 (d, J = 2.0 Hz, 1H), 7.43 (d, J = 8.8 Hz, 2H), 6.89 (d, J 
= 8.8 Hz, 2H), 5.79 (dddd, J = 16.8, 14.4, 8.4, 5.6 Hz, 1H), 5.53 (s, 1H), 5.04 (m, 2H), 3.79 (s, 
3H), 3.60 (dd, J = 9.8, 2.0 Hz, 1H), 3.34 (d, J = 10.8 Hz, 1H), 2.52-2.61 (m, 2H), 2.24-2.31 (m, 
1H), 1.86-1.96 (m, 2H), 1.74-1.82 (m, 2H), 1.21 (d, J = 7.2 Hz, 3H), 1.15 (d, J = 7.2 Hz, 3H), 
1.02 (d, J = 6.4 Hz, 3H), 1.02 (m, 1H), 0.88 (d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
204.3, 159.7, 136.9, 131.8, 127.1, 116.2, 113.5, 95.3, 84.3, 78.7, 55.2, 44.2, 37.2, 35.1, 33.8, 
29.7, 29.1, 16.0, 15.0, 13.7, 13.2; IR (film, cm-1): 3073, 2973, 2937, 2839, 2711, 1724, 1617, 
1518, 1460, 1249; HRMS (ESI) m/z calc’d for C23H35O4 [M + H]+: 375.2535, found 375.2540; 
[α]D23 = -42.1o (c = 0.38, CH2Cl2). 
 
Figure 17. Synthesis of β-keto imide 18 
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 (R)-4-benzyl-3-propionyloxazolidin-2-one: A flame dried 250 mL round bottom 
flask under Ar was charged with (R)-4-Benzyl-2-oxazolidinone (TCI, 5.226 g, 29.49 
mmol, 1.0 equiv.) and THF (85.2 mL, 0.346 M). The reaction was cooled to -78°C and a solution 
of n-butyllithium in hexanes (2.45 M, 12.0 mL, 29.49 mmol, 1.0 equiv.) was added via syringe 
over 30 min. The resulting dark red solution was stirred for 15 min at -78°C. The reaction was 
then charged with propionyl chloride (2.88 mL, 33.0 mmol, 1.12 equiv.) and stirred for 1.5 hr. 
The reaction was quenched with satd K2CO3 (30 mL) and diluted with satd NaCl (15 mL) and 
EtOAc (20 mL) to achieve a homogenous solution. The layers were separated and the aqueous 
layer was extracted with EtOAc (3 x 20 mL). The combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo to afford a clear oil. Purification by flash 
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chromatography (15% EtOAc/hexanes) furnished (R)-4-benzyl-3-propionyloxazolidin-2-one as a 
clear oil (6.647 g, 28.49 mmol, 97%). 
 1H NMR (400 MHz, CDCl3) δ 7.20-7.36 (m, 5H), 4.67 (m, 1H), 4.16-4.23 (m, 2H), 3.31 
(dd, J = 16.5, 4.0 Hz, 1H), 2.96 (m, 2H), 2.77 (dd, J = 16.5, 12.0 Hz, 1H), 1.20 (t, J = 9.3 Hz, 
3H). Note that this spectroscopic data is in full agreement with a previous literature report.39 
 
 (R)-4-benzyl-3-((2R,3S)-3-hydroxy-2-methylpentanoyl)oxazolidin-2-one: A 
flame dried 100 mL round bottom flask under Ar was charged with (R)-4-benzyl-
3-propionyloxazolidin-2-one (3.39 g, 14.53 mmol, 1.0 equiv.) and CH2Cl2 (27.4 mL, 0.53 M). 
The reaction was cooled to -78°C and a solution of Bu2BOTf (1 M in CH2Cl2, 17.15 mL, 17.15 
mmol, 1.18 equiv.) was added via syringe over 5 min. The resulting orange solution was charged 
with NEt3 (2.63 mL, 18.89 mmol, 1.3 equiv.) dropwise, and the resulting light yellow solution 
was stirred at -78°C for 15 min, warmed to r.t. briefly, then cooled down to 0°C. Once 0°C 
achieved, propionaldehyde (1.37 mL, 18.89 mmol, 1.3 equiv.) was syringed into rxn dropwise 
and stirred for 3.5 hr at 0°C. The reaction was quenched consecutively with H2O (13 mL), 
MeOH (40 mL), and H2O2 (30% wt solution, 13 mL), and stirred for 2.5 hr at room temperature. 
The reaction was then concentrated in vacuo to give a slurry, which was partitioned between 
H2O (20 mL) and EtOAc (20 mL). After separating the layers, the aqueous layer was extracted 
with EtOAc (3 x 20 mL) and the combined organic layers were washed with satd NaHCO3 (1 x 
20 mL) and brine (1 x 30 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated in vacuo to afford a yellow oil. 1H NMR analysis of the crude product showed a d.r. 
> 20:1. Purification by flash chromatography (30% EtOAc/hexanes) furnished aldol adduct (R)-
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4-benzyl-3-((2R,3S)-3-hydroxy-2-methylpentanoyl)oxazolidin-2-one as a white solid (3.294 g, 
11.31 mmol, 78%). 
 1H NMR (500 MHz, CDCl3) δ 7.20-7.35 (m, 5H), 4.71 (m, 1H), 4.18-4.25 (m, 2H), 3.87 
(m, 1H), 3.79 (dq, J = 2.5, 7.0 Hz, 1H), 3.25 (dd, J = 13.5, 3.5 Hz, 1H), 2.88 (d, J = 2.5 Hz, 1H),  
2.79 (dd, J = 13.5, 9.5 Hz, 1H), 1.58 (m, 1H), 1.47 (m, 1H), 1.25 (d, J = 7.5 Hz, 3H), 0.98 (t, J = 
7.5 Hz, 3H). [α]D23 = -39.9 o (c = 1.07, CHCl3). Note that this spectroscopic data is in full 
agreement with a previous literature report.40 
 
 (R)-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-2-methylpentane-1,3-dione [18]: A 
flame dried 500 mL round bottom flask was charged with aldol adduct (R)-4-
benzyl-3-((2R,3S)-3-hydroxy-2-methylpentanoyl)oxazolidin-2-one (3.274 g, 11.24 mmol, 1.0 
equiv.), CH2Cl2 (56 mL, 0.20 M), and DMSO (56 mL). The reaction was cooled to -10°C and 
NEt3 (4.74 mL, 34.1 mmol, 3.03 equiv.) was added via syringe. A separate flame-dried 100 mL 
round bottom flask was charged with SO3-Pyr. complex (Sigma-Aldrich, 5.42 g, 34.05 mmol, 
3.03 equiv.) and DMSO (56 mL). The SO3-pyr solution was cannulated into the reaction vessel, 
taking precautions to keep the temperature below 0 °C, and let stir for 2 hr. The reaction was 
diluted with Et2O (100 mL) and quenched with satd KHSO4 (60 mL). The layers were separated 
and the aqueous layer was extracted with Et2O (1 x 50 mL). The combined organic layers were 
washed consecutively with satd NaHCO3 (1 x 60 mL) and brine (1 x 60 mL). The organic layer 
was dried over MgSO4, filtered, and concentrated in vacuo to afford a white solid. The crude 
solid was dissolved in refluxing Et2O/hexanes (20/80) and let cool to r.t. overnight. The mother 
liquor was decanted and discarded to afford β-keto imide 18 as clear crystalline solid (2.691 g, 
9.301 mmol, 83%). 
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 1H NMR (400 MHz, CDCl3) δ 7.19-7.36 (m, 5H), 4.74 (m, 1H), 4.60 (q, J = 7.2 Hz, 1H), 
4.24 (dd, J = 9.2, 8.0 Hz, 1H), 4.17 (dd, J = 9.2, 2.8 Hz, 1H), 3.31 (dd, J = 13.2, 3.2 Hz, 1H), 
2.76 (dd, J = 13.6, 10.0 Hz, 1H), 2.66 (m, 2H), 1.44 (d, J = 7.2 Hz, 3H), 1.07 (t, J = 7.2 Hz, 3H). 
[α]D23 = -141.4 o (c = 0.99, CH2Cl2). Note that this spectroscopic data is in full agreement with a 
previous literature report.41 
 
 (R)-4-benzyl-3-((2R,4R,5S,6S,8R)-5-hydroxy-8-((2S,4S,5R,6S)-2-(4-
methoxyphenyl)-5-methyl-6-((S)-pent-4-en-2-yl)-1,3-dioxan-4-yl)-2,4,6-
trimethyl-3-oxononanoyl)oxazolidin-2-one [19]: A flame-dried 100 mL 
round bottom flask under Ar at 0°C was charged sequentially with CH2Cl2 
(15.1 mL), TiCl4 (263 µL, 2.396 mmol, 1.16 equiv.), and Ti(O-iPr)4 (234 
µL, 0.7975 mmol, 0.386 equiv.). The mixture was stirred for 15 min, at 
which time a solution of β-keto imide 18 (0.8907 g, 3.078 mmol, 1.49 equiv.) in CH2Cl2 (7.5 
mL) was cannulated into reaction flask. To the resulting dark yellow solution was added NEt3 
(0.461 mL, 3.30 mmol, 1.6 equiv.) drop wise, eventually turning the solution dark red. The dark 
red solution was stirred for 1 hr at 0°C, then cooled to -78°C. A solution of aldehyde 17 (0.7737 
g, 2.066 mmol, 1.0 equiv.) in CH2Cl2 (8.0 mL) at -78°C was cannulated drop wise into reaction, 
using 2 mL of CH2Cl2 to quantitate the transfer. The reaction was stirred at -78°C for 2 hr at 
which time it was quenched with satd NH4Cl (30 mL), diluted with CH2Cl2 (10 mL), and let 
warm to room temperature. The layers were then separated and the aqueous layer was extracted 
with Et2O (2 x 20 mL). The combined organic layers were washed with satd NaHCO3 (1 x 30 
mL), dried over MgSO4, filtered, and concentrated in vacuo to afford a yellow oil. 1H NMR 
analysis of the crude product showed a d.r. > 20:1. Purification by flash chromatography (25% 
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EtOAc/hexanes) furnished syn-syn aldol adduct 19 as a white foam (1.209 g, 1.822 mmol, 88%). 
Note: Epimerization of C-2 (erythronolide numbering) occurred on silica gel, lowering the d.r. to 
~12:1. This epimerization was avoided by running short silica gel columns.  
 1H NMR (500 MHz, CDCl3) δ 7.44 (d, J = 8.5 Hz, 2H), 7.27-7.35 (m, 3H), 7.19 (d, J = 5.6 
Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 5.78 (dddd, J = 16.5, 10.5, 8.0, 5.8 Hz, 1H), 5.60 (s, 1H), 5.02 
(m, 2H), 4.85 (q, J = 7.3 Hz, 1H), 4.79 (m, 1H), 4.28 (app. t, J = 8.5 Hz, 1H), 4.20 (app. dd, J = 
9.0, 3.0 Hz, 1H), 3.80 (m, 1H), 3.79 (s, 3H), 3.65 (dd, J = 10.0, 2.0 Hz, 1H), 3.32 (d, J = 10.5 Hz, 
1H), 3.30 (dd, J = 13.0, 3.0 Hz, 1H), 3.01 (dq, J = 7.5, 1.5 Hz, 1H), 2.78 (m, 2H), 2.52 (m, 2H), 
1.98 (q, J = 7.0 Hz, 1H), 1.73-1.89 (m, 3H), 1.59 (m, 1H), 1.49 (d, J = 7.5 Hz, 3H), 1.17 (d, J = 
7.0 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 1.05 (d, J = 6.5 Hz, 3H), 0.94 (d, J = 7.0 Hz, 3H) 0.87 (m, 
1H), 0.80 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 211.9, 170.2, 159.6, 154.2, 137.3, 
134.8, 132.2, 129.4, 129.0, 127.5, 127.2, 116.1, 113.5, 95.0, 85.5, 78.8, 77.8, 76.0, 66.7, 55.3, 
51.7, 46.3, 39.9, 37.9, 37.2, 34.7, 33.9, 30.8, 28.8, 18.1, 17.8, 13.8, 13.3, 13.2, 8.1; IR (film, cm-
1): 3548, 3070, 2967, 2933, 2878, 1775, 1720, 1618, 1518, 1456, 1247; HRMS (ESI) m/z calc’d 
for C39H54NO8 [M + H]+: 664.3849, found 664.3879; [α]D23 = -71.9o (c = 0.30, CH2Cl2). 
 
(R)-4-benzyl-3-((2R,3S,4R,5S,6S,8R)-3,5-dihydroxy-8-((2S,4S,5R,6S)-2-
(4-methoxyphenyl)-5-methyl-6-((S)-pent-4-en-2-yl)-1,3-dioxan-4-yl)-
2,4,6-trimethylnonanoyl)oxazolidin-2-one: Zn(BH4)2 solution42 was 
prepared according to the following procedure: A flame dried 50 mL round 
bottom flask was charged (in glove box) with ZnCl2 (Strem, ultradry, 1 g, 
7.19 mmol, 1.0 equiv.), removed from the glove box, and suspended in Et2O 
(12.4 mL, 0.57 M). The reaction was topped with a reflux condenser, put under Ar, and refluxed 
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at 80°C for 2 hr, resulting in complete solvation of the ZnCl2. The ZnCl2 solution was then 
removed from stirring and let cool, during which time a flame dried 100 mL round bottom flask 
was charged with NaBH4 (Sigma-Aldrich, 0.657 g, 17.10 mmol, 2.37 equiv.) and suspended in 
Et2O (37.0 mL, 0.46 M). Upon cooling, the ZnCl2 solution was cannulated into the NaBH4 
suspension under Ar, being careful to leave behind residual amounts of solid ZnCl2. This white 
suspension was allowed to stir for 12 hr as it gradually turned grey. The grey suspension was 
then allowed to settle, and the clear solution was transferred to a flame dried 100 mL round 
bottom flask under Ar via syringe, being careful to leave behind solids. The resulting clear 
Zn(BH4)2 solution (0.145M) under Ar was then used immediately in the next reaction. 
 A flame dried 25 mL round bottom flask under Ar was charged with syn-syn aldol adduct 
19 (99.1 mg, 0.149 mmol, 1.0 equiv.) and CH2Cl2 (3.04 mL, 0.049 M). The reaction flask was 
cooled to -78°C and a freshly prepared solution of Zn(BH4)2 (0.145 M, 1.64 mL, 0.2384 mmol, 
1.6 equiv.) was added dropwise via syringe.  The reaction was allowed to stir at -78°C for 2.5 
hrs, at which time it was quenched with H2O (5 mL) and warmed to r.t. AcOH added dropwise 
until bubbling ceased (~10 drops) and diluted with satd NH4Cl (5 mL). This solution was stirred 
for 5 min. and then partitioned between satd NaHCO3 and CH2Cl2. After separation, the aqueous 
layer was extracted with CH2Cl2 (3 x 15 mL). The combined organic layers were then dried over 
Na2SO4, filtered, and concentrated in vacuo to afford a clear oil. 1H NMR analysis of the crude 
product showed a d.r. > 20:1. Purification by flash chromatography (35% EtOAc/hexanes) 
furnished the syn-diol product as a white foam (83 mg, 0.125 mmol, 84%). 
 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.8 Hz, 2H), 7.29-7.36 (m, 3H), 7.20 (m, 2H), 
6.88 (d, J = 8.8 Hz, 2H), 5.79 (dddd, J = 16.6, 10.8, 8.6, 6.0 Hz, 1H), 5.63 (s, 1H), 5.02 (m, 2H), 
4.69 (m, 1H), 4.22 (m, 2H), 4.00 (m, 2H), 3.79 (s, 3H), 3.64 (dd, J = 10.2, 1.8 Hz, 1H), 3.39 (d, J 
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= 9.2 Hz, 1H), 3.34 (d, J = 10.4 Hz, 1H), 3.27 (dd, J = 13.6, 3.2 Hz, 1H), 2.78 (dd, J = 13.6, 9.6 
Hz, 1H), 2.65 (bs, 2H), 2.53-2.57 (m, 1H), 2.41 (m, 1H), 1.97 (q, J = 6.9 Hz, 1H), 1.88 (dt, J = 
13.6, 8.8 Hz, 1H), 1.74-1.82 (m, 3H), 1.52-1.58 (m, 1H), 1.28 (d, J = 6.4 Hz, 3H), 1.18 (d, J = 
6.8 Hz, 3H), 1.06 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H), 0.87 (m, 
1H), 0.82 (d, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 176.1, 159.6, 153.3, 137.2, 134.9, 
132.1, 129.4, 129.0, 127.4, 127.2, 116.1, 113.5, 95.2, 84.9, 79.4, 78.7, 75.5, 66.3, 55.3 (2 peaks), 
40.7, 39.3, 37.7, 37.4, 37.2, 35.5, 33.9, 30.6, 29.2, 18.0, 17.5, 13.8, 13.3, 11.5, 6.7; IR (film, cm-
1): 3556, 2973, 2934, 2877, 1781, 1694, 1517, 1455, 1382; HRMS (ESI) m/z calc’d for 
C39H56NO8 [M + H]+: 666.4006, found 666.4009; [α]D23 = -47.2o (c = 0.36, CH2Cl2). 
 
 (R)-4-benzyl-3-((R)-2-((4S,5R,6S)-6-((2S,4R)-4-((2S,4S,5R,6S)-2-(4-
methoxyphenyl)-5-methyl-6-((S)-pent-4-en-2-yl)-1,3-dioxan-4-
yl)pentan-2-yl)-2,2,5-trimethyl-1,3-dioxan-4-yl)propanoyl)oxazolidin-
2-one [21]: A flame dried 100 mL round bottom flask was charged 
sequentially with syn-diol (0.4443 g, 0.6672 mmol, 1.0 equiv.), CH2Cl2 
(37.1 mL, 0.018 M), and 2,2-dimethoxypropane (Sigma-Aldrich, 0.80 mL, 
6.54 mmol, 9.8 equiv.). CSA (Sigma-Aldrich, 36.6 mg, 0.157 mmol, 0.236 equiv.) was added to 
the reaction and the conversion was carefully monitored by TLC (Upon complete conversion of 
diol, some PMB hydrolysis occurred). After 30 min., the reaction was quenched with satd 
NaHCO3 (30 mL) and stirred for 5 min. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 x 15 mL). The combined organic layers were then dried over MgSO4, 
filtered, and concentrated in vacuo to afford a clear oil. Purification by flash chromatography 
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(12% EtOAc/hexanes) furnished acetonide 21 as a white foam that could be stored for long 
periods at 4°C without decomposition of the PMB group (0.3968 g, 0.562 mmol, 84%). 
 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.8 Hz, 2H), 7.28-7.36 (m, 3H), 7.22 (m, 2H), 
6.89 (d, J = 8.4 Hz, 2H), 5.79 (dddd, J = 16.2, 10.2, 8.2, 5.8 Hz, 1H), 5.60 (s, 1H), 5.03 (m, 2H), 
4.70 (m, 1H), 4.20 (m, 2H), 4.09 (dd, J = 9.6, 2.0 Hz, 1H), 3.94 (dq, J = 10.8, 6.8 Hz, 1H), 3.80 
(s, 3H), 3.60 (dd, J = 10.2, 1.4 Hz, 1H), 3.42 (dd, J = 9.6, 2.0 Hz, 1H), 3.32 (d, J = 10.8 Hz, 1H), 
3.24 (dd, J = 13.4, 3.4 Hz, 1H), 2.76 (dd, J = 14.0, 9.6 Hz, 1H), 2.51-2.55 (m, 1H), 2.37 (m, 1H), 
1.87-1.99 (m, 2H), 1.76-1.83 (m, 1H), 1.62-1.70 (m, 2H), 1.47-1.54 (m, 1H), 1.43 (s, 3H), 1.38 
(s, 3H), 1.32 (d, J = 6.8 Hz, 3H), 1.18 (d, J = 7.2 Hz, 3H), 1.05 (d, J = 6.4 Hz, 3H), 0.85 (d, J = 
7.6 Hz, 3H), 0.83 (d, J = 6.8, 3H), 0.78 (d, J = 6.8, 3H), 0.72-0.78 (m, 1H). 13C NMR (100 MHz, 
CDCl3) δ 175.1, 159.6, 152.5, 136.9, 135.0, 132.1, 129.4, 128.9, 127.4, 127.1, 116.3, 113.5, 98.8, 
94.8, 86.2, 78.6, 77.9, 74.5, 66.0, 55.2, 55.0, 39.8, 39.1, 37.7, 37.2, 34.2, 33.9, 30.7, 30.4, 29.9, 
28.6, 19.6, 18.3, 16.1, 15.8, 13.9, 13.4, 5.5; IR (film, cm-1): 2968, 2933, 2880, 1784, 1693, 1517, 
1455, 1380; HRMS (ESI) m/z calc’d for C42H60NO8 [M + H]+: 706.4319, found 706.4329; [α]D23 
= -71.4o (c = 0.21, CH2Cl2). 
 
 (R)-2-((4S,5R,6S)-6-((2S,4R)-4-((2S,4S,5R,6S)-2-(4-methoxyphenyl)-5-
methyl-6-((S)-pent-4-en-2-yl)-1,3-dioxan-4-yl)pentan-2-yl)-2,2,5-
trimethyl-1,3-dioxan-4-yl)propanoic acid [20]: A 25 mL round bottom 
flask was charged sequentially with acetonide 21 (51.4 mg, 0.0728 mmol, 
1.0 equiv.), THF (3.81 mL, 0.0191 M), and H2O (0.76 mL, 0.0956 M). 
The reaction was placed in a 0°C bath and charged sequentially with H2O2 (30% wt solution, 
60.0 µL, 0.583 mmol, 8.0 equiv.) and a 0.2 M LiOH(aq) solution (0.73 mL, 0.145 mmol, 2.0 
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equiv.). The reaction was gradually warmed to r.t. over 12 hours, at which point it was filtered 
through a silica plug with 100% EtOAc + 1% AcOH, and concentrated in vacuo. The crude 
yellow oil was loaded directly onto a silica column (25/75 EtOAc/Hex + 1% AcOH) to furnish 
alkenoic acid 20 as a yellow oil (39.5 mg, 0.0722 mmol, 99%). 
 1H NMR (500 MHz, CDCl3) δ 7.44 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 6.8 Hz, 2H), 5.78 (ddt, 
J = 17.2, 10.0, 7.2 Hz, 1H), 5.60 (s, 1H), 5.03 (m, 2H), 3.87 (dd, J = 9.5, < 1.0 Hz, 1H), 3.80 (s, 
3H), 3.59 (dd, J = 10.0, 2.0 Hz, 1H), 3.37 (dd, J = 9.8, 1.3 Hz, 1H), 3.32 (d, J = 11.0 Hz, 1H), 
2.66-2.69 (m, 1H), 2.53 (m, 1H), 2.36 (m, 1H), 1.88-1.97 (m, 2H), 1.80 (m, 1H), 1.60-1.68 (m, 
2H), 1.53 (m, 1H), 1.41 (s, 3H), 1.39 (s, 3H), 1.26 (d, J = 6.5 Hz, 3H), 1.17 (d, J = 7.0 Hz, 3H), 
1.05 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 7.0, 3H), 0.83 (d, J = 7.0, 3H), 
0.75 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 179.6, 159.6, 136.9, 132.1, 127.2, 116.3, 113.6, 
99.2, 94.9, 86.2, 78.6, 78.2, 74.9, 55.3, 41.9, 39.1, 37.2, 34.2, 34.0, 31.5, 30.4, 29.9, 28.7, 19.6, 
18.3, 16.0, 14.7, 13.9, 13.4, 5.0; IR (film, cm-1): 2968, 2933, 2880, 1784, 1693, 1517, 1455, 
1380; HRMS (ESI) m/z calc’d for C32H50O7Na [M + Na]+: 569.3454, found 569.3448; [α]D23 = -
27.5o (c = 1.12, CHCl3). 
 
C–H Oxidative Macrocyclization Reactions for Table 1 and Figure 11  
 
Macrolide [4]: In-Situ Pd(II)/bis-sulfoxide Catalyst (1) Preparation for C–
H Oxidative Macrolactonization: An oven dried 1 dram borosilicate vial 
(topped with a Teflon-lined cap) was charged sequentially with 
recrystallized Pd(OAc)2 (2.9 mg, 0.0127 mmol, 0.3 equiv.), meso-1,2-
bis(phenylsulfinyl)ethane (3.6 mg, 0.0127 mmol, 0.3 equiv.), CH2Cl2 (142 µL), and a teflon stir 
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bar. The 1 dram vial was then stirred for 12 hours in 40°C bath, at which time a clear bright red 
solution resulted. Note: The following precautions were taken to avoid moisture: recrystallized 
Pd(OAc)2 was stored under an atmosphere of Ar (glove box), and meso-1,2-
bis(phenylsulfinyl)ethane and the stir bar were stored in a dessicator. The reagents were added 
quickly to the 1 dram vial on a benchtop balance. 
 C–H Oxidative Macrolactonization: (Note: The in-situ catalyst (1) preparation was the 
only portion of this reaction found to be sensitive to moisture. No precautions were taken to 
avoid moisture during the macrolactonization setup, as all transfers were performed in an air 
atmosphere, on the benchtop.) To a freshly prepared catalyst (1) batch in a 1 dram vial, 1,4-
benzoquinone (9.2 mg, 0.0852 mmol, 2.0 equiv.) was added via wax paper. Alkenoic acid 20 
(23.3 mg, 0.0426 mmol, 1.0 equiv.) was then dissolved/transferred (via pipette) to the 1 dram 
vial using CH2Cl2 (1.99 mL, total molarity-0.02 M) and the reaction was topped with a Teflon-
lined cap. This bright red solution was stirred in a 45°C bath 72 hrs. The resulting dark green 
reaction was cooled to r.t. and transferred to a separatory funnel with CH2Cl2, where it was 
quenched with satd NH4Cl (5 mL). The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were then dried over MgSO4, 
filtered, and concentrated in vacuo to afford a clear oil. 1H NMR analysis of the crude product 
showed a d.r. >20:1, and a product:SM ratio of 0.75:1. Purification by flash chromatography 
(10% EtOAc/hexanes to 25% EtOAc/hexanes + 1% AcOH) furnished macrolide 4 as a clear oil 
(7.8 mg, 0.0143 mmol, 34%) and recovered alkenoic acid 20 (10.5 mg, 0.0192 mmol, 45%). 
 Recycling Experiment (the alkenoic acid 20 collected at the end of a reaction was re-
exposed to two further C–H oxidative macrolactonizations): Starting with alkenoic acid 20 (41.2 
mg, 0.0753 mmol), macrolide 4 was obtained in 56% overall yield (22.9 mg, 0.0420 mmol) 
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along with recovered alkenoic acid 20 (3.3 mg, 0.00606 mmol, 8%). Run 1 - macrolide 4 (13.2 
mg, 0.0242 mmol, 32% yield) and recovered alkenoic acid 20 (22.0 mg, 0.0402 mmol, 53%). 
Run 2 - macrolide 4 (6.4 mg, 0.0117 mmol, 29% yield) and recovered alkenoic acid 20 (11.9 mg, 
0.0218 mmol, 54%). Run 3 - macrolide 4 (3.3 mg, 0.00606 mmol, 28% yield) and recovered 
alkenoic acid 20 (3.3 mg, 0.00603 mmol, 28%). 
 Determination of diastereomeric ratio: Authentic (and purified) samples of macrolides 4 
and 5 allowed the diastereomeric ratio of the crude C–H oxidative macrolactonization mixture to 
be obtained (Agilent Zorbax SB-CN, 40%H2O/60%CH3CN, 2mL/min, 30°C, tR = 3.27, 3.67 
min). Macrolide 4, tR = 3.67. Macrolide 5, tR = 3.27. The d.r. for the reaction was measured to be 
41.7:1 4:5. 
 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 6.03 (m, 
1H), 5.78 (ddd, J = 17.0, 10.8, 4.5 Hz, 1H), 5.73 (s, 1H), 5.21 (dt, J = 17.0, 1.5 Hz, 1H), 5.17 (dt, 
J = 10.5, 1.5 Hz, 1H), 3.97 (d, J = 6.5 Hz, 1H), 3.84 (d, J = 10.5 Hz, 1H), 3.80 (s, 3H), 3.70 (d, J 
= 9.0 Hz, 1H), 3.41 (d, J = 10.5 Hz, 1H), 2.82 (dq, J = 11.0, 6.5 Hz, 1H), 2.38 (m, 1H), 2.21 (m, 
1H), 1.93 (q, J = 6.5 Hz, 1H), 1.74-1.82 (m, 2H), 1.49 (s, 3H), 1.47 (s, 3H), 1.40 (app t, J = 13.3 
Hz, 2H), 1.22 (d, J = 6.5 Hz, 3H), 1.20 (d, J = 6.5 Hz, 3H), 1.07 (d, J = 6.0 Hz, 3H), 1.05 (d, J = 
6.0 Hz, 3H), 1.01 (d, J = 7.0, 3H), 0.87 (d, J = 7.0, 3H). 13C NMR (125 MHz, CDCl3) δ 175.2, 
159.9, 135.5, 131.6, 127.5, 115.8, 113.6, 100.6, 95.2, 85.5, 77.6, 74.8, 73.5 (2 peaks), 55.3, 41.6, 
39.6, 35.9, 32.6, 31.9, 29.7, 28.3, 26.8, 20.1, 16.3, 16.0, 13.5, 12.3, 8.0, 7.4; IR (film, cm-1): 
2961, 2937, 2856, 1729, 1616, 1517, 1456, 1382; HRMS (ESI) m/z calc’d for C32H49O7 [M + 
H]+: 545.3478, found 545.3500; [α]D23 = -6.4o (c = 0.34, CH2Cl2). 
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 Macrolide [5]: In-Situ Pd(II)/bis-sulfoxide Catalyst (1) Preparation for C–
H Oxidative Macrolactonization: An oven dried 2 dram borosilicate vial 
(topped with a Teflon-lined cap) was charged sequentially with 
recrystallized Pd(OAc)2 (5.24 mg, 0.0233 mmol, 0.3 equiv.), meso-1,2-
bis(phenylsulfinyl)ethane (6.49 mg, 0.0233 mmol, 0.3 equiv.), CH2Cl2 (250 µL), and a teflon stir 
bar. The 2 dram vial was then stirred for 12 hours in 40°C bath, at which time a clear bright red 
solution resulted. Note: The following precautions were taken to avoid moisture: recrystallized 
Pd(OAc)2 was stored under an atmosphere of Ar (glove box), and meso-1,2-
bis(phenylsulfinyl)ethane and the stir bar were stored in a dessicator.. The reagents were added 
quickly to the 2 dram vial on a benchtop balance. 
 C–H Oxidative Macrolactonization + TBAF: (Note: The in-situ catalyst (1) preparation 
was the only portion of this reaction found to be sensitive to moisture. No precautions were taken 
to avoid moisture during the macrolactonization setup, as all transfers were performed in an air 
atmosphere, on the benchtop.) To a freshly prepared catalyst (1) batch in a 2 dram vial, 1,4-
benzoquinone (16.8 mg, 0.155 mmol, 2.0 equiv.) was added via wax paper. Alkenoic acid 20 
(42.5 mg, 0.0777 mmol, 1.0 equiv.) was then dissolved/transferred (via pipette) to the 2 dram 
vial using CH2Cl2 (3.62 mL, total molarity-0.02 M). Solid tetrabutyl ammonium fluoride 
trihydrate (Fluka, 7.34 mg, 0.0233 mmol, 0.30 equiv.) was then added to reaction vial and the 
reaction was topped with a Teflon-lined cap. This bright red solution was stirred in a 45°C bath 
72 hrs. The resulting dark brown reaction was cooled to r.t. and transferred to a separatory funnel 
with CH2Cl2, where it was quenched with satd NH4Cl (5 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were then 
dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. 1H NMR analysis of 
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the crude product showed a d.r. 1.3:1 (4:5), and a products:SM ratio of 0.25:1. Purification by 
flash chromatography (10% EtOAc/hexanes to 25% EtOAc/hexanes + 1% AcOH) furnished a 
1.3:1 mixture of macrolides 4:5 as a clear oil (8.3 mg, 0.0152 mmol, 20%) and recovered 
alkenoic acid 20 (32.0 mg, 0.0585 mmol, 75%). Separation of 4 and 5 was then accomplished 
using MPLC (2 stacked 12 g SiO2 columns, 2.5% Acetone/hex) to afford clean macrolide 4 and 
the title compound 5. 
 Recycling Experiment (the alkenoic acid 20 collected at the end of a reaction was re-
exposed to two further C–H oxidative macrolactonizations): Starting with alkenoic acid 20 (42.5 
mg, 0.0777 mmol), macrolides 4 and 5 were obtained in 44% overall yield (18.6 mg, 0.0341 
mmol) as a 1.3:1 mixture, along with recovered alkenoic acid 20 (15.5 mg, 0.0284 mmol, 36%). 
Run 1 - macrolides 4 and 5 (8.3 mg, 0.0152 mmol, 20% yield) and recovered alkenoic acid 20 
(32.0 mg, 0.0585 mmol, 75%). Run 2 - macrolides 4 and 5  (6.4 mg, 0.0117 mmol, 20% yield) 
and recovered alkenoic acid 20 (23.3 mg, 0.0426 mmol, 73%). Run 3 - macrolides 4 and 5  (3.9 
mg, 0.00716 mmol, 17% yield) and recovered alkenoic acid 20 (15.5 mg, 0.0284 mmol, 67%). 
 1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 8.5 Hz, 2H), 6.90 (d, J = 8.5 Hz, 2H), 5.95 
(ddd, J = 17.0, 11.0, 6.5 Hz, 1H), 5.73 (s, 1H), 5.52 (br s, 1H), 5.19 (d, J = 17.0 Hz, 1H), 5.07 (d, 
J = 10.5 Hz, 1H), 4.27 (d, J = 8.0 Hz, 1H), 4.09 (d, J = 5.5 Hz, 1H), 3.90 (d, J = 10.0 Hz, 1H), 
3.81 (s, 3H), 3.36 (d, J = 11.0 Hz, 1H), 2.66 (dq, J = 9.5, 7.0 Hz, 1H), 2.53 (m, 1H), 2.15-2.21 
(m, 2H), 1.80 (m, 2H), 1.51 (s, 3H), 1.46 (s, 3H), 1.38 (m, 1H), 1.31 (d, J = 6.5 Hz, 3H), 1.30-
1.38 (m, 1H), 1.26 (d, J = 7.0 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 7.5 Hz, 3H), 0.97 (d, 
J = 7.0, 3H), 0.96 (d, J = 7.0, 3H). 13C NMR (125 MHz, CDCl3) δ 172.9, 159.8, 136.9, 131.7, 
127.2, 114.5 (broad), 113.6, 99.6, 94.6, 85.2, 77.5, 76.2, 72.9, 72.6, 55.3, 43.8, 40.3, 36.3, 33.0, 
31.9, 29.9, 28.9, 27.1, 19.8, 16.5, 16.4, 15.8, 13.8, 7.8, 5.0; IR (film, cm-1): 3071.5, 2969, 2938, 
 54 
2889, 1736, 1616, 1516, 1461, 1381, 1248; HRMS (ESI) m/z calc’d for C32H49O7 [M + H]+: 
545.3478, found 545.3495; [α]D23 = -15.7o (c = 1.30, CH2Cl2). 
Note: The broad carbon signal at 114.5 ppm, corresponding to the terminal olefin carbon, was 
verified by 2D HMQC experiments, where the diastereotopic terminal olefin hydrogens were 
clearly coupled with the terminal olefin carbon. 
 
Intermolecular C–H Oxidation Reaction and Seco Acid Syntheses for Figure 12 and 13 
 
 Allylic p-nitrobenzoates [22 and 23]: Intermolecular 
C–H Oxidation Stock Solution: A stock solution was 
prepared by charging a 1 dram borosilicate vial (topped 
with a Teflon-lined cap) sequentially with Pd(II)/bis-sulfoxide catalyst 1 (28.2 mg, 0.0559 mmol, 
1.0 equiv.), 1,4-benzoquinone (120.8 mg, 1.119 mmol, 20.0 equiv.), p-nitrobenzoic acid (140 
mg, 0.839 mmol, 15.0 equiv.), 1,4-dioxane (1.89 mL), and a Teflon stir bar. The stock solution 
was stirred vigorously for 30 min to dissolve all of the p-nitrobenzoic acid. Note: No precautions 
were taken to avoid moisure during the setup, as all transfers were performed in an open 
atmosphere on the benchtop. 
 Intermolecular C–H Oxidation: 0.189 ml of the stock solution [Pd(II)/bis-sulfoxide 
catalyst 1 (2.82 mg, 0.00559 mmol, 0.1 equiv.), 1,4-benzoquinone (12.08 mg, 0.1119 mmol, 2.0 
equiv.), p-nitrobenzoic acid (14 mg, 0.0839 mmol, 1.5 equiv.), 1,4-dioxane (0.189 mL, 0.296 
M)] was then syringed into a ½ dram vial containing acetonide 21 (39.5 mg, 0.0559 mmol, 1.0 
equiv.). The resulting dark brown solution was then capped with a teflon top, and stirred at 45°C 
for 72 hrs. At this time, the black solution was cooled to r.t. and pippetted into a separatory 
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funnel washing with CH2Cl2. A 5% K2CO3 solution (10 mL) was added and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 x 10 mL) and the combined organic 
layers were washed with a 5% K2CO3 solution (2 x10 mL). The organic layer was then dried 
over MgSO4, filtered, and concentrated in vacuo to afford a yellow oil. 1H NMR analysis of the 
crude product showed a d.r. of 1.11:1 (22 to 23). Purification by flash chromatography (20% 
EtOAc/hexanes) furnished p-nitrobenzoate 22 (18.7 mg, 0.0215 mmol, 38.5%, rf = 0.28) and p-
nitrobenzoate 23 (16.8 mg, 0.0193 mmol, 34.5%, rf = 0.22) as yellow oils (73% combined yield). 
 p-nitrobenzoate 22: 1H NMR (500 MHz, CDCl3) δ 8.24 
(d, J = 9.0 Hz, 2H), 8.18 (d, J = 9.0 Hz, 2H), 7.45 (d, J = 
9.0 Hz, 2H), 7.27-7.36 (m, 3H), 7.22 (d, J = 7.0 Hz, 2H), 
6.90 (d, J = 8.5 Hz, 2H), 6.07 (m, 1H), 5.89 (ddd, J = 15.5, 10.5, 5.0 Hz, 1H), 5.53 (s, 1H), 5.24 
(m, 2H), 4.75 (m, 1H), 4.29 (t, J = 8.0 Hz, 1H), 4.22 (dd, J = 9.0, 2.5 Hz, 1H), 4.06 (dd, J = 9.5, 
1.5 Hz, 1H), 3.94 (m, 1H), 3.81 (s, 3H), 3.77 (dd, J = 10.0, 2.0 Hz, 1H), 3.36 (m, 2H), 3.25 (dd, J 
= 13.5, 3.0 Hz, 1H), 2.76 (dd, J = 13.0, 10.0 Hz, 1H), 2.16 (m, 1H), 2.03 (m, 2H), 1.67 (m, 1H), 
1.61 (m, 1H), 1.41 (m, 1H), 1.38 (s, 3H), 1.32 (s, 3H), 1.30 (d, J = 6.5 Hz, 3H), 1.19 (d, J = 7.0 
Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 6.5 Hz, 3H), 0.75 (d, J = 7.0, 3H), 0.72 (d, J = 7.0 
Hz, 3H), 0.72 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 175.1, 163.5, 159.7, 152.7, 150.5, 136.0, 
135.0, 134.9, 131.7, 130.6, 129.4, 129.0, 127.4, 127.2, 123.5, 116.5, 113.6, 98.9, 94.7, 86.1, 77.4, 
75.2, 74.9, 74.5, 66.1, 55.3, 55.0, 39.9, 38.9, 38.6, 37.8, 35.2, 30.6, 30.1, 29.9, 28.3, 19.6, 19.1, 
15.9, 15.3, 13.2, 8.6, 5.7; IR (film, cm-1): 3060, 2968, 2936, 2882, 1784, 1729, 1695, 1609, 1530, 
1456, 1382; HRMS (ESI) m/z calc’d for C49H63N2O12 [M + H]+: 871.4381, found 871.4351; 
[α]D23 = -67.8o (c = 1.73, CH2Cl2). Note: 22 was inseparable from p-anisaldehyde (an acid 
decomposition product), which did not effect the following reactions. 
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 p-nitrobenzoate 23: 1H NMR (500 MHz, CDCl3) δ 8.23 
(d, J = 9.0 Hz, 2H), 8.14 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 
8.5 Hz, 2H), 7.29-7.36 (m, 3H), 7.22 (d, J = 6.5 Hz, 2H), 
6.84 (d, J = 9.0 Hz, 2H), 5.89 (m, 2H), 5.54 (s, 1H), 5.35 (m, 2H), 4.71 (m, 1H), 4.21 (m, 2H), 
4.09 (dd, J = 10.0, 2.0 Hz, 1H), 3.94 (m, 1H), 3.80 (m, 1H), 3.78 (s, 3H), 3.42 (dd, J = 10.0, 2.0 
Hz, 1H), 3.33 (d, J = 11.0 Hz, 1H), 3.24 (dd, J = 13.5, 3.0 Hz, 1H), 2.76 (dd, J = 13.5, 9.5 Hz, 
1H), 2.33 (m, 2H), 1.98 (m, 1H), 1.65 (m, 2H), 1.47 (m, 1H), 1.43 (s, 3H), 1.37 (s, 3H), 1.31 (d, 
J = 6.5 Hz, 3H), 1.22 (d, J = 7.0 Hz, 3H), 1.05 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H), 0.86 
(d, J = 6.5, 3H), 0.77 (d, J = 6.5 Hz, 3H), 0.76 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 175.1, 
163.5, 159.8, 152.6, 150.3, 136.1, 135.0, 132.4, 131.6, 130.6, 129.4, 129.0, 127.4, 127.2, 123.4, 
119.4, 113.6, 98.9, 95.0, 86.2, 77.9, 77.2 (under CHCl3), 76.4, 74.6, 66.0, 55.3, 55.1, 39.9, 39.1, 
38.0, 37.8, 34.4, 30.7, 30.4, 30.0, 28.3, 19.7, 18.4, 16.0, 15.9, 13.4, 9.4, 5.5; IR (film, cm-1): 
3065, 2971, 2927, 2878, 1784, 1727, 1695, 1615, 1529, 1456, 1387; HRMS (ESI) m/z calc’d for 
C49H63N2O12 [M + H]+: 871.4381, found 871.4361; [α]D23 = -38.2o (c = 1.22, CH2Cl2). 
 
 Seco Acid [24]: A 10 mL round bottom flask was charged 
sequentially with p-nitrobenzoate 22 (18.7 mg, 0.0214 
mmol, 1.0 equiv.), THF (1.12 mL, 0.0191 M), and H2O (0.224 mL, 0.0956 M). The reaction was 
placed in a 0°C bath and charged sequentially with H2O2 (30% wt solution, 17.7 µL, 0.172 
mmol, 8.0 equiv.) and a 0.2 M LiOH(aq) solution (0.215 mL, 0.043 mmol, 2.0 equiv.). The 
reaction was gradually warmed to r.t. over 9 hours at which point it was filtered through a silica 
plug with 100% EtOAc + 1% AcOH, and concentrated in vacuo. The crude yellow oil was taken 
directly onto next step without further purification. 
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 A 25 mL round bottom flask containing the crude benzoate ester was dissolved in MeOH 
(1.48 mL, 0.0145 M) and charged with K2CO3(s) (8.9 mg, 0.0644 mmol, 3.0 equiv.) and stirred 
for 1 hr at room temperature. The reaction was then quenched with satd NH4Cl(aq) (5 mL) and 
filtered through a ½ celite/silica plug with 100% EtOAc + 1% AcOH, and concentrated in vacuo. 
Purification by flash chromatography (30% EtOAc/hexanes + 1% AcOH) furnished seco acid 24 
as a clear oil (11.4 mg, 0.0203 mmol, 95% over 2-steps). 
 1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 8.8 Hz, 2H), 6.89 (d, J = 8.8 Hz, 2H), 5.92 
(ddd, J = 16.8, 10.4, 4.4 Hz, 1H), 5.61 (s, 1H), 5.29 (d, J = 17.2, 1H), 5.21 (d, J = 10.8, 1H), 4.38 
(br s, 1H), 3.97 (d, J = 9.6, 1H), 3.87 (d, J = 8.8 Hz, 1H), 3.80 (s, 3H),  3.47 (d, J = 7.6 Hz, 1H), 
3.33 (d, J = 10.4 Hz, 1H), 2.67 (m, 1H), 2.37 (m, 1H), 2.00-2.18 (m, 2H), 1.89 (q, J = 6.8 Hz, 
1H), 1.61 (m, 3H), 1.42 (s, 3H), 1.40 (s, 3H), 1.26 (d, J = 6.4 Hz, 3H), 1.22 (d, J = 6.8 Hz, 3H), 
1.03 (d, J = 6.4 Hz, 3H), 0.87 (m, 6H), 0.80 (d, J = 6.8, 3H). 13C NMR (125 MHz, CDCl3) δ 
159.9, 138.4, 131.4, 127.2, 123.7, 115.1, 113.7, 99.3, 95.0, 86.2, 76.8, 75.2, 74.2, 55.3, 41.7, 
39.0, 38.7, 33.9, 31.6, 29.9 (2 peaks), 29.7, 28.6, 19.6, 17.8, 16.0, 14.5, 13.4, 10.1, 5.5; IR (film, 
cm-1): 3498 (br), 3117, 3064, 2972, 2932, 2875, 2612, 1733, 1704, 1607, 1520, 1456, 1431; 
HRMS (ESI) m/z calc’d for C32H51O8 [M + H]+: 563.3584, found 563.3574. 
 
 Seco Acid [25]: A 10 mL round bottom flask was charged 
sequentially with p-nitrobenzoate 23 (16.8 mg, 0.0193 
mmol, 1.0 equiv.), THF (1.01 mL, 0.0191 M), and H2O 
(0.202 mL, 0.0956 M). The reaction was placed in a 0°C bath and charged sequentially with 
H2O2, 30% wt solution, 15.9 µL, 0.154 mmol, 8.0 equiv.) and a 0.2 M LiOH(aq) solution (0.193 
mL, 0.039 mmol, 2.0 equiv.). The reaction was gradually warmed to r.t. over 9 hours at which 
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point it was filtered through a silica plug with 100% EtOAc + 1% AcOH, and concentrated in 
vacuo. The crude yellow oil was taken directly onto next step without further purification. 
 A 25 mL round bottom flask containing the crude benzoate ester was dissolved in MeOH 
(1.33 mL, 0.0145 M) and charged with K2CO3(s) (8.0 mg, 0.0579 mmol, 3.0 equiv.) and stirred 
for 1 hr at room temperature. The reaction was then quenched with satd NH4Cl(aq) (5 mL) and 
filtered through a ½ celite/silica plug with 100% EtOAc + 1% AcOH, and concentrated in vacuo. 
Purification by flash chromatography (35% EtOAc/hexanes + 1% AcOH) furnished seco acid 25 
as a clear oil (10.6 mg, 0.0188 mmol, 97% over 2-steps). 
 1H NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 5.82 
(ddd, J = 17.0, 10.0, 7.0 Hz, 1H), 5.66 (s, 1H), 5.23 (d, J = 17.0, 1H), 5.16 (d, J = 10.0, 1H), 4.21 
(app t, J = 7.0, 1H), 3.92 (d, J = 10.5, 1H), 3.88 (d, J = 8.5 Hz, 1H), 3.79 (s, 3H), 3.39 (d, J = 9.5 
Hz, 1H), 3.34 (d, J = 10.5 Hz, 1H), 2.69 (m, 1H), 2.36 (m, 1H), 1.91-2.05 (m, 3H), 1.63 (m, 3H), 
1.51 (m, 1H), 1.41 (s, 3H), 1.39 (s, 3H), 1.26 (m, 3H), 1.23 (d, J = 7.0 Hz, 3H), 1.05 (d, J = 6.5 
Hz, 3H), 0.86 (d, J = 7.0 Hz, 6H), 0.79 (d, J = 7.0, 3H). 13C NMR (125 MHz, CDCl3) δ 160.0, 
138.5, 131.2, 127.2, 116.6, 113.7, 109.8, 99.3, 95.1, 86.1, 80.2, 77.9, 75.0, 55.3, 48.6, 39.5, 38.8, 
34.4, 31.4, 30.3, 29.9,  29.7, 28.8, 19.6, 18.4, 15.9, 14.1, 13.4, 10.9, 5.1; IR (film, cm-1): 3427, 
3189, 3081, 2972, 2930, 2862, 1730, 1717, 1616, 1517, 1458, 1379, 1249; HRMS (ESI) m/z 
calc’d for C32H51O8 [M + H]+: 563.3584, found 563.3591. 
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Yamaguchi Macrolactonization Studies for Figure 13 
 
 Macrolide [4]: Yamaguchi Macrolactonization: A flame-dried 25 mL 
round bottom flask under Ar was charged with seco acid 24 (11.4 mg, 
0.0197 mmol, 1.0 equiv.). The substrate was then azeotroped with benzene 
(3 x 1 mL) under high vacuum. The reaction flask was then charged 
sequentially with benzene (1.97 mL), DIPEA (34.4 µL, 0.1976 mmol, 10.0 equiv.), and 2,4,6-
trichlorobenzoyl chloride (Sigma-Aldrich, 15.4 µL, 0.0988 mmol, 5.0 equiv.) and stirred for 1 hr. 
At this time, an additional portion of DIPEA (34.4 µL, 0.1976 mmol, 10.0 equiv.) and 2,4,6-
trichlorobenzoyl chloride (Sigma-Aldrich, 30.8 µL, 0.1976 mmol, 10.0 equiv.) was added to the 
reaction and it was stirred for 4 hr. The reaction was then charged with DMAP (Sigma-Aldrich, 
96.9 mg, 0.794 mmol, 40.1 equiv.) in one portion and immediately diluted with benzene (1.91 
mL – 0.005 M total). The resulting white slurry was stirred for 45 min before it was quenched 
with 1 M NaHSO4 (10 mL) and diluted with CH2Cl2 (5 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were then 
washed with satd NaHCO3, dried over MgSO4, filtered, and concentrated in vacuo to afford a 
clear oil. Purification by flash chromatography (10% EtOAc/hexanes) furnished macrolide 4 as a 
clear oil (9.4 mg, 0.0172 mmol, 87%). 
 For spectroscopic data, see 4 in the C–H oxidative macrolactonization section. 
 
Oligomer: Yamaguchi Macrolactonization: A flame-dried 25 mL round bottom flask under Ar 
was charged with seco acid 25 (10.4 mg, 0.01803 mmol, 1.0 equiv.). The substrate was then 
azeotroped with benzene (3 x 1 mL) under high vacuum. The reaction flask was then charged 
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sequentially with benzene (1.80 mL), DIPEA (31.4 µL, 0.1803 mmol, 10.0 equiv.), and 2,4,6-
trichlorobenzoyl chloride (Sigma-Aldrich, 14.5 µL, 0.091 mmol, 5.0 equiv.) and stirred for 1 hr. 
At this time, an additional portion of DIPEA (31.4 µL, 0.1803 mmol, 10.0 equiv.) and 2,4,6-
trichlorobenzoyl chloride (Sigma-Aldrich, 29.0 µL, 0.1803 mmol, 10.0 equiv.) was added to the 
reaction and it was stirred for 4 hr. The reaction was then charged with DMAP (Sigma-Aldrich, 
88.3 mg, 0.723 mmol, 40.1 equiv.) in one portion and immediately diluted with benzene (1.81 
mL – 0.005 M total). The resulting white slurry was stirred for 45 min before it was quenched 
with 1 M NaHSO4 (10 mL) and diluted with CH2Cl2 (5 mL). The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were then 
washed with satd NaHCO3 and concentrated in vacuo (not dried or filtered) to afford the 
oligomeric material (confirmed by 1H NMR and GPC analysis).  
 
Completion of 6-deoxyerythronolide B Synthesis for Figure 14 
 
 (1S,2R,5R,6R,7R,8S,9S,10R,12S,13S,17R)-5-ethyl-7,9-dihydroxy-
2,6,8,10,12,15,15,17-octamethyl-4,14,16-
trioxabicyclo[11.3.1]heptadecan-3-one: A 10 mL round bottom flask was 
charged with macrolide 4 (15.2 mg, 0.0279 mmol, 1.0 equiv.) and H2 purged 
i-PrOH (0.74 mL, 0.0375M) at ambient temperature. The reaction was then charged with 
Pd(OH)2/C (20 wt%, 2.8 mg), topped with H2 balloon, and let stir at r.t. for 6 hr. At this time, the 
reaction was diluted with EtOAc (3 mL) and filtered through celite plug (washing with EtOAc), 
and concentrated in vacuo to afford a clear oil. Purification by flash chromatography (25% 
EtOAc/hexanes) furnished the diol product as a clear oil (11.5 mg, 0.0268 mmol, 96%). 
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 1H NMR (500 MHz, CDCl3) δ 5.23 (ddd, J = 9.5, 4.5, <1.0 Hz, 1H), 3.87 (d, J = 6.0 Hz, 
1H), 3.73 (d, J = 10.0 Hz, 1H), 3.66 (d, J = 10.5 Hz, 1H), 3.60 (d, J = 3.5 Hz, 1H), 3.34 (d, J = 
9.0 Hz, 1H), 3.07 (app td, J = 10.5, 3.0 Hz, 1H), 2.77 (dq, J = 11.0, 7.0 Hz, 1H), 2.16 (m, 1H), 
1.98 (q, J = 7.5 Hz, 1H), 1.68-1.83 (m, 3H), 1.51 (m, 2H), 1.46 (s, 6H), 1.20-1.25 (m, 2H), 1.18 
(d, J = 7.0 Hz, 3H), 1.08 (d, J = 7.5 Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H), 1.00 (d, J = 6.5 Hz, 3H), 
0.96 (d, J = 7.0, 3H), 0.90 (t, J = 7.5 Hz, 3H), 0.83 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ 177.4, 101.0, 82.0, 78.0, 75.7, 73.4, 71.1, 42.0, 40.8, 36.3, 34.3, 32.5, 32.4, 32.0, 29.7, 
25.5, 19.9, 16.2, 15.9, 13.5, 10.6, 9.9, 8.8, 7.8; IR (film, cm-1): 3446, 2966, 2928, 2857, 1728, 
1455, 1381, 1267; HRMS (ESI) m/z calc’d for C24H45O6 [M + H]+: 429.3216, found 429.3214; 
[α]D23 = +25.0o (c = 0.12, CH2Cl2). Note that this spectroscopic data is in full agreement with a 
previous literature report.10 
 
 (1S,2R,5R,6R,7S,8R,10R,12S,13S,17R)-5-ethyl-7-hydroxy-
2,6,8,10,12,15,15,17-octamethyl-4,14,16-
trioxabicyclo[11.3.1]heptadecane-3,9-dione: A flame-dried 10 mL round 
bottom flask was charged with diol (9.2 mg, 0.021465 mmol, 1.0 equiv.), 
powdered 4Å mol sieves (60 mg), and CH2Cl2 (2.15 mL, 0.01M). The reaction was then placed 
in a 0°C bath and charged sequentially with NMO (Sigma-Aldrich, 12.6 mg, 0.1073 mmol, 5.0 
equiv.) and TPAP (Sigma-Aldrich, 97%, 2.3 mg, 0.0064 mmol, 0.3 equiv.) and let stir at 0°C for 
20 min. The reaction was then diluted with EtOAc (3 mL) and filtered through a short silica plug 
(washing with EtOAc), and concentrated in vacuo to afford a clear oil. Purification by flash 
chromatography (20% EtOAc/hexanes) furnished the β-hydroxyketone product as a clear oil (7.7 
mg, 0.0181 mmol, 84%) and recovered diol SM (1.2 mg, 0.002799 mmol, 13% rSM). 
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 1H NMR (500 MHz, CDCl3) δ 5.30 (ddd, J = 9.5, 4.5, 1.0 Hz, 1H), 3.97 (m, 1H), 3.93 (d, J 
= 6.0 Hz, 1H), 3.79 (d, J = 10.5 Hz, 1H), 3.05 (d, J = 4.5 Hz, 1H), 2.80 (m, 2H), 2.66 (m, 1H), 
2.15 (m, 1H), 1.89 (q, J = 6.5 Hz, 1H), 1.65-1.84 (m, 3H), 1.53 (m, 1H), 1.47 (s, 6H), 1.25 (m, 
1H), 1.20 (d, J = 6.5 Hz, 3H), 1.08 (d, J = 6.5 Hz, 3H), 1.05 (d, J = 6.5 Hz, 3H), 1.02 (d, J = 7.0 
Hz, 3H), 0.99 (d, J = 7.0, 3H), 0.92 (d, J = 7.0, 3H), 0.91 (t, J = 7.0 Hz, 3H). 13C NMR (125 
MHz, CDCl3) δ 213.2, 177.8, 101.1, 77.9, 76.1, 73.2, 71.2, 44.2, 42.1, 41.0, 39.0, 37.5, 32.9, 
32.3, 29.7, 25.6, 20.0, 15.9, 13.5, 13.2, 10.6, 9.3, 7.8, 6.1; IR (film, cm-1): 3479 (br), 2975, 2941, 
2879, 1709, 1456, 1381, 1271; HRMS (ESI) m/z calc’d for C24H42O6Na [M + Na]+: 449.2903, 
found 449.2889; [α]D23 = -50.1o (c = 0.64, CH2Cl2). Note that this experimental data is in full 
agreement with a previous literature report.9 
 
 6-deoxyerythronolide B: A 10 mL round bottom flask was charged with 
β-hydroxyketone (3.97 mg, 0.0093 mmol, 1.0 equiv.), THF (0.21 mL, 
0.044M), and 1M HClaq (100 µL, 0.1 mmol, 10.8 equiv.). After stirring for 
8 hrs, the reaction was diluted with Et2O (5 mL) and partitioned between 
Et2O and H2O (5 mL). After separating the phases, the organic layer was washed with satd 
NaHCO3 (1 x 10 mL), dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. 
Purification by flash chromatography (35% EtOAc/hexanes) furnished 6-deoxyerythronolide B 
as a clear oil (3.53 mg, 0.0091 mmol, 98%). 
 1H NMR (500 MHz, CDCl3) δ 5.15 (ddd, J = 9.5, 4.0, 1.0 Hz, 1H), 4.00 (m, 1H), 3.92 (d, J 
= 10.5 Hz, 1H), 3.87 (d, J = 4.0 Hz, 1H), 3.68 (ddd, J = 10.0, 4.5, 2.0 Hz, 1H), 2.87 (d, J = 1.5 
Hz, 1H), 2.78 (m, 2H), 2.63 (m, 1H), 2.00-2.05 (m, 2H), 1.79-1.89 (m, 2H), 1.64-1.75 (m, 2H), 
1.53 (m, 1H), 1.30 (d, J = 7.0 Hz, 3H), 1.25 (m, 1H), 1.07 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 7.0 
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Hz, 3H), 1.05 (d, J = 7.0 Hz, 3H), 1.02 (d, J = 6.5, 3H), 0.93 (t, J = 7.5, 3H), 0.89 (d, J = 7.0 Hz, 
3H). 13C NMR (125 MHz, CDCl3) δ 213.5, 178.4, 79.5, 76.5, 76.3, 70.9, 43.9, 43.4, 40.6, 39.2, 
37.7, 37.5, 35.6, 25.4, 16.6, 14.8, 13.2, 10.6, 9.2, 6.9, 6.2; IR (film, cm-1): 3489, 2974, 2931, 
1708, 1460, 1381, 1381; HRMS (ESI) m/z calc’d for C21H38O6Na [M + Na]+: 409.2566, found 
409.2555; [α]D23 = -39.4o (c = 0.64, CH2Cl2). Note that this experimental data is in full 
agreement with previous literature reports.8,9,10 
 
 (3R,4S,5R,6S,7S,9R,11R,12S,13S,14R)-14-ethyl-3,5,7,9,11,13-
hexamethyl-2,10-dioxooxacyclotetradecane-4,6,12-triyl triacetate [26]: 
A 10 mL round bottom flask was charged with 6-deoxyerythronolide B 
(3.53 mg, 0.0091 mmol, 1.0 equiv.), pyridine (0.70 mL, 0.013 M), Ac2O 
(80.0 µL, 0.846 mmol, 93.0 equiv.), and 1 crystal of DMAP. The reaction was stirred for 40 hr, 
at which time the reaction was concentrated in vacuo and purified by flash chromatography (50% 
Et2O/pentane) to furnish triacetate 26 as a white solid (4.5 mg, 0.00878 mmol, 96%). This white 
solid was dissolved in refluxing CH2Cl2/hexanes (100 µL/ 500 µL) and placed in -40°C freezer 
overnight. The mother liquor was decanted and discarded to afford clear X-ray quality crystals 
(See X-ray crystal structure data). Note that this compound has been synthesized previously.43 
 
 (1S,2R,5S,6R,7R,8S,9S,10R,12S,13S,17R)-5-ethyl-7,9-dihydroxy-
2,6,8,10,12,15,15,17-octamethyl-4,14,16-
trioxabicyclo[11.3.1]heptadecan-3-one: A 10 mL round bottom flask was 
charged with macrolide 5 (10.6 mg, 0.0195 mmol, 1.0 equiv.) and H2 purged 
i-PrOH (0.52 mL, 0.0375M) at ambient temperature. The reaction was then charged with 
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Pd(OH)2/C (20 wt%, 2.4 mg), topped with H2 balloon, and let stir at r.t. for 6 hr. At this time, the 
reaction was diluted with EtOAc (3 mL) and filtered through celite plug (washing with EtOAc), 
and concentrated in vacuo to afford a clear oil. Purification by flash chromatography (25% 
EtOAc/hexanes) furnished the title compound as a clear oil (6.91 mg, 0.0161 mmol, 83%). 
 1H NMR (500 MHz, CDCl3) δ 5.13 (dd, J = 10.0, 3.0, 1H), 4.22 (d, J = 9.0 Hz, 1H), 4.01 
(d, J = 4.0 Hz, 1H), 3.87 (dd, J = 10.0, 2.0 Hz, 1H), 3.28 (br s, 1H), 3.25 (d, J = 10.5 Hz, 1H), 
2.61 (dq, J = 10.0, 7.0 Hz, 1H), 2.37 (br s, 1H), 2.14 (m, 1H), 2.04 (m, 1H), 1.80-1.96 (m, 4H), 
1.71 (m, 1H), 1.47 (s, 3H), 1.44 (s, 3H), 1.35-1.40 (m, 2H), 1.32 (d, J = 7.0 Hz, 3H), 1.08 (d, J = 
7.5 Hz, 6H), 0.98 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.86 (t, J = 7.0 Hz, 3H), 0.86 (d, J 
= 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 173.9, 99.5, 83.1, 81.0, 76.3, 72.3, 69.6, 44.0, 
41.2, 36.0, 33.4, 33.2, 32.8, 31.6, 29.9, 27.8, 19.8, 16.8 (2 peaks), 16.3, 15.9, 11.2, 10.7, 7.8; IR 
(film, cm-1): 3454, 2971, 2933, 2881, 2855, 1731, 1461, 1381, 1257; HRMS (ESI) m/z calc’d for 
C24H45O6 [M + H]+: 429.3216, found 429.3232; [α]D23 = -3.9o (c = 0.69, CH2Cl2). 
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X-ray Crystal Structural Data for Figure 14 
 
 
 
 
 
 
 
 
 
 
 
(3R,4S,5R,6S,7S,9R,11R,12S,13S,14R)-14-ethyl-3,5,7,9,11,13-
hexamethyl-2,10-dioxooxacyclotetradecane-4,6,12-triyl triacetate [26]: 
 
 
 
 
 
Table.  Crystal data and structure refinement for b91cas. 
Identification code  b91cas 
Empirical formula  C28 H46 Cl2 O9 
Formula weight  597.55 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21    
Unit cell dimensions a = 8.353(2) Å a= 90°. 
 b = 23.757(6) Å b= 108.566(4)°. 
 c = 8.573(2) Å g = 90°. 
Volume 1612.7(7) Å3 
Z 2 
Density (calculated) 1.231 Mg/m3 
Absorption coefficient 0.248 mm-1 
F(000) 640 
Crystal size 0.20 x 0.16 x 0.08 mm3 
Theta range for data collection 1.71 to 25.40°. 
Index ranges -10<=h<=10, -28<=k<=28, -10<=l<=10 
Reflections collected 12585 
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O
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Independent reflections 5782 [R(int) = 0.0777] 
Completeness to theta = 25.40° 99.8 %  
Absorption correction Integration 
Max. and min. transmission 0.9799 and 0.9474 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5782 / 91 / 362 
Goodness-of-fit on F2 0.867 
Final R indices [I>2sigma(I)] R1 = 0.0571, wR2 = 0.1126 
R indices (all data) R1 = 0.1317, wR2 = 0.1298 
Absolute structure parameter 0.21(9) 
Largest diff. peak and hole        0.368 and -0.353 e.Å-3 
 
 
 
Crystallographic data have been deposited at the Cambridge Crystallographic Centre, 12 Union 
Road, Cambridge CB2 1EZ, UK, and copies can be obtained on request, free of charge, by 
quoting the publication citation and the deposition number 726952. 
 
 
Molecular Modeling Studies for Figure 6 
 
 
Monte Carlo conformational searches were performed for both macrolide 4 and 5 using the 
Molecular Operating Environment program (MOE), Version 2006.0844, with the empirical 
MMFF94s force field with no distance cutoffs for non-bonded interactions. 3500 random 
conformations were generated and minimized with Gaussian distribution of dihedrals biased 
towards multiples of 30°, dihedral minimization (RMS = 100), 0.001 Cartesian minimization 
RMS gradient, 0.0001 Cartesian perturbation, 0.1 RMS tolerance, a maximum of 2000 energy 
minimization steps for each minimization, a failure limit of 5000, no chiral inversion, no rotation 
about π-bonds or amide bonds, and an energy cutoff of 5 kcal/mol. Without further energy 
minimizations, macrolide 4 was found to be 2.16 kcal/mol more stable than macrolide 5. 
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The lowest energy structures obtained from the Monte Carlo conformational searches were then 
energy-minimized using the MMFF94s force field (1) implemented in the Program MOE (2), 
version 2009.2, to a root mean square energy gradient inferior to 10-5 kcal/mol/angstrom. No 
non-bonded cutoff functions were used and the dielectric constant was set to 1 (i.e. in vacuo 
calculations). No additional parameterization of the MMFF94s potential energy function was 
necessary. In addition, the heat of formation of both macrolides (4 and 5) were calculated at the 
semi-empirical PM3 level using the program MOPAC (3) as implemented in MOE. 
 
Macrolide 4: 
MMFF94s potential energy: 49.8 kcal/mol 
PM3 heat of formation: -275.1 kcal/mol 
 
Macrolide 5: 
MMFF94s potential energy: 52.8 kcal/mol 
PM3 heat of formation: -273.7 kcal/mol 
 
Energy difference Delta E (4 – 5) 
MMFF94s potential energy: -3.0 kcal/mol 
PM3 heat of formation: -1.4 kcal/mol 
 
These results were confirmed with DFT/ B3LYP/6-31G*//HF/3-21G single points calculations 
i.e. HF/3-21G energy minimized structures were used to calculate single-point DFT B3LYP/6-
31G* energies, without additional minimization. 
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CHAPTER 2 
 
ON THE MACROCYCLIZATION OF THE ERYTHROMYCIN CORE: 
PREORGANIZATION IS NOT REQUIRED 
 
2.1 INTRODUCTION 
 The erythromycins, discovered and isolated in the early 1950’s, are the best-known 
members of the clinically important macrolide class of antibiotics.45 The 14-membered 
macrolactone core imbedded in these natural products has inspired new synthetic methodology 
for the construction of large ring lactones, beginning with the landmark synthesis of 
erythronolide B by the Corey group in 1978.46 During these studies, a single acetonide protecting 
group was utilized at the C3/C5 position. Similarly, this protecting group was used by the 
Masamune group years later for the synthesis of 6-deoxyerythronolide B (6-dEB).47 While no 
rationale was given for the use of this acetonide at the time, its function was revealed during the  
Figure 18. Woodward Cyclization Studies 
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Woodward group’s historic synthesis of erythromycin A in 1981.48 In three consecutive 
communications, the Woodward group extensively explored the conformational requirements for 
efficient acylation-based macrolactonization of erythromycin A seco acid derivatives (Figure 
18). In particular, cyclic protecting groups were placed at varying positions in order to serve as 
biasing elements,49 i.e. artificial structural features intended to aid macrocyclic ring closure 
through substrate preorganization. The results from this study led the Woodward group to 
conclude that “certain structural features such as… cyclic protecting groups at C3/C5 and 
C9/C11 are required for efficient lactonization” and that “these structural requirements probably 
arise from conformation requirements for lactonization.” This conclusion – that preorganization 
is required for efficient cyclization – has become a well-accepted doctrine that has influenced the 
planning of all ensuing erythromycin syntheses (vide infra).  
Figure 19. Cyclization Substrates Utilizing Cyclic Biasing Elements at C3/C5 and C9/C11 
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Inspired by the Woodward report, synthetic endeavors by Stork, Nakata, Yonemitsu, 
Danishefsky, Kochetkov, Hoffmann, Evans, Woerpel, Nelson, and our labs have reduced 
conformational space available to the seco acid backbones of the erythronolide series (i.e. 6-dEB, 
erythronolide B, and erythronolide A) through the use of six-membered ring protecting groups 
on C3/C5 and C9/C11 (Figure 19).50,51 In addition to cyclic protecting group scaffolds, other 
types of biasing elements (e.g. heterocycles, olefins, etc.) have been employed in similar 
positions to rigidify the hydroxy acid backbone (Figure 20).52,53 In a particularly notable 
example, Paterson validated this approach using two olefinic rigidifying elements in place of 
cyclic protecting groups.54 Furthermore, the Martin group demonstrated that steric bulk at C5 
coupled to a C9/C11 cyclic acetal could enable cyclization.55 In this case, the use of a sterically 
bulky desosamine sugar residue at the C5, or a C3 cladinose and C5 desosamine sugar residue 
together, were thought to reduce the conformational mobility along the C1-C8 subunit of the 
polypropionate backbone and facilitate cyclization of erythromycin B precursors. 
Figure 20. Cyclization Substrates Utilizing ‘Other’ Biasing Elements Strategies 
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Since the original Corey erythronolide B synthesis, which utilized the newly developed 
Corey-Nicoloau macrocyclization56 technique, a wide variety of lactonization methods have been 
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employed for macrolide construction of the erythromycins including the Masamune,57 Keck,58 
Yamaguchi,59 Yonemitsu-Yamaguchi,60 and the Shiina61 macrolactonization reactions. Despite 
these significant advances in macrocyclization methods and dilution techniques,62 the use of 
biasing elements has been universal for the cyclization of erythromycin substrates. The steadfast 
application of one or more structural biasing elements in erythromycin’s synthetic history 
demonstrates the resonating impact of Woodward’s cyclization studies.  
We previously reported a late-stage C–H oxidation strategy for the total synthesis of 6-
deoxyerythronolide B (6-dEB), using a palladium(II)/bis-sulfoxide(1)-catalyzed C–H oxidative 
macrolactonization reaction developed in our labs.51,63 As a part of our synthetic planning, we 
also chose to employ traditional cyclic protecting groups at C9/C11 and C3/C5 (20) in order to 
facilitate macrocyclic ring closure (vide supra, Table 1). In the presence of these biasing 
elements, the 14-membered macrolide product was formed in 34% yield (45% recovered starting 
material, rSM; 56% yield recycled 2x) and with >40:1 d.r. in favor of the natural C13 
diastereomer 4. Based on the Hammond postulate, we attributed the inability to form the 
unnatural C13 diastereomer under the chelate-controlled C–H oxidative macrolactonization 
conditions64 to the large difference in ground-state product energies between the C13 
diastereomers (the natural C13 diastereomer was calculated to be 3 kcal/mol more stable than the 
C13 epimer). Similarly, while acylation-based Yamaguchi cyclization of 24 provided the natural 
macrolide 4 in high yield, the unnatural C13 diastereomer (5) could not be formed (Figure 13). 
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Figure 21. Cyclization Strategy Without Substrate Preorganization. From reference 69  
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Upon revisiting the Woodward studies, in which the positioning of cyclic protecting groups 
had been optimized for the natural erythromycin structure, we questioned whether the biasing 
elements were in fact hampering the cyclization of stereochemical analogues. In this vein, we 
recognized the absence of a key control experiment: attempted cyclization of a substrate 
completely devoid of biasing elements. Surprisingly, this experiment has remained unreported in 
the literature despite over 30 years of erythromycin syntheses. We therefore set out to test the 
well-accepted idea that preorganization is necessary for cyclization of the erythromycin structure 
(Figure 21).  
 
2.2 RESULTS AND DISCUSSION 
2.2.1 Synthesis of the Unbiased Alkenoic Acid and Yamaguchi Cyclization Precursors 
6-Deoxyerythronolide B, the aglycone precursor to the erythromycins, serves as the 
archetypical core of the polyketide macrolide antibiotics. In Nature, a seco acid bearing 
unadorned hydroxyl groups at C3, C5, and C11 and ketone functionality at C9 is cyclized to 
form 6-dEB, which is then hydroxylated at the C6 and C12 positions through enzymatic C–H 
functionalization to form erythronolides B and A, respectively (Figure 22).65 To mimic the 
biosynthesis of 6-dEB, cyclization was first attempted on a substrate (27) with unprotected 
hydroxyl groups at C3, C5, C9, and C11 under C–H oxidative macrolactonization conditions 
(Figure 23). Unfortunately, these attempts were met with failure, due to facile olefin oxidation  
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Figure 22. Biosynthesis of the Erythromycins and Macrocyclization to form 6-dEB  
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processes. In addition to preventing such competing olefin oxidation pathways, protecting groups 
were deemed necessary to preclude the formation of unwanted ring sizes66 and to inhibit 
preorganization via 1,3-hydrogen bonding (hydrogen bonding in acyclic 1,3-diols may induce a 
solution conformation analogous to that of acetonide protecting groups).67 Polypropionate 
molecules typically adopt conformations that minimize syn-pentane interactions, and thus will 
have inherent preorganization that may aid cyclization.68 However, in attempts to minimize  
Figure 23. Attempted C–H Oxidative Macrocyclization Without Protecting Groups  
OH OHOHOHO
HO 13 BQ, 45!C
S S PhPh
OO
Pd(OAc)2
(30 mol%) OH
OH
OH
OHO
O
1
27
28  
Conditions: 27 (1.0 equiv.), 1 (30 mol%), BQ (2.0 equiv.), CH2Cl2 (0.02 M), 45°C, 
72 h. 
 
artificial bias (bias not present in the native polypropionate structure), we selected methyl ether 
protecting groups for these cyclization studies because of their inability to induce electrostatic 
preorganization while maintaining similar steric properties to the natural substrate’s free 
hydroxyls. We reasoned that the use of any other protecting group, albeit potentially more 
synthetically useful, might inadvertently enable cyclization through either steric55 or electronic 
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preorganization of the substrate. Accordingly, we synthesized a tetramethyl ether protected 
hydroxy acid and alkenoic acid as the unbiased cyclization precursors.69 
Figure 24. Synthesis of Tetramethylated Common Synthetic Intermediate 29  
O O
PMP
OOO
N 13O
O
Bn
43%
 (over 2 steps)
a,b OMeOMeOMeOMeO
N 13O
O
Bn
21 29  
Conditions: (a) 1M HCl(aq) (2.0 equiv.), 45°C, 70% (b) Me3OBF4 (50.0 equiv.), proton 
spongeTM (75.0 equiv.), 62%. 
 
The syntheses of both unbiased cyclization precursors 30 and 31 proceeded conveniently 
via a common intermediate, terminal olefin 29. Global deprotection of a previously synthesized 
bis-acetal intermediate (21) under aqueous HCl conditions, followed by permethylation with 
Me3OBF4 and proton sponge furnished tetramethylated terminal olefin 29 (Figure 24). 
Straightforward chiral auxiliary removal with LiOOH provided the C–H oxidative cyclization 
substrate 30 in 99% yield (Figure 25). Intermolecular palladium(II)/bis-sulfoxide(1)-catalyzed 
C–H oxidation provided the C13 oxidized products as diastereomeric allylic p-nitrobenzoates in 
59% yield (1.2:1 d.r.). Chiral auxiliary hydrolysis with LiOOH and methanolysis of the p-
nitrobenzoates furnished the unbiased seco acids 31 in 89% yield (over 2-steps, 1.2:1 d.r.).69 
Notably, C–H oxidation greatly aided these studies by circumventing de novo syntheses of both 
epimeric Yamaguchi precursors 31.51,70 
Figure 25. Synthesis of Unbiased Alkenoic Acid 30 and Epimeric Seco Acids 31 
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Conditions: (a) LiOOH(aq) (2.0 equiv.), 0°C, 99% (b) 1 (10 mol%), BQ (2.0 equiv.), p-
NO2BzOH (1.5 equiv.), 45oC, 72 h, 1.2:1 d.r., 59% combined (c) LiOOH(aq) (2.0 
equiv.), 0°C (d) K2CO3 (3.0 equiv.), MeOH, 89% over 2-steps. Adapted from reference 
69. 
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2.2.2 Yamaguchi Macrolactonization Reaction Without Substrate Preorganization 
In order to evaluate if preorganization is needed for efficient macrolactonization of 
erythromycin precursors, we attempted a traditional acylation-based macrolactonization with 
unbiased hydroxy acids 31 (1.2:1 d.r.). Although in the original Woodward studies, acylation-
based macrolactonization was effected via the Corey-Nicolaou method, most subsequent studies 
utilized the Yamaguchi protocol. Therefore, we again decided to employ the Yamaguchi 
cyclization method for these studies.59 Strikingly, both the natural and unnatural C13 
diastereomeric hydroxy acids cyclized efficiently under standard Yamaguchi macrolactonization 
conditions, to afford the 14-membered macrolide products 32 and 33 in 70% yield (2:1 d.r., 
Figure 26). The ease with which these hydroxy acids cyclized in the absence of biasing elements 
is remarkable; matching the best yield obtained from Woodward’s original preorganization 
studies. Despite decades of erythromycin syntheses, this is the first reported case where 
precursors to any member of the erythromycins have been cyclized successfully without the use 
of biasing elements to aid in 14-membered macrolide formation.69 
Figure 26. Yamaguchi Macrolactonization of Unbiased 6-dEB Precursor 31  
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HO 13
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Conditions: Cl3C6H2COCl (15.0 equiv.), i-Pr2NEt (20.0 equiv.), DMAP (40.0 equiv.), 
Benzene (0.005 M), r.t., 2:1 d.r., 70% combined. Adapted from reference 69. 
 
2.2.3 C–H Oxidative Macrolactonization Reaction Without Substrate Preorganization 
The C–H oxidative macrolactonization of unbiased alkenoic acid (30 → 32/33) also 
proceeded in the absence of biasing elements (Figure 27), providing comparable yields (36% 
yield, 44% recovered SM) to the analogue containing biasing elements (20 → 4, Table 1).  More 
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importantly, in contrast to previous results with cyclic protecting groups at C9/C11 and C3/C5, 
the unnatural C13-diastereomer 33 could be now be accessed from this unbiased precursor (1:3.3 
d.r. from 30 vs. 1:>40 d.r. from 20).69 Based on these results, we may conclude that Pd/bis-
sulfoxide-catalyzed C–H oxidative macrolactonizaton of erythromycin precursors also does not 
require biasing elements, although such elements can significantly improve the diastereomeric 
outcome of the cyclization.  
Figure 27. C–H Oxidative Macrolactonization of Unbiased 6-dEB Precursor 30 
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Conditions: 1 (30 mol%), BQ (2.0 equiv.), CH2Cl2 (0.02 M), 45°C, 72 h, 3.3:1 d.r., 36% + 
45% rSM. Adapted from reference 69. 
 
2.3 CONCLUSIONS 
We demonstrate for the first time that a linear seco acid and alkenoic acid substrate, both 
precursors to the erythromycin core structure (6-dEB), can be efficiently lactonized when devoid 
of preorganizational elements. These results definitively demonstrate that artificial 
preorganization is not a requirement for the efficient cyclization of erythromycin’s 
polypropionate core (6-dEB). While we cannot exclude the possibility that erythronolide B or A 
would still require preorganization due to the presence of a C6 and/or C12 hydroxyl(s), this study 
suggests that the inherent conformation of the linear biosynthetic polypropionate structure is 
sufficient for facile macrolactonization. Significantly, we show that designed preorganization 
dramatically impacts the cyclization outcome of stereochemical analogues of the erythromycins. 
Removal of artificial biasing elements allows for increased stereochemical flexibility in the 
macrocyclization process. Overall these findings require the revision of the thirty-year-old 
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dogma that preorganization is mandatory for achieving macrocyclization of the erythromycins. 
We anticipate that empowered with the knowledge that preorganization is not a requirement for 
cyclization, a broader evaluation of protecting groups will lead to the syntheses of 
stereochemically modified and/or functional group deficient analogues of erythromycin that may 
have been difficult and/or impossible to generate under the former perceived constraints.  
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2.4 EXPERIMENTAL SECTION 
General Information: Unless otherwise noted, all reactions were conducted in flame-dried 
glassware with magnetic stirring under an inert atmosphere of dry nitrogen. Solvents 
tetrahydrofuran (THF), diethyl ether (Et2O), methanol (MeOH), 1,4-dioxane, benzene, and 
methylene chloride (CH2Cl2) were purified prior to use by passage through a bed of activated 
alumina (Glass Contour, Laguna Beach, California). Deuterochloroform was stored over 3 Å 
molecular sieves. Diisopropylethylamine (DIPEA) was distilled from calcium hydride. The 
following commercially obtained reagents were used as received: Pd(II)/bis-sulfoxide catalyst 
(Sigma-Aldrich, lot #68482-1), proton-spongeTM (Sigma-Aldrich), Me3OBF4 (Sigma-Aldrich), 
H2O2 (Fisher Scientific, 30% wt solution), 1,4-benzoquinone (Sigma-Aldrich), 2,4,6-
trichlorobenzoyl chloride (Sigma-Aldrich). 
 Optical rotations were measured using a 1 mL cell with a 0.5 dm path length on a Perkin-
Elmer 341 polarimeter. Optical rotations were obtained with a sodium lamp and are reported as 
follows: [α]λ
TºC (c = g/100 mL, solvent). Infrared spectra were recorded as thin films on NaCl 
plates on a Mattson Galaxy Series FTIR 5000 and are reported in frequency of absorption (cm-1). 
High- and low-resolution mass spectra were obtained through the Mass Spectrometry 
Laboratory, School of Chemical Sciences, University of Illinois. Electrospray ionization (ESI) 
spectra were performed on a Waters Q-Tof Ultima spectrometer. Field desorption (FD) spectra 
were performed on a Micromass 70-VSE spectrometer. 1H NMR spectra were recorded on a 
Varian Unity-500 (500 MHz) spectrometer and are reported in ppm using solvent as an internal 
standard (CDCl3 at 7.26 ppm).  Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, br = broad, app = apparent; coupling constant(s) in Hz; integration. Proton-
decoupled 13C-NMR spectra were recorded on a Varian Unity-500 (125 MHz) or Varian Unity-
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600 (150 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3 at 77.0 ppm). Thin-layer chromatography (TLC) was conducted with E. Merck silica gel 
60 F254 precoated plates (0.25 mm) and visualized with UV, potassium permanganate, and ceric 
ammonium molybdate staining.  Flash column chromatography was performed as described by 
Still et al.71 using EM reagent silica gel 60 (230-400 mesh). 
 
Synthesis of Unbiased Alkenoic Acid and Epimeric Seco Acids for Figures 24 and 25 
 
 (R)-4-benzyl-3-((2R,3S,4R,5S,6S,8R,9S,10R,11S,12S)-
3,5,9,11-tetrahydroxy-2,4,6,8,10,12-
hexamethylpentadec-14-enoyl)oxazolidin-2-one: A 1 
dram borosilicate vial was charged sequentially with bis-acetal 2151 (50.0 mg, 0.0708 mmol, 1.0 
equiv.) THF (1.77 mL, 0.04 M) and 1M(aq) HCl (0.14 ml, 0.142 mmol, 2.0 equiv.). The reaction 
vial was topped with a teflon-lined cap and was heated at 45°C for 12 hrs. Upon completion, the 
reaction was partitioned between H2O (10 mL) and Et2O (10 mL). After separation, the organic 
layer was washed with satd. NaHCO3 (1 x 15 mL). The combined aqueous layers were then 
extracted with Et2O (2 x 20 mL) and EtOAc (2 x 20 mL). The combined organic layers were 
then dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. Purification by 
flash chromatography (60% EtOAc/hexanes to 100% EtOAc) furnished the tetraol product as a 
white foam (27 mg, 0.0498 mmol, 70%). 
 1H NMR (500 MHz, CDCl3) δ 7.33 (t, 7.3 Hz, 2H), 7.29 (d, J = 7.0 Hz, 1H), 7.20 (d, J = 
7.0 Hz, 2H), 5.84 (dddd, J = 16.5, 10.0, 8.0, 6.0 Hz, 1H), 5.05 (d, J = 17.0 Hz, 1H), 5.01 (d, J = 
10.0 Hz, 1H), 4.66-4.71 (m, 1H), 4.18-4.26 (m, 2H), 4.04 (app t, J = 5.0 Hz, 1H), 3.98 (dq, J = 
OH OHOHOHO
NO
O
Bn
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6.5, 6.5 Hz, 1H), 3.98 (m, 1H), 3.74 (d, J = 10.0 Hz, 1H), 3.56 (d, J = 8.5 Hz, 1H), 3.46 (bs, 2H), 
3.41 (d, J = 8.5 Hz, 1H), 3.25 (dd, J = 13.5, 3.0 Hz, 1H), 2.77 (dd, J = 13.5, 9.5 Hz, 1H), 2.51-
2.54 (m, 1H), 1.90-1.96 (m, 2H), 1.76-1.80 (m, 3H), 1.60-1.68 (m, 2H), 1.30 (d, J = 7.0 Hz, 3H), 
1.25 (m, 1H), 0.94 (d, J = 7.0 Hz, 3H), 0.88-0.91 (m, 1H), 0.86 (d, J = 6.5 Hz, 3H), 0.81 (d, J = 
6.0 Hz, 3H), 0.80 (d, J = 6.0 Hz, 3H), 0.79 (d, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 
176.1, 153.1, 137.7, 134.9, 129.4, 129.0, 127.4, 116.0, 80.4, 76.1, 74.6, 71.6, 66.2, 55.2, 41.0, 
38.4, 37.8, 37.7, 36.9, 36.8, 36.0, 32.8, 31.9, 16.3, 15.5, 14.2, 12.9, 8.9, 6.2; IR (film, cm-1): 
3406, 3068, 3030, 2970, 2929, 2881, 1780, 1695, 1456, 1383, 1354, 1211; HRMS (ESI) m/z 
calc’d for C31H50NO7 [M + H]+: 548.3587, found 548.3586; [α]D23 = -56.4o (c = 1.43, CH2Cl2). 
 
 (R)-4-benzyl-3-((2R,3S,4R,5S,6S,8R,9S,10R,11S,12S)-
3,5,9,11-tetramethoxy-2,4,6,8,10,12-
hexamethylpentadec-14-enoyl)oxazolidin-2-one [29]: A 10 mL round bottom flask was 
charged with tetraol (18.1 mg, 0.0330 mmol, 1.0 equiv.) and dissolved in CH2Cl2 (2.4 mL, 0.014 
M). Proton-spongeTM (531 mg, 2.47 mmol, 75.0 equiv.) and Me3OBF4 (244 mg, 1.65 mmol, 50.0 
equiv.) were then added to the reaction and allowed to stir for 18 hrs at room temperature in the 
dark. The reaction was quenched with satd NH4Cl (5 mL), transferred to a separatory funnel and 
diluted with EtOAc (15 mL), and the layers were separated. The organic layer was washed with 
1M HCl (1 x 10 mL) and H2O (1 x 15 mL). The combined aqueous layers were extracted with 
EtOAc (2 x 15 mL) and the combined organic layers were then dried over MgSO4, filtered, and 
concentrated in vacuo to afford a yellow oil. Purification by flash chromatography (20% 
EtOAc/hexanes) furnished tetramethyl ether 29 as a clear oil (12.3 mg, 0.0204 mmol, 62%). 
OMeOMeOMeOMeO
NO
O
Bn
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 1H NMR (500 MHz, CDCl3) δ 7.33 (t, J = 7.3 Hz, 2H), 7.28 (d, J = 7.5 Hz, 1H), 7.21 (d, 
J = 7.5 Hz, 2H), 5.81 (dddd, J = 17.0, 10.0, 8.0, 6.5 Hz, 1H), 5.04 (d, J = 18.0 Hz, 1H), 5.01 (d, J 
= 11.5 Hz, 1H), 4.58-4.63 (m, 1H), 4.18 (m, 2H), 4.02 (dq, J = 7.0, 7.0 Hz, 1H), 3.54 (s, 3H), 
3.49 (m, 1H), 3.48 (s, 3H), 3.46 (s, 3H), 3.39 (s, 3H), 3.26 (dd, J = 13.5, 3.0 Hz, 1H), 3.22 (d, J = 
8.5 Hz, 1H), 3.11 (d, J = 9.5 Hz, 1H), 3.04 (dd, J = 4.5, 4.0 Hz, 1H), 2.77 (dd, J = 13.5, 10.0 Hz, 
1H), 2.43 (m, 1H), 2.00 (m, 1H), 1.73-1.92 (m, 5H), 1.68 (m, 1H), 1.30 (d, J = 7.0 Hz, 3H), 1.11 
(m, 1H), 0.94 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 7.5 Hz, 3H), 0.89 (d, J = 7.0 Hz, 3H), 0.84 (d, J = 
6.5, 3H), 0.80 (d, J = 7.0, 3H). 13C NMR (125 MHz, CDCl3) δ 175.7, 152.8, 137.8, 135.2, 129.4, 
128.9, 127.4, 115.8, 85.7, 85.0, 84.8, 84.6, 66.0, 60.8, 60.5, 60.4, 59.4, 55.6, 40.7, 38.1, 38.0, 
37.9, 37.8, 37.7, 36.2, 33.1, 32.5, 16.8, 16.0, 14.2 (2 peaks), 10.5, 10.4; IR (film, cm-1): 3070, 
2968, 2931, 2829, 1784, 1695, 1639, 1456, 1381, 1352; HRMS (ESI) m/z calc’d for C35H58NO7 
[M + H]+: 604.4213, found 604.4216; [α]D23 = -1.7o (c = 0.6, CH2Cl2). 
 
 (2R,3S,4R,5S,6S,8R,9S,10R,11S,12S)-3,5,9,11-
tetramethoxy-2,4,6,8,10,12-hexamethylpentadec-14-enoic 
acid [30]: A 10 mL round bottom flask was charged sequentially with tetramethyl ether 29 
(16.8 mg, 0.0278 mmol, 1.0 equiv.), THF (1.45 mL, 0.0191 M), and H2O (0.29 mL, 0.0956 M). 
The reaction was placed in a 0°C bath and charged sequentially with H2O2 (30% wt solution, 
22.9 µL, 0.2227 mmol, 8.0 equiv.) and a 0.2 M LiOH(aq) solution (0.28 mL, 0.0556 mmol, 2.0 
equiv.). The reaction was gradually warmed to r.t. over 12 hours, at which point it was 
concentrated in vacuo, and loaded directly onto a silica column (25/75 EtOAc/Hex + 1% AcOH) 
to furnish tetramethyl alkenoic acid 30 as a yellow oil (12.3 mg, 0.0277 mmol, 99%). This 
material was then used immediately in the C–H oxidative macrolactonization reaction. 
OMeOMeOMeOMeO
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 1H NMR (500 MHz, CDCl3) δ 5.80 (dddd, J = 17.0, 10.0, 7.5, 5.5 Hz, 1H), 5.04 (d, J = 
17.5 Hz, 1H), 5.01 (d, J = 11.0 Hz, 1H), 3.51 (s, 3H), 3.50 (m, 1H), 3.50 (s, 3H), 3.46 (s, 3H), 
3.45 (s, 3H), 3.27 (dd, J = 7.5, 1.0 Hz, 1H), 3.06 (d, J = 10.0 Hz, 1H), 2.85 (dd, J = 5.5, 4.0 Hz, 
1H), 2.79 (m, 1H), 2.42 (m, 1H), 1.73-1.91 (m, 7H), 1.21 (d, J = 7.0 Hz, 3H), 1.03 (app t, J = 9.0 
Hz, 1H), 0.98 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.89 (d, J = 6.0 Hz, 3H), 0.84 (d, J = 
7.0 Hz, 3H), 0.78 (d, J = 6.5 Hz, 3H). 
 
 (4R,5S,6S,7S,8R,10S,11S,12R,13S,14R)-15-((R)-4-
benzyl-2-oxooxazolidin-3-yl)-5,7,11,13-tetramethoxy-
4,6,8,10,12,14-hexamethyl-15-oxopentadec-1-en-3-yl 4-nitrobenzoate: A stock solution was 
made of Pd(II)/bis-sulfoxide catalyst 1 (11.8 mg, 0.0235 mmol, 10.0 equiv.) in dioxane (0.789 
mL, 0.0296 M) in a 1 dram vial. A ½ dram vial was charged sequentially with tetramethyl ether 
29 (14.1 mg, 0.0234 mmol, 1.0 equiv.), BQ (5.04 mg, 0.0467 mmol, 2.0 equiv.), and p-
NO2BzOH (5.86 mg, 0.35 mmol, 1.5 equiv.). The ½ dram reaction vial was then charged with 
78.9 µL of Pd(II)/dioxane stock solution (10 mol% Pd, 0.296M dioxane), and topped with a 
Teflon-lined cap, and stirred in a 45°C bath for 72 hrs. The resulting black solution was cooled to 
r.t. and transferred to a separatory funnel with CH2Cl2, where it was quenched with 5% K2CO3 (5 
mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). 
The combined organic layers were then dried over MgSO4, filtered, and concentrated in vacuo to 
afford a clear oil. 1H NMR analysis of the crude product showed a d.r. of 1.2:1. Purification by 
flash chromatography (25% EtOAc/hexanes) furnished the p-nitrobenzoate ester products as a 
clear oil (10.6 mg, 0.01379 mmol, 59%, 1.2:1 d.r.). 
OMeOMeOMeOMeO
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 1H NMR (500 MHz, CDCl3) Major diastereomer: δ 8.30 (app. t, J = 9.0 Hz, 2H), 8.23 
(m, 2H), 7.28-7.34 (m, 3H), 7.19 (app. t, J = 7.5 Hz, 2H), 5.87-5.99 (m, 1H), 5.78 (app. t, J = 6.0 
Hz, 1H), 5.41 (d, J = 17.0 Hz, 1H), 5.35 (d, J = 9.0 Hz, 1H), 4.56-4.62 (m, 1H), 4.14-4.21 (m, 
2H), 3.98-4.04 (m, 1H), 3.50-3.52 (m, 1H), 3.47-3.49 (m, 1H), 3.37-3.51 (m, 12H), 3.22-3.27 (m, 
1H), 3.11-3.15 (m, 1H), 3.02-3.03 (m, 1H), 2.73-2.79 (m, 1H), 2.28 (m, 1H), 1.74-1.97 (m, 4H), 
1.63-1.70 (m, 1H), 1.28-1.30 (m, 3H), 1.07-1.15 (m, 1H), 0.98-1.03 (m, 3H), 0.81-0.94 (m, 12H). 
Minor Diastereomer (Diagnostic): δ 5.88 (m, 1H), 5.25 (d, J = 9.0 Hz, 1H), 5.23 (d, J = 17.0 Hz, 
1H). 13C NMR (150 MHz, CDCl3) δ 175.7 (2 peaks), 163.9, 163.6, 152.8, 150.6, 150.4, 136.2, 
135.8, 135.5, 135.2 (2 peaks), 133.1, 130.7, 130.6, 129.4 (2 peaks), 128.9 (2 peaks), 127.4, 
123.7, 123.5, 119.2, 116.3, 85.7, 85.6, 84.9, 84.5 (2 peaks), 81.7, 80.8, 77.6, 76.2, 66.0, 61.2 (2 
peaks), 60.7 (4 peaks), 60.5 (2 peaks), 60.4, 59.9 (2 peaks), 59.4 (2 peaks), 55.6, 40.7 (2 peaks), 
40.6, 40.1, 38.2, 38.1 (2 peaks), 37.9, 37.8 (2 peaks), 37.7, 33.3, 33.2, 32.8, 32.6, 16.9, 16.8, 14.2 
(2 peaks), 14.0 (2 peaks), 11.7, 10.5 (3 peaks), 10.4, 9.9; IR (film, cm-1): 3111, 3086, 3057, 3028, 
2972, 2933, 2829, 1782, 1726, 1693, 1608, 1529, 1456, 1381, 1350, 1273, 1211, 1196, 1101; 
HRMS (ESI) m/z calc’d for C42H61N2O11 [M + H]+: 769.4275, found 769.4269.  
 
 (2R,3S,4R,5S,6S,8R,9S,10S,11S,12S)-13-hydroxy-
3,5,9,11-tetramethoxy-2,4,6,8,10,12-hexamethylpentadec-
14-enoic acid [31]: A 10 mL round bottom flask was charged sequentially with the p-
nitrobenzoate esters (8.8 mg, 0.01144 mmol, 1.0 equiv.), THF (0.59 mL, 0.0191 M), and H2O 
(0.12 mL, 0.0956 M). The reaction was placed in a 0°C bath and charged sequentially with H2O2 
(30% wt solution, 9.4 µL, 0.0915 mmol, 8.0 equiv.) and a 0.2 M LiOH(aq) solution (0.114 mL, 
0.0229 mmol, 2.0 equiv.). The reaction was gradually warmed to r.t. over 12 hours, at which 
OMeOMeOMeOMeO
HO
OH
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point it was filtered through a short silica plug with 100% EtOAc + 1% AcOH, and concentrated 
in vacuo. The crude p-nitrobenzoate esters/carboxylic acid compounds were then taken onto the 
next step without any further purification. 
 A 10 mL round bottom flask was charged sequentially with p-nitrobenzoate 
esters/carboxylic acids (0.01144 mmol, 1.0 equiv.), MeOH (0.79 mL, 0.0145M), and K2CO3 (4.7 
mg, 0.0343 mmol, 3.0 equiv.). The reaction was stirred at r.t. for 2 hr, then filtered through short 
silica plug with 100% EtOAc + 1% AcOH and concentrated in vacuo to afford a clear oil. 
Purification by flash chromatography (40% EtOAc/hexanes + 1% AcOH) furnished tetramethyl 
hydroxy acid 31 as a clear oil (4.7 mg, 0.0102 mmol, 89% over 2 steps, 1.2:1 d.r.). This purified 
material was used immediately in the following Yamaguchi reaction. 
 1H NMR (500 MHz, CDCl3) Major diastereomer: δ 5.86 (ddd, J = 17.0, 10.5, 7.0, 1H), 
5.31 (d, J = 12.5 Hz, 1H), 5.28 (d, J = 17.0 Hz, 1H), 4.04 (app t, J = 7.5 Hz, 1H), 3.54-3.56 (m, 
1H), 3.45-3.53 (m, 12H), 3.06 (d, J = 10.5 Hz, 1H), 2.85 (m, 1H), 2.79 (m, 1H), 1.79-1.92 (m, 
6H), 1.25-1.33 (m, 1H), 1.20 (d, J = 6.0 Hz, 3H), 1.03 (m, 1H), 0.98 (d, J = 7.0 Hz, 3H), 0.80-
0.91 (m, 12H). Minor Diastereomer (Diagnostic): δ 5.92 (ddd, J = 15.5, 10.5, 5.0 Hz, 1H), 5.19 
(d, J = 16.0 Hz, 1H), 5.18 (d, J = 10.5 Hz, 1H), 4.41 (m, 1H), 3.08 (d, J = 9.0 Hz, 1H). 
 
Unbiased Yamaguchi Macrolactonization Study for Figure 26 
 
 (3R,4S,5R,6S,7S,9R,10S,11S,12S,13R)-4,6,10,12-
tetramethoxy-3,5,7,9,11,13-hexamethyl-14-
vinyloxacyclotetradecan-2-one [32 and 33]: This 
reaction was run according to literature precedent.50,51 
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A 25 mL round bottom flask was charged with tetramethyl hydroxyacid 31 (4.6 mg, 0.00998 
mmol, 1.0 equiv.), and this material was azeotropically dried with benzene (3 x 1 mL) under high 
vacuum. The reaction flask was then charged sequentially with benzene (1.0 mL), DIPEA (17.4 
µL, 0.0998 mmol, 10.0 equiv.), and 2,4,6-trichlorobenzoyl chloride (7.8 µL, 0.0499 mmol, 5.0 
equiv.) and stirred for 1 hr. At this time, an additional portion of DIPEA (17.4 µL, 0.0998 mmol, 
10.0 equiv.) and 2,4,6-trichlorobenzoyl chloride (15.6 µL, 0.0998 mmol, 10.0 equiv.) was added 
to the reaction and it was stirred for 4 hr. The reaction was then charged with DMAP (48.9 mg, 
0.400 mmol, 40.1 equiv.) in one portion and immediately diluted with benzene (1.0 mL – 0.005 
M total). The resulting white slurry was stirred for 45 min before it was quenched with 1 M 
NaHSO4 (10 mL) and diluted with CH2Cl2 (5 mL). The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were then washed 
with satd. NaHCO3, dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. 
1H NMR analysis of the crude product showed a d.r. of 2:1 (32 : 33).  Purification by flash 
chromatography (10% EtOAc/hexanes) furnished a 2:1 mixture of tetramethyl macrolides 32 and 
33 as a clear oil (3.1 mg, 0.0070 mmol, 70%). 
 1H NMR (500 MHz, CDCl3) Major diastereomer: δ 5.80 (ddd, J = 14.5, 10.0, 4.0 Hz, 
1H), 5.72 (m, 1H), 5.17 (dd, J = 16.5, 2.0 Hz, 1H), 5.17 (dd, J = 12.0, 2.0 Hz, 1H), 3.49 (s, 3H), 
3.45 (s, 3H), 3.45 (s, 3H), 3.41 (s, 3H), 3.25 (dd, J = 7.0, 2.5 Hz, 1H), 3.12 (d, J = 9.0 Hz, 1H), 
3.05 (dd, J = 5.0, 2.0 Hz, 1H), 2.80 (dq J = 7.0, 7.0 Hz, 1H), 2.65 (dd, J = 9.0, 3.5 Hz, 1H), 1.89-
2.02 (m, 2H), 1.78-1.88 (m, 1H), 1.69-1.76 (m, 2H), 1.29-1.34 (m, 1H), 1.23 (d, J = 7.0 Hz, 3H), 
1.08 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 7.5, 3H), 
0.82 (d, J = 7.0, 3H), 0.72-0.78 (m, 1H). Minor Diastereomer (Diagnostic): δ 5.15-5.26 (m, 3H), 
3.44 (s, 3H), 3.43 (s, 3H), 3.36 (s, 3H), 3.34 (s, 3H), 2.94 (d, J = 8.5 Hz, 1H), 2.73 (dq, J = 7.0, 
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7.0 Hz, 1H), 2.72-2.74 (m, 1H), 2.20 (m, 1H), 2.02-2.07 (m, 1H), 1.53-1.62 (m, 1H), 1.27 (d, J = 
7.0 Hz, 3H), 1.24 (d, J = 6.5 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 1.02 (m, 3H), 0.95 (d, J = 7.5 Hz, 
3H), 0.93 (d, J = 8.5 Hz, 3H). 13C NMR (asterisk denotes minor diastereomer peaks, 125 MHz, 
CDCl3) δ 175.7, 173.4*, 136.4, 136.0*, 117.4*, 115.3, 91.3, 87.6*, 85.4, 85.4*, 85.1, 79.4, 74.2, 
62.0, 61.4*, 61.3, 59.5*, 59.2, 58.7*, 45.1*, 43.6, 42.4, 40.7, 39.2*, 36.6*, 36.2*, 35.3, 34.7, 
34.6, 33.9, 32.3*, 29.7, 24.7*, 23.3*, 22.7*, 19.9*, 19.3*, 17.9, 17.1, 13.4*, 12.6, 12.0*, 11.2, 
9.5, 9.4*, 8.5; IR (film, cm-1): 3089, 2970, 2929, 2829, 1732, 1458, 1371, 1171, 1099. HRMS 
(ESI) m/z calc’d for C25H47O6 [M + H]+: 443.3373, found 443.3372; LRMS (FD) m/z found 
443.6.  
 
Unbiased C–H Oxidative Macrolactonization Study for Figure 27 
 
 (3R,4S,5R,6S,7S,9R,10S,11S,12S,13R)-4,6,10,12-
tetramethoxy-3,5,7,9,11,13-hexamethyl-14-
vinyloxacyclotetradecan-2-one [32 and 33]: An 
oven-dried 1 dram vial was charged sequentially with 
Pd(II)/bis-sulfoxide catalyst 1 (4.2 mg, 0.00834 mmol, 0.30 equiv.) and BQ (6.0 mg, 0.0556 
mmol, 2.0 equiv.). Tetramethyl alkenoic acid 30 (12.3 mg, 0.0278 mmol, 1.0 equiv.) was then 
dissolved/transferred (via pipette) to the 1 dram vial using CH2Cl2 (1.45 mL, 0.02 M) and the 
reaction was topped with a Teflon-lined cap. This bright red solution was stirred vigorously in a 
45°C bath for 72 hrs. The resulting dark green reaction was cooled to r.t. and transferred to a 
separatory funnel with CH2Cl2, where it was quenched with satd. NH4Cl (5 mL). The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic 
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layers were then dried over MgSO4, filtered, and concentrated in vacuo to afford a clear oil. 1H 
NMR analysis of the crude product showed a d.r. of 3.3:1 (32 : 33), and a product:SM ratio of 
0.8:1. Purification by flash chromatography (10% EtOAc/hexanes to 25% EtOAc/hexanes + 1% 
AcOH) furnished a mixture of tetramethyl macrolides 32 and 33 as a clear oil (4.4 mg, 0.0099 
mmol, 36%) and recovered tetramethyl alkenoic acid 30 (5.5 mg, 0.0124 mmol, 45%). 
 1H NMR (500 MHz, CDCl3) Major diastereomer: δ 5.80 (ddd, J = 15.0, 10.5, 4.5 Hz, 
1H), 5.72 (m, 1H), 5.17 (dd, J = 16.0, 2.0 Hz, 1H), 5.17 (dd, J = 12.5, 2.0 Hz, 1H), 3.49 (s, 3H), 
3.45 (s, 3H), 3.45 (s, 3H), 3.40 (s, 3H), 3.25 (dd, J = 7.0, 2.5 Hz, 1H), 3.12 (d, J = 9.5 Hz, 1H), 
3.05 (dd, J = 5.5, 2.5 Hz, 1H), 2.80 (dq J = 7.0, 7.0 Hz, 1H), 2.64 (dd, J = 9.0, 3.5 Hz, 1H), 1.89-
2.02 (m, 2H), 1.79-1.88 (m, 1H), 1.69-1.78 (m, 2H), 1.28-1.33 (m, 1H), 1.23 (d, J = 7.0 Hz, 3H), 
1.08 (d, J = 6.5 Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 7.5 Hz, 
3H), 0.81 (d, J = 7.0 Hz, 3H), 0.72-0.78 (m, 1H). Minor Diastereomer (Diagnostic): δ 5.15-5.26 
(m, 3H), 3.44 (s, 3H), 3.43 (s, 3H), 3.36 (s, 3H), 3.34 (s, 3H), 2.94 (d, J = 8.5 Hz, 1H), 2.73 (dq, 
J = 7.5, 7.5 Hz, 1H), 2.72-2.74 (m, 1H), 2.20 (m, 1H), 2.02-2.06 (m, 1H), 1.53-1.62 (m, 1H), 
1.27 (d, J = 7.5 Hz, 3H), 1.24 (d, J = 7.0 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 1.02 (m, 3H), 0.95 (d, 
J = 7.5 Hz, 3H), 0.93 (d, J = 8.0 Hz, 3H). 13C NMR (asterisk denotes minor diastereomer peaks, 
125 MHz, CDCl3) δ 175.7, 173.4*, 136.4, 136.0*, 117.4*, 115.3, 91.3, 87.6*, 85.4, 85.4*, 85.1, 
79.4, 74.2, 62.0, 61.4*, 61.3, 59.5*, 59.2, 58.7*, 45.1*, 43.6, 42.4, 40.7, 39.2*, 36.6*, 36.2*, 
35.3, 34.7, 34.6, 33.9, 32.3*, 29.7, 24.7*, 23.3*, 22.7*, 19.9*, 19.3*, 17.9, 17.1, 13.4*, 12.6, 
12.0*, 11.2, 9.5, 9.4*, 8.5; IR (film, cm-1): 3089, 2970, 2929, 2829, 1732, 1458, 1371, 1171, 
1099; HRMS (ESI) m/z calc’d for C25H47O6 [M + H]+: 443.3373, found 443.3375; LRMS (FD) 
m/z found 443.3. 
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Synthesis of Authentic Tetramethoxy Macrolide Standard 
 
Figure 28. Structural Confirmation of Macrolide 32 
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 (3R,4S,5R,6S,7S,9R,10S,11S,12R,13R,14R)-4,6,10,12-tetrahydroxy-
3,5,7,9,11,13-hexamethyl-14-vinyloxacyclotetradecan-2-one: Compound 4 
is a previously synthesized intermediate.51 A 1 dram borosilicate vial was 
charged sequentially with macrolide 4 (7.7 mg, 0.0141 mmol, 1.0 equiv.) 
THF (0.35 mL, 0.04 M) and 1M(aq) HCl (28.2 µL, 0.0282 mmol, 2.0 equiv.). The reaction vial 
was topped with a teflon-lined cap and was heated at 45°C for 12 hrs. Upon completion, the 
reaction was partitioned between H2O (10 mL) and Et2O (10 mL). After separation, the organic 
layer was washed with satd NaHCO3 (1 x 15 mL). The combined aqueous layers were then 
extracted with Et2O (2 x 20 mL). The combined organic layers were then dried over MgSO4, 
filtered, and concentrated in vacuo to afford a clear oil. Purification by flash chromatography 
(50% EtOAc/hexanes) furnished the tetrahydroxy macrolide product as a clear oil (4.1 mg, 
0.0106 mmol, 75%). 
 1H NMR (500 MHz, CDCl3) δ 5.84 (dddd, J = 15.5, 11.0, 4.5 Hz, 1H), 5.69 (m, 1H), 5.31 
(d, J = 17.5 Hz, 1H), 5.27 (d, J = 10.5 Hz, 1H), 4.22 (d, J = 4.0 Hz, 1H), 4.00 (bs, 1H), 3.87 (d, J 
= 10.5 Hz, 1H), 3.58 (d, J = 10.0 Hz, 1H), 3.41 (m, 1H), 3.16 (s, 1H), 3.00 (dt, J = 3.0, 9.5 Hz, 
1H), 2.80 (dq, J = 10.0, 6.5 Hz, 1H), 2.10 (m, 1H), 2.04 (m, 1H), 1.96 (m, 1H), 1.83 (m, 1H), 
1.75 (q, J = 7.0 Hz, 1H), 1.41 (m, 1H), 1.29 (d, J = 6.5 Hz, 3H), 1.17 (m, 1H), 1.10 (d, J = 6.5 
OH
O
OH
O
OH
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Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H), 1.02 (d, J = 7.0 Hz, 3H), 1.01 (d, J = 7.0 Hz, 3H), 0.86-0.89 
(m, 1H), 0.79 (d, J = 6.5 Hz, 3H). 
 
 (3R,4S,5R,6S,7S,9R,10S,11S,12S,13R,14R)-4,6,10,12-tetramethoxy-
3,5,7,9,11,13-hexamethyl-14-vinyloxacyclotetradecan-2-one [32]: A 10 
mL round bottom flask was charged with tetrahydroxy macrolide (4.1 mg, 
0.0106 mmol, 1.0 equiv.) and dissolved in CH2Cl2 (0.76 mL, 0.014 M). 
Proton-spongeTM (113.5 mg, 0.53 mmol, 50.0 equiv.) and Me3OBF4 (52.2 mg, 0.353 mmol, 33.3 
equiv.) were then added to the reaction and allowed to stir for 18 hrs at room temperature in the 
dark. The reaction was quenched with satd. NH4Cl (5 mL), transferred to a separatory funnel and 
diluted with EtOAc (15 mL), and the layers were separated. The organic layer was washed with 
1M HCl (1 x 10 mL) and H2O (1 x 15 mL). The combined aqueous layers were extracted with 
EtOAc (2 x 15 mL) and the combined organic layers were then dried over MgSO4, filtered, and 
concentrated in vacuo to afford a yellow oil. Purification by flash chromatography (10% 
EtOAc/hexanes) furnished tetramethyl macrolide 32 as a clear oil (2.6 mg, 0.00587 mmol, 55%). 
 1H NMR (500 MHz, CDCl3) δ 5.80 (ddd, J = 15.0, 10.5, 4.5 Hz, 1H), 5.72 (m, 1H), 5.17 
(dd, J = 15.5, 1.5 Hz, 1H), 5.17 (dd, J = 12.5, 1.5 Hz, 1H), 3.49 (s, 3H), 3.45 (s, 3H), 3.45 (s, 
3H), 3.41 (s, 3H), 3.25 (dd, J = 6.5, 2.0 Hz, 1H), 3.12 (d, J = 9.0 Hz, 1H), 3.05 (dd, J = 5.0, 2.0 
Hz, 1H), 2.80 (dq J = 7.0, 7.0 Hz, 1H), 2.65 (dd, J = 9.0, 3.5 Hz, 1H), 1.89-2.02 (m, 2H), 1.80-
1.87 (m, 1H), 1.69-1.78 (m, 2H), 1.27-1.32 (m, 1H), 1.23 (d, J = 7.0 Hz, 3H), 1.08 (d, J = 6.5 Hz, 
3H), 1.01 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H), 0.97 (d, J = 7.5 Hz, 3H), 0.82 (d, J = 7.0 
Hz, 3H), 0.72-0.78 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 175.7, 136.4, 115.3, 91.3, 85.4, 85.1, 
79.4, 74.2, 62.0, 61.3, 59.2, 43.6, 42.4, 40.7, 35.3, 34.7, 34.6, 33.9, 29.7, 18.0, 17.1, 12.6, 11.3, 
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9.5, 8.5; IR (film, cm-1): 2958, 2927, 2854, 2831, 1732, 1458, 1369, 1171, 1099; HRMS (ESI) 
m/z calc’d for C25H47O6 [M + H]+: 443.3373, found 443.3373; [α]D23 = +20.7o (c = 0.22, 
CH2Cl2). 
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CHAPTER 3 
 
MOLECULAR COMPLEXITY VIA C–H OXIDATION: A DEHYDROGENATIVE 
DIELS-ALDER REACTION 
 
3.1 INTRODUCTION 
The selective transformation of inert C–H bonds into more reactive functionality is a 
challenging problem given the vast number of C–H bonds present in any organic molecule, but 
one that also presents great opportunities for streamlining complex molecule synthesis.72,73 Akin 
to Nature,74 synthetic chemists traditionally utilize C–H oxidation reactions to install oxidized 
functionality onto a preformed molecular skeleton, resulting in a local molecular change. Recent 
examples are Du Bois nitrene insertion strategy for the synthesis of tetrodatoxin,75 Baran’s 
hydroxylation of the Eudesmane terpenes,76 oxyfunctionalization of Bryostatin analogues by 
Wender,77 and iron-catalyzed hydroxylation of artemisinin78 and pleuromutilin79 derivatives 
performed in our labs (Figure 29). Although C–H oxidation reactions have been primarily used 
to install functional groups onto established carbon frameworks, this reaction class also holds 
tremendous promise for directly accessing reactive intermediates that can be coupled to 
productive secondary reactions to forge new carbon frameworks. The use of C–H activation as a  
Figure 29. Examples of C–H Oxidation Reactions for Installing Functionality  
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“substrate-activating” strategy is exemplified by catalytic dehydrogenative oxidation of alkanes 
to form alkenes.80 This activation step is typically followed by a bond construction step, such as 
an alkene metathesis reaction, which proceeds under ‘one-pot’ conditions.81  Although extremely 
rare, preparatively useful processes have utilized such a secondary reaction to generate valuable, 
stable products while avoiding undesired side reactions and reactive intermediate isolations. The 
ability to perform this inert substrate activation and bond construction step in tandem makes 
transition metal-catalyzed dehydrogenation reactions a particularly powerful C–H activation 
strategy.82 In this regard, we questioned whether a dehydrogenation reaction could be developed 
that would convert simple terminal olefins into reactive 1,3-diene intermediates83 capable of 
participating in a wide range of complexity generating transformations84 (e.g. cycloadditions,85 
1,2- and 1,4-additions,86 cycloisomerizations87). Performing such a sequence in tandem would 
enable the rapid construction of diverse molecular skeletons from topologically simple starting 
materials (Figure 30).88  
Figure 30. Synthetic Utility of a Terminal Olefin Dehydrogenation for 1,3-Diene Formation 
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One terminal olefin dehydrogenation system has been reported previously, which utilizes a 
palladium-(0) catalyst and is thought to proceed through a 1,3-diene intermediate. This reactive 
intermediate is then trapped with a diamine ligand to provide convenient access to vicinal 
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diamine products (Figure 31).89 However, the source of nitrogen for the diamination (di-tert-
butyldiaziridinone) is also the palladium oxidant and ligand, and 2.5 equivalents are required. 
Because the palladium ligand is also the source of nucleophilic nitrogen, and is used in 
superstoichiometric amounts, it is unlikely that this reaction manifold would allow for a 
secondary process other than diamination. We therefore desired a truly general olefin 
dehydrogenation reaction for the synthesis of 1,3-dienes, which could be coupled to a variety of 
secondary reactions. In order to accomplish this, we required a ligand that wouldn’t functionalize 
the newly formed diene. 
Figure 31. Yian Shi Diamination of Terminal Olefins 
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Within recent years, our laboratory has introduced electrophilic Pd(II)/sulfoxide catalysis 
as a general platform for allylic C–H activation that enables direct allylic esterification,90 
amination,91 and alkylation92 of terminal olefins through the intermediacy of a π-allylPd species. 
We hypothesized that a dehydrogenation reaction of terminal olefins could also be developed 
using this reaction manifold by promoting β-hydride elimination from the π-allylPd intermediate, 
in the absence of nucleophile (Figure 32). Given the abundance of bulk commodity terminal 
olefins (>1,600 commercial) versus the relative scarcity of commercial 1,3-dienes (120 
commercial) along with the inefficient synthetic routes required for their construction, we 
anticipated that such a dehydrogenation transformation would provide a significant synthetic 
advantage. Moreover, because 1,3-dienes are typically used as synthetic building blocks, ideally 
this dehydrogenation reaction could be coupled to a desirable secondary reaction. While diene 
products arising from dehydrogenation reactions have not been previously observed in our  
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Figure 32. General Strategy for Dehydrogenation of Terminal Olefins Using Pd(II)/sulfoxide Catalysis.  
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Pd(II)/sulfoxide systems, diene formation has been achieved using Pd(0) catalysis with oxidized 
substrates (i.e. allylic oxygenates) via β-hydride elimination from π-allylPd intermediates.93 
However, in addition to general difficulties associated with dehydrogenation chemistry (e.g. 
thermodynamically uphill), generating 1,3-butadienes from terminal olefin substrates poses 
several unique challenges: 1) dienes are reactive intermediates prone to isomerizations and olefin 
oxidations and 2) the electrophilic catalysts needed for the C–H activation step often catalyze 
diene oligomer- and polymerization processes.94 Performing dehydrogenation chemistry in 
tandem with a useful secondary reaction has proven to be an effective strategy for circumventing 
such issues.81 We therefore sought to generate low concentrations of the reactive 1,3-butadiene 
intermediate in the presence of high concentrations of a reactive component capable of 
furnishing a stable product. Of the possible secondary transformations, the Diels-Alder reaction 
would be particularly enabling, as it remains one of the most powerful complexity-generating 
reactions in organic chemistry.85 
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3.2 RESULTS AND DISCUSSION 
3.2.1 Optimization of the Dehydrogenative Diels-Alder Reaction 
We began our study by examining the viability of the dehydrogenation step in the absence 
of dienophile, using limiting amounts of α-olefin 34 under standard allylic C–H activation 
conditions (Table 2).95 Although 1,4-benzoquinone is typically used as an oxidant for such 
allylic C–H functionalization processes, bulky 2,6-dimethyl-1,4-benzoquinone (2,6-Me2BQ) was 
used here, both to prevent a possible  quinone Diels-Alder with the diene products (While BQ 
reacts readily with 1,3-butadienes, 2,6-dimethylbenzoquinone typically requires prolonged 
reaction times at temperatures >100°C)96 and to prevent functionalization of the intermediate π-
allylPd species with the acetate counterion (BQ promotes the functionalization of π-allyl 
complexes with carboxylates, a process slowed with increasing steric bulk around the quinone 
ligand).90a While the use of Pd(OAc)2 resulted in only recovered starting material (entry 1), 
commercially available Pd(II)/phenylbis-sulfoxide catalyst 35 provided initial dehydrogenation 
reactivity, albeit in low yield (6% yield of 36, entry 2). We hypothesized that the electron poor 
phenylbis-sulfoxide ligand generated an aggregated/dimeric π-allylPd species after C–H 
cleavage, which was unable to decompose through β-hydride elimination due to insufficient 
palladium coordination sites. Mono-heterocyclic catalysts were then evaluated in attempts to 
disrupt such aggregated/dimeric intermediates, however, these highly electron rich ligands were 
not compatible with the C–H cleavage event (entry 3,4). Alkylbis-sulfoxide ligands proved to be 
ideal for this dehydrogenation chemistry by promoting C–H cleavage and destabilizing the 
resulting π-allylPd intermediates, enabling a more facile β-hydride elimination step. It was found 
that 10 mol% of the Pd(II)/benzylbis-sulfoxide catalyst 3990,92b resulted in the highest catalytic 
turnover, leading to 28% diene product (4:1 E:Z selectivity, entry 5). Longer reaction times led  
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Table 2. Development of a Dehydrogenative Diels-Alder Reaction 
(±) NPM (1 equiv.),
2,6Me2BQ (1 equiv.),
solvent, 45oC, 48 h
PhN
O
O
H
H
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>20:1
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entry yield
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6
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·
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L4 39
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NPM
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S
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S
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dioxane <1d
dioxane <1d
L3 384
L2 37
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a Conditions: 34 (1.0 equiv.), catalyst (10 mol%), 2,6Me2BQ (1.0 equiv.), solvent 
(1.0 M), 45°C, 48h. Ligands pre-complexed with Pd(OAc)2 b 36 isolated after 24 hr 
as a 4:1 mixture of E/Z isomers along with rSM c isolated yield of 40 d Determined 
by GC analysis e NPM = N-phenylmaleimide (1.0 equiv.) f 10 mol%. Adapted from 
reference 95. 
 
to significantly diminished yields, indicating that the 1,3-butadiene product was not stable to the 
reaction conditions. As further evidence of this, when authentic (E)-diene (36) was subjected to 
the electrophilic Pd(II) conditions, significant conversion occurred after 24h (75% conversion), 
likely due to polymerization (Figure 33). In the hopes of generating the desired Diels-Alder 
adduct, one equivalent of the reactive N-phenylmaleimide (NPM) dienophile was included in the 
dehydrogenation reaction to trap the unstable diene intermediate. Gratifyingly, the 
dehydrogenative Diels-Alder adduct was furnished in encouraging yield (33% of 40) and as a 
single diastereomer (Table 2, entry 6). Switching to chlorinated solvents, such as 1,2-
dichloroethane (DCE), dramatically improved the tandem yield to 52% (entry 7). The yield was 
increased further to 74% upon the addition of 10 mol% p-NO2BzOH (entry 8), which likely aids 
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with Pd(0)  Pd(II) catalyst reoxidation.97 For all tandem dehydrogenation/Diels-Alder 
reactions, very little diene (<1%) could be detected by GC analysis (entries 6-8). Maintaining 
low concentrations of diene is thought to be critical for retarding polymerization pathways and 
enabling the use of limiting olefin starting material. Consistent with this, when NPM was 
excluded from the optimized reaction conditions the diene was isolated in only 35% yield (24 
hr), suggesting that diene decomposition pathways were still operative (entry 9). 
Figure 33. 1,3-Butadiene Reactivity Study 
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Conditions
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Conditions: Diene 36 (1.0 equiv.), ± catalyst 39 (10 mol%), 
2,6Me2BQ (1.0 equiv.), dioxane (1.0 M), 45°C, 24h. Conversion 
measured by GC analysis. 
 
 
3.2.2 Developing a Dehydrogenative Diels-Alder Reaction: Olefin and Maleimide Scope 
Experiments to probe the scope of both the terminal olefin and maleimide dienophile are 
summarized in Figure 34 and 35.95 A wide range of polar groups that can serve as synthetic 
handles for further elaboration are well-tolerated in terminal olefin dehydrogenations: silyl 
(41,42,43,45) and benzyl ethers (45), phthalimide (Phth)-protected amines (44), nitro 
functionality (46), amides (47), acid sensitive acetals (48), and a,β-unsaturated enones (49). 
Although terminal olefins that form 1-oxy-1,3-butadienes and 1,1-disubstituted olefins are less 
reactive dehydrogenation substrates, they furnish the Diels-Alder adducts in synthetically useful 
yields (42 and 43, respectively). Terminal olefins containing stereogenic branching elements 
undergo facile tandem dehydrogenation/Diels-Alder cycloaddition without epimerization of the 
preexisting stereogenic center(s) (adducts 45 and 47). While the Diels-Alder reaction still 
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Figure 34. Dehydrogenative Diels-Alder Reaction: Olefin Scope 
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a Terminal olefin (1.0 equiv.), catalyst 39 (10 mol%), maleimide (1.0 equiv.),  2,6Me2BQ (1.0 
equiv.), p-NO2BzOH (10 mol%), DCE (1.0 M), 45°C, 48h. All isolated yields. b ~1.3:1 
Diastereomeric ratio of facial selectivity. Diastereomers separated using standard chromatography. 
Major diastereomer shown. Adapted from reference 95. 
  
proceeds with exclusive endo selectivity, the chiral substituent displays little control over 
diastereofacial selectivity (~1:1 d.r.), as expected for maleimide dienophiles.98 Access to the 
functionalized dienes traditionally requires differentiation of bifuncitonal starting materials using 
lengthy protecting group manipulation sequences.99 Alternatively, this dehydrogenation manifold 
provides direct access to 1,3-diene intermediates from mono-functional terminal olefins, the 
majority of which are commercial, or are generated in one step from commercial materials. 
The high functional group tolerance of the dehydrogenative Diels-Alder reaction enables 
rapid access to functionally dense motifs found in biologically active molecules (Figure 34). For 
example, cycloadducts containing monocyclic β-lactam pharmacophores, known to furnish 
antibiotics with activity against gram-negative organisms, can be rapidly generated in 3-steps 
using this methodology (47).100 Furthermore, adduct 48 (generated in just 2 steps from 
commercial materials) contains the core structure needed for the synthesis of gelsemine,101 an 
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alkaloid that possesses anxiolytic and analgesic properties.102 Because of the high reactivity of 
maleimides in the Diels-Alder reaction, other potentially reactive dienophiles are tolerated on the 
diene precursors (e.g. α,β-unsaturated enones, 49, vide infra). Cycloadduct 49 provides an 
expedient route to synthetic intermediates used to construct the [5-7-6] tricyclic core of 
Guanacastepene A, an active antibiotic against methicillin- and vancomycin-resistant bacterial 
strains.103 
Figure 35. Dehydrogenative Diels-Alder Reaction: Maleimide Scope 
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a Terminal olefin 34 (1.0 equiv.), catalyst 39 (10 mol%), maleimide (1.0 equiv.), 2,6Me2BQ (1.0 
equiv.), p-NO2BzOH (10 mol%), DCE (1.0 M), 45°C, 48h. All isolated yields. Adapted from 
reference 95. 
 
The dehydrogenative Diels-Alder reaction was also examined with a series of maleimide 
dienophile substrates (Figure 35).95 Both electron-donating (50) and withdrawing (51 and 52) N-
aryl substituents are well tolerated, including functionalities that can be further elaborated using 
Pd(0)-catalysis (i.e. aryl bromide 53). In addition to N-methyl (adducts 48 and 54), a variety of 
densely functionalized N-alkylmaleimides also undergo dehydrogenative Diels-Alder reactions 
with good yields and selectivities. These substituents provide additional opportunities for 
 104 
synthetic elaboration (e.g. N-ethylamine derivatives can undergo cyclization to furnish 
imidazolines,104 55) and amide diversification (i.e. potent pharmacophoric esters,105 56).  
3.2.3 Developing a Dehydrogenative Diels-Alder Reaction: Dienophile Scope 
Maleimides proved to be superior dienophiles for trapping the reactive 1,3-diene 
intermediates under these dehydrogenation conditions. Less reactive dienophiles, such as α,β-
unsaturated esters and quinones, exhibit low reactivity under the current intermolecular 
conditions (<25% yields), although the dehydrogenation step is still operative. This is a common 
limitation of non-Lewis acid catalyzed Diels-Alder cycloadditions of unactivated dienes under 
mild conditions. However, tethering terminal olefin functionality to the dienophile reaction 
partner, led to significant rate enhancements of the Diels-Alder cycloaddition. Under such 
intramolecular cyclization conditions, the scope of the dienophile class could be expanded to 
include acrylamide (57) and enone dienophiles (58), providing expedient access106 to 
synthetically/medicinally important hydroisoindolines (59) and cis-decalin (60) frameworks, 
respectively (Figure 36).95  
 
Figure 36. Dehydrogenative Intramolecular Diels-Alder Reaction: Dienophile Scope 
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Conditions: (a) acrylamide 57 (1.0 equiv.), catalyst 39 (10 mol%), 2,6Me2BQ (1.0 
equiv.), p-NO2BzOH (10 mol%), DCE (1.25 M), 45°C, 48h, 4:1 d.r., 60% (b) enone 
58 (1.0 equiv.), catalyst 39 (10 mol%), 2,6Me2BQ (1.0 equiv.), p-NO2BzOH (10 
mol%), DCE (1.5 M), 45°C, 48h, 16:1 cis:trans, 61%. Adapted from reference 95. 
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3.2.4 Synthetic Applications: Hydroisoquinolines and Isoindoloquinolines 
Maleimide-based cycloadducts containing synthetic handles at the C4 and nitrogen 
positions are powerful synthetic intermediates that can be readily elaborated to a wide range of 
alkaloid frameworks. Towards this end, we incorporated an amine nucleophile onto the α-olefin 
component for an ultimate intramolecular cyclization onto the succinimide moiety of the 
cycloadduct. Subjecting Troc-protected hexenamine 61 to the dehydrogenative Diels-Alder 
reaction gave cycloadduct 62 in 73% yield and >20:1 d.r. (Figure 37). This operationally simple 
reaction can be conducted on a gram-scale, with no precautions taken to exclude moisture. 
Removal of the Troc protecting group with zinc dust, followed by a thermally promoted imide 
acylation, provided the hydroisoquinoline heterocycle 63 in 87% yield over 2 steps. This tandem 
dehydrogenation/Diels-Alder reaction provides an expedient route to such substituted 
hydroisoquinolines,107 which are common structural elements found in a variety of alkaloid 
natural products.108 
Figure 37. Synthetic Utility: Hydroisoquinoline Synthesis 
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Conditions: (a) 61 (1.0 equiv.), 39 (10 mol%), NPM (1.0 equiv.), 2,6Me2BQ (1.0 
equiv.), p-NO2BzOH (10 mol%), DCE (1.0 M), 45°C, 48 hr., >20:1 d.r., 73% (b) Zn 
(18.4 equiv.), AcOH, THF (c) PhMe, 80°C, 87% over 2-steps. Adapted from ref. 95. 
 
We next incorporated a nucleophilic phenethyl moiety onto the maleimide for an ultimate 
cyclization onto the succinimide group. One equivalent of 3,4-dimethoxy-phenethyl maleimide 
(65) was coupled to commercially available methyl 6-heptenoate (64) using the tandem  
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Figure 38. Synthetic Utility: Isoindoloquinoline Synthesis 
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Conditions: (a) 64 (1.0 equiv.), 39 (10 mol%), 65 (1.0 equiv.), 2,6Me2BQ (1.0 equiv.), p-
NO2BzOH (10 mol%), DCE (1.0 M), 45°C, 48 hr., >20:1 d.r., 71% (b) Pd/C (cat.), H2 (1 
atm), MeOH (c) NaBH4 (8.0 equiv.), 2 M H2SO4 (cat.), EtOH (d) CSA (1.5 equiv.), PhMe, 
80°C, >20:1 d.r., 71% over 3-steps. Adapted from reference 95. 
 
dehydrogenation/Diels-Alder reaction, providing adduct 66 in 71% yield and >20:1 d.r. (Figure 
38). With this adduct in hand, we next sought to differentiate the two imide carbonyls as a 
prelude to regioselective intramolecular cyclization. It had been previously shown on related 
hexahydrophthalimide compounds that the imide carbonyl distal to the pendant side chain could 
be mono-reduced with NaBH4 in >95:5 selectivity.109 In accord with these results, following 
olefin hydrogenation, a regioselective mono-reduction with NaBH4 afforded a single 
hydroxylactam compound (67), with hydride addition occurring solely at the carbonyl furthest 
from the methyl ester side chain. With the 3,4-dimethoxyphenyl moiety acting as the 
nucleophile, hydroxylactam 67 underwent stereoselective (>20:1 d.r.) cyclization under typical 
N-acyliminium ion conditions,110 to afford the isoindoloquinoline polycycle 68 as a single 
diastereomer in 71% yield (over 3 steps). This isoindoloquinoline skeleton is found in several 
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alkaloids, such as jamtine, which displays significant antihyperglycemic activity.111 In total, this 
stereochemically dense azapolycyclic architecture was constructed in just 4 steps from 
commercially available terminal olefin 64.95 
 
3.2.5 Mechanistic Studies 
In all achiral substrates examined, the maleimide-based products were isolated with >20:1 
diastereoselectivities, resulting from cycloadditions of (E)-1,3-dienes with maleimide 
dienophiles. It did not escape notice, however, that the dehydrogenation produced a mixture (4:1 
E:Z) of diene isomers. Based on the low reactivity of (Z)-1,3-dienes in the Diels-Alder reaction 
at these temperatures, this isomer was likely either reacting in non-productive pathways (e.g. 
polymerization), or isomerizing under the reaction conditions to yield the Diels-Alder capable 
(E)-1,3-diene. To determine the fate of the (Z)-1,3-diene, we performed a crossover experiment 
utilizing 0.5 equiv of terminal olefin 34 and 0.5 equiv of (Z)-1,3-diene 69 (Figure 39). Under 
these reaction conditions, the dehydrogenation cycloadduct 40, derived from terminal olefin 34, 
was formed in 64% yield (>20:1 d.r.). Cycloadduct 70, derived from isomerization of (Z)-diene 
69 to the (E)-isomer, was formed in good yield (69%) and as a single diastereomer (>20:1 d.r.).  
Figure 39. Crossover Experiment: Diene Isomerization Study 
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Conditions: 34 (0.5 equiv.), 69 (0.5 equiv.), 39 (10 mol%), NPM (1.0 equiv.), 2,6Me2BQ 
(1.0 equiv.), p-NO2BzOH (10 mol%), DCE (1.0 M), 45°C, 48 hr, >20:1 d.r., 64% of 40 and 
69% of 70. Adapted from reference 95. 
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Interestingly, when pure (Z)-diene 69 was reacted with NPM and catalyst 39, endo cycloadduct 
70 was formed in >20:1 d.r., suggesting that diene isomerization is Pd(II)-promoted. In the 
absence of Pd(II), (Z)-diene 69 is fully recovered. These results support a Pd(II)-catalyzed 
dynamic diene isomerization pathway in which both the (E)- and (Z)- diene isomers generated 
during the dehydrogenation step are funneled to the desired cycloadducts in situ.95 Consequently, 
this dehydrogenation chemistry circumvents the need for geometrically pre-defined diene 
starting materials. 
 
3.3 CONCLUSIONS 
In summary, a novel approach to stereochemically dense cyclohexenyl rings from terminal 
olefins has been achieved using Pd(II)/sulfoxide C–H activation catalysis. This dehydrogenative 
Diels-Alder reaction underscores the power of coupling transition metal-catalyzed C–H 
activation to complexity generating transformations for the rapid synthesis of complex molecular 
skeletons from topologically simple starting materials. Currently, maleimide dienophiles are 
unique in terms of the rate of Diels-Alder cycloaddition under intermolecular conditions. 
However, intramolecular dehydrogenative Diels-Alder reactions show significant promise, 
broadening the scope of the dienophile to include acrylamides and enones. Further investigations 
are focused on expanding the scope of this transformation with respect to both the olefin class 
(internal olefins) and dienophile, specifically through Lewis acid co-catalyst activation. 
Moreover, based on the general dehydrogenation manifold developed here, future studies will 
begin to explore this dehydrogenation chemistry in tandem with secondary reactions other than 
Diels-Alder cycloadditions. 
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3.4 EXPERIMENTAL SECTION 
General Information: All dehydrogenative Diels-Alder reactions were run under air, with no 
precautions to exclude moisture. All other reactions were conducted in flame-dried glassware 
with magnetic stirring under an inert atmosphere of dry nitrogen, unless otherwise noted. 
Solvents tetrahydrofuran (THF), diethyl ether (Et2O), methanol (MeOH), benzene, toluene, 1,4-
dioxane, dimethylformamide (DMF), and methylene chloride (DCM or CH2Cl2) were purified 
prior to use by passage through a bed of activated alumina (Glass Contour, Laguna Beach, 
California). Deuterochloroform was stored over 3 Å molecular sieves. Diisopropylamine (DIPA) 
and pyridine were distilled from calcium hydride. The following commercially obtained reagents 
were used as received: N-phenylmaleimide (NPM, TCI America), N-methylmaleimide (NMM, 
TCI America), 1,2-dichloroethane (DCE, Sigma-Aldrich), 2,6-dimethylbenzoquinone (2,6-
Me2BQ, Sigma-Aldrich), p-nitrobenzoic acid (Sigma-Aldrich), Pd[1,2-
bis(phenylsulfinyl)ethane](OAc)2 catalyst (TCI America), acetic acid 5-hexen-1-yl ester (TCI 
America), and lithium aluminum hydride (LAH, Sigma-Aldrich, 95%). Oxalyl Chloride (Sigma-
Aldrich), benzylbromide, and acrolein were distilled prior to use. Triphenylphosphine was 
recrystallized from ethanol and stored under argon. Pd(OAc)2 (Johnson-Matthey Chemicals) was 
recrystallized prior to use (see catalyst preparation). n-Butyllithium in hexanes (Sigma-Aldrich, 
1.6 M) was titered using No-D NMR spectroscopy with 1,5-cyclooctadiene (Sigma-Aldrich) as 
the internal standard.112  
 Optical rotations were measured using a 1 mL cell with a 1 dm path length on a Perkin-
Elmer 341 polarimeter. Optical rotations were obtained with a sodium lamp and are reported as 
follows: [α]λ
T°C (c = g/100 mL, solvent). Infrared spectra were recorded as thin films on NaCl 
plates on a Mattson Galaxy Series FTIR 5000 and are reported in frequency of absorption (cm-1). 
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High-resolution mass spectra were obtained through the Mass Spectrometry Laboratory, School 
of Chemical Sciences, University of Illinois. Electrospray ioniztion (ESI) spectra were 
performed on a Waters Q-Tof Ultima spectrometer and electron ionization (EI) spectra were 
performed on a Micromass 70-VSE spectrometer. 1H NMR spectra were recorded on a Varian 
Unity-400 (400 MHz) or Varian Unity-500 (500 MHz) spectrometer and are reported in ppm 
using solvent as an internal standard (CDCl3 at 7.26 ppm).  Data reported as: s = singlet, d = 
doublet, t = triplet, q = quartet, pent = pentet, oct = octet, m = multiplet, br = broad, app = 
apparent; coupling constant(s) in Hz; integration. Proton-decoupled 13C-NMR spectra were 
recorded on a Varian Unity-400 (100 MHz) or Varian Unity-500 (125 MHz) spectrometer and 
are reported in ppm using solvent as an internal standard (CDCl3 at 77.0 ppm). Chiral HPLC 
analysis was performed on an Agilent 1100 Series instrument (see individual compounds for 
conditions). Thin-layer chromatography (TLC) was conducted with E. Merck silica gel 60 F254 
precoated plates (0.25 mm) and visualized with UV, potassium permanganate, and ceric 
ammonium molybdate staining.  Flash column chromatography was performed as described by 
Still et al.113 using EM reagent silica gel 60 (230-400 mesh). 
 All dehydrogenative Diels-Alder products were assigned as “endo” products between an 
(E)-1,3-diene and a maleimide dienophile. The relative stereochemistry of the tandem 
dehydrogenation/Diels-Alder products could not be determined directly through analysis of 1H 
NMR J-values. Therefore, the stereochemistry was determined by direct comparisons to 
literature compounds (product 47 major, 47 minor, and compound 63), NOE analysis (products 
40 and 41), and X-ray crystallographic analysis (product 42, product 44, and compound 68). The 
other dehydrogenative Diels-Alder products were assigned based on analogy to these compounds 
or similar literature compounds.  
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Synthesis of the Palladium Catalyst for Dehydrogenative Diels-Alder Reactions 
 
Figure 40. Synthesis of Catalyst 39 
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Pd(OAc)2 Recrystallization: Pd(OAc)2 (Johnson-Matthey Chemicals) was dissolved in minimal 
refluxing benzene (0.5 g Pd(OAc)2/ 8.0 mL benzene).  A black precipitate was removed from the 
refluxing solution by Acrodisc® filtration.  The resulting solution was cooled to room 
temperature, and amber crystals began to form immediately.  After 1 hr the solution was filtered 
to give the recrystallized Pd(OAc)2 as gold plates. The recrystallized Pd(OAc)2 was stored for 
months under an Ar atmosphere with no deleterious effects. Reported hydrogen values are 
normalized ratios of the smallest peak in the acetate region.  “Old” Pd(OAc)2: 1H NMR (500 
MHz, CDCl3) δ 2.17 (s, 1H), 2.10 (s, 3.6H), 2.07 (s, 6.1H), 2.06 (s, 6.1H), 2.03 (m, 15.3H), 2.00 
(m, 95.7H), 1.97 (s, 5.7H), 1.95 (s, 6.3), 1.89 (s, 9.4H). Recrystalized Pd(OAc)2: 1H NMR (500 
MHz, CDCl3) δ 2.10 (s, 1H), 2.03 (s, 2.8H), 2.00 (s, 40.1H), 1.97 (s, 1.2H), 1.90 (s, 2.3H).  
 
Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 [39]: This catalyst was prepared using a 
modified procedure.90a A flame dried 2 L round bottom flask was charged with 
NaOEt (11.65 g, 171.2 mol 2.0 equiv) and absolute EtOH (800 mL, 0.107 M) and allowed to stir 
for 5 min, resulting in an orange solution. 1,2-ethanedithiol (Fluka, 7.18 mL, 85.6 mmol, 1.0 
equiv) was added to the reaction, followed by a solution of benzylbromide (20.3 mL, 171.2 
mmol, 2.0 equiv) in benzene (400 mL, 0.214 M) via cannula. After 4.5 hours, the reaction was 
concentrated to near dryness in vacuo, redissolved in DCM (500 mL), and quenched with satd 
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NH4Cl (200 mL). The layers were then separated and the aqueous layer was extracted with DCM 
(2 x 200 mL), dried over MgSO4, filtered, and concentrated in vacuo to give a yellow oil. This 
product was then allowed to sit at 0°C for ~1 hr. The resulting light yellow solid was placed on a 
fritted funnel, and washed with cold (-20°C) EtOH until the solid was white. This white solid 
was put under high vacuum to afford bis(benzylthio)ethane (21.14 g, 77.03 mmol, 90% yield). 
A flame-dried 100 mL round bottom flask was charged with bis(benzylthio)ethane (3.293 
g, 12.0 mmol, 1.0 equiv) and dissolved (mostly) in glacial AcOH (30 mL, 0.40 M) and cooled to 
0°C. H2O2 (50% wt solution, Sigma-Aldrich, 1.25 mL, 20.4 mmol, 1.7 equiv) was then added to 
reaction dropwise. The reaction was then warmed up to r.t. and allowed to stir for 12 hr. The 
resulting white suspension was placed under high vacuum to remove the AcOH. The white solids 
were placed on a fritted funnel and washed with EtOH (6 x 20 mL), and then dried under high 
vacuum to afford 1,2-bis(benzylsulfinyl)ethane (3.117 g, 10.17 mmol, 85% yield) 
 A flame-dried 100 mL round bottom flask was charged sequentially with recrystallized 
Pd(OAc)2 (0.684 g, 3.045 mmol, 1.0 equiv), 1,2-bis(benzylsulfinyl)ethane (0.933 g, 3.045 mmol, 
1.0 equiv), and DCM (45 mL, 0.67 M). The reaction was topped with a water condenser and an 
Ar balloon, and let stir in a 45°C bath for 12 hr. The resulting dark purple solution was 
concentrated to near dryness in vacuo, and placed under a stream of N2 for 12 hr to dry 
completely. The dark purple solids were scraped from the sides of the round bottom flask and 
collected to afford Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 (39) (1.267 g, 2.386 mmol, 78% 
yield). 
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Synthesis of the Diene Authentic Standard for Table 2 and Figure 33 
 
Figure 41. Synthesis of Diene 36 Authentic Standard 
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 (E)-hexa-3,5-dien-1-yl acetate [36]: A flame-dried 500 mL round bottom 
flask was charged with THF (68.5 mL) and DIPA (14.4 mL, 102.7 mmol, 1.80 equiv), and 
cooled to -78°C. n-BuLi (64.2 mL, 102.7 mmol, 1.80 equiv) was then syringed into the reaction 
dropwise, and the reaction was warmed to -10°C and stirred for 30 min. The reaction was then 
re-cooled to -78°C and HMPA (Sigma-Aldrich, 22.8 ml, 2.5 M) was added to the reaction, 
resulting in a dark green reaction mixture. After stirring at -78°C for 20 min, a solution of ethyl 
sorbate (Sigma-Aldrich, 8.0 g, 57.07 mmol, 1.0 equiv) in THF (22.8 mL) was cannulated into the 
LDA/HMPA solution, resulting in a dark red solution. The reaction was allowed to stir for 20 
min, at which time it was carefully quenched by pouring into a 1L round bottom flask containing 
H2O (115 mL) and glacial AcOH (20.5 mL). After diluting with hexanes, the layers were 
separated, and the aqueous layer was extracted with hexanes (3 x 125 mL). The combined 
organic layers were washed with satd NaHCO3 (1 x 75 mL), satd NaCl (1 x 75 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. The crude (E)-3,5-diene-ethyl ester product (>20:1 
E:Z, 6.5079 g, 46.4 mmol, 81% crude yield) was taken on to the next step without purification. 
 A flam-dried 250 mL round bottom flask was charged with LAH (2.39 g, 63.1 mmol, 
1.36 equiv), suspended in Et2O (36 mL), and cooled to 0°C. A solution of (E)-3,5-diene-ethyl 
ester (6.5079 g, 46.4 mmol, 1.0 equiv) in Et2O (12 mL) was slowly cannulated into the LAH 
suspension, and the reaction mixture was allowed to warm to room temperature. After stirring at 
room temperature for 4.5 hr, the reaction was re-cooled to 0°C, diluted with Et2O, and slowly 
AcO
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quenched with a solution of sat’d rochelle’s salt(aq) (100 mL). This biphasic mixture was stirred 
vigorously for 12 hr. The layers were then separated, and the aqueous layer was extracted with 
Et2O (2 x 100 mL). The combined organic layers were washed with sat’d NaCl (1 x 50 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. The crude (E)-hexa-3,5-dien-1-ol (4.3667 
g, 44.5 mmol, 96% crude yield) was taken on to the next step without purification. 
 A 50 mL round bottom flask was charged with (E)-hexa-3,5-dien-1-ol (2.488 g, 25.35 
mmol, 1.0 equiv), DCM (5.1 mL, 5.0 M), pyridine (6.12 mL, 76.05 mmol, 3.0 equiv), and acetic 
anhydride (7.18 mL, 76.05 mmol, 3.0 equiv). The reaction flask was then cooled to 0°C, and 
DMAP (154 mg, 1.26 mmol, 0.05 equiv) was added. The reaction was warmed up to room 
temperature and stirred for 12 hr. The reaction was quenched by the addition of 1M HCl (20 mL) 
and the layers were separated. The organic layer was washed with 1M HCl (2 x 20 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. The crude product was purified through flash 
chromatography (10% Et2O/pentane) to afford (E)-hexa-3,5-dien-1-yl acetate (36) as a clear oil 
(2.9889 g, 21.334 mmol, 84% yield). 
 1H NMR (500 MHz, CDCl3) δ 6.31 (ddd, J = 17.0, 10.5, 10.0 Hz, 1H), 6.12 (dd, J = 15.0, 
10.5 Hz, 1H), 5.65 (dt, J = 15.0, 7.5 Hz, 1H), 5.13 (d, J = 17.0 Hz, 1H), 5.02 (d, J = 10.0 Hz, 
1H), 4.11 (t, J = 7.0 Hz, 2H), 2.41 (q, J = 7.0 Hz, 2H), 2.04 (s, 3H). 13C NMR (125 MHz, CDCl3) 
δ 171.0, 136.7, 133.3, 129.7, 116.0, 63.5, 31.8, 20.9. IR (film, cm-1): 3087, 3039, 3012, 2960, 
2902, 1741, 1655, 1604, 1385, 1365, 1238, 1036, 1007, 955. LRMS (EI) m/z calc’d for C8H13O2 
[M + H]+: 141.1, found 141.1. 
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Dehydrogenative Diels-Alder Optimization Studies for Table 2 
 
General Optimization Procedure: A ½ dram borosilicate vial was charged sequentially with 
Pd(II) catalyst (0.03 mmol, 0.10 equiv), N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv, 
entries 4-6), 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv), and p-nitrobenzoic acid (5.01 mg, 
0.03 mmol, 0.10 equiv, entries 6 and 7). Acetic acid 5-hexen-1-yl ester (34) substrate (42.6 mg, 
0.30 mmol, 1.0 equiv) was then added to the ½ dram vial, and the reaction was immediately 
dissolved in solvent (0.3 mL, 1.0 M). The resulting dark red reaction mixture was charged with a 
stir bar, capped with a teflon-lined cap, and suspended in an oil bath at 45°C for 48 hr (or 24 hr 
for entries 1, 2, and 7). Upon completion, the dark red reaction mixture was filtered through a 
short silica plug, eluting with ~5 mL EtOAc, and concentrated in vacuo at 25°C for entries 3-6 or 
0°C for entries 1, 2, and 7  (~25 torr), to afford a dark red crude oil. A small aliquot of this 
mixture was added to a NMR tube and diluted with CDCl3. After analysis, the sample was 
returned to the crude mixture and the solvent was removed. Purification by flash chromatography 
(SiO2, 20 x 160 mm) furnished either the Diels-Alder adduct 40 or hexa-3,5-dien-1-yl acetate 
(36) as a 4:1 mixture of E:Z isomers. 
 
Entry 1: Pd(OAc)2 (6.7 mg, 0.030 mmol, 0.10 equiv) and 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 
equiv) were used. 1,4-dioxane (0.30 mL) was used as solvent. Run 1: <1% yield. Run 2: <1% 
yield. Average: 0% yield. 
 
Entry 2: Pd[1,2-bis(phenylsulfinyl)ethane](OAc)2 35 (15.1 mg, 0.030 mmol, 0.10 equiv) and 
2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv) were used. 1,4-dioxane (0.30 mL) was used as 
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solvent. Reaction run for 24 hrs. Purification by flash chromatography (10% Et2O/petroleum 
ether) produced diene 36. Run 1: 6% yield. Run 2: 5% yield. Average: 6% yield. 
 
Entry 3: Pd(II)-catalyst 37 (11.6 mg, 0.030 mmol, 0.10 equiv) and 2,6-Me2BQ (40.8 mg, 0.30 
mmol, 1.0 equiv) were used. 1,4-dioxane (0.30 mL) was used as solvent. Run 1: <1% yield. Run 
2: <1% yield. Average: 0% yield. 
 
Entry 4: Pd(II)-catalyst 38 (10.9 mg, 0.030 mmol, 0.10 equiv) and 2,6-Me2BQ (40.8 mg, 0.30 
mmol, 1.0 equiv) were used. 1,4-dioxane (0.30 mL) was used as solvent. Run 1: <1% yield. Run 
2: <1% yield. Average: 0% yield. 
 
Entry 5: Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 39 (15.9 mg, 0.030 mmol, 0.10 equiv) and 
2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv) were used. 1,4-dioxane (0.30 mL) was used as 
solvent. Reaction run for 24 hrs. Purification by flash chromatography (10% Et2O/petroleum 
ether) produced diene 36. Run 1: 30% yield. Run 2: 26% yield. Average: 28% yield. 
 
Entry 6: Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 39 (15.9 mg, 0.030 mmol, 0.10 equiv), N-
phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv), and 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 
equiv) were used. 1,4-dioxane (0.30 mL) was used as solvent. Purification by flash 
chromatography (35% EtOAc/hexanes) produced adduct 40. Run 1: 32% yield. Run 2: 33% 
yield. Average: 33% yield. 
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Entry 7: Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 39 (15.9 mg, 0.030 mmol, 0.10 equiv), N-
phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv), and 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 
equiv) were used. DCE (0.30 mL) was used as solvent. Purification by flash chromatography 
(35% EtOAc/hexanes) produced adduct 40. Run 1: 53% yield. Run 2: 51% yield. Average: 52% 
yield. 
 
Entry 8: Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 39 (15.9 mg, 0.030 mmol, 0.10 equiv), N-
phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv), 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv), 
and p-nitrobenzoic acid (5.0 mg, 0.030mmol, 0.1 equiv) were used. DCE (0.30 mL) was used as 
solvent. Purification by flash chromatography (35% EtOAc/hexanes) produced adduct 40. Run 1: 
71% yield. Run 2: 76% yield. Average: 74% yield. 
 
Entry 9: Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 39 (15.9 mg, 0.030 mmol, 0.10 equiv), 2,6-
Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv), and p-nitrobenzoic acid (5.0 mg, 0.030mmol, 0.1 
equiv) were used. DCE (0.30 mL) was used as solvent. Reaction run for 24 hrs. Purification by 
flash chromatography (10% Et2O/petroleum ether) produced diene 36. Run 1: 37% yield. Run 2: 
33% yield. Average: 35% yield. 
 
Dehydrogenative Diels-Alder Olefin Scope for Figure 34 
 
General Procedure: A ½ dram borosilicate vial was charged sequentially with Pd[1,2-
bis(benzylsulfinyl)ethane](OAc)2 catalyst 39 (15.9 mg, 0.03 mmol, 0.10 equiv), maleimide (0.30 
mmol, 1.0 equiv), 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv), and p-nitrobenzoic acid (5.01 
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mg, 0.03 mmol, 0.10 equiv). Olefin substrate (0.30 mmol, 1.0 equiv) was then added to the ½ 
dram vial, and the reaction was immediately dissolved in DCE (0.3 mL, 1.0 M). The resulting 
dark red reaction mixture was charged with a stir bar, capped with a teflon-lined cap, and 
suspended in an oil bath at 45°C for 48 hr. Upon completion, the dark red reaction mixture was 
filtered through a short silica plug, eluting with ~5 mL EtOAc (or 2% MeOH/CH2Cl2 when 
specified), and concentrated in vacuo at 25°C (~25 torr) to afford a dark red crude oil. A small 
aliquot of this mixture was added to a NMR tube and diluted with CDCl3. 1H NMR analysis of 
the crude product showed a >20:1 endo:exo selectivity. After analysis, the sample was returned 
to the crude mixture and the solvent was removed. Purification by flash chromatography (SiO2, 
20 x 160 mm) furnished the Diels-Alder products in 52-84% yields with >20:1 d.r. (unless 
otherwise noted). 
 
 (±)-2-((3aS,4S,7aR)-1,3-dioxo-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-
isoindol-4-yl)ethyl acetate [40]: Acetic Acid 5-hexen-1-yl ester 34 (42.6 mg, 
0.30 mmol, 1.0 equiv) and N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 
equiv) were reacted using the general procedure. Purification by flash chromatography (35% 
EtOAc/hexanes) produced adduct 40 as a pale yellow oil. Run 1 (67.1 mg, 0.214 mmol, 71% 
yield); Run 2 (71.7 mg, 0.229 mmol, 76% yield). The product was isolated in >20:1 d.r. by 1H 
NMR for both experiments. Average: 74% yield. 
 1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 7.37 (t, J = 7.5 Hz, 1H), 7.20 (dd, 
J = 8.5, 1.0 Hz, 2H), 6.02 (ddd, J = 9.5, 6.5, 3.5 Hz, 1H), 5.86 (dt, J = 9.0, 3.5 Hz, 1H), 4.36 
(ddd, J = 11.0, 7.0, 5.5 Hz, 1H), 4.24 (ddd, J = 11.5, 6.0, 5.0 Hz, 1H), 3.30-3.34 (m, 2H), 2.84 
(ddd, J = 14.5, 7.0, 1.5 Hz, 1H), 2.48-2.51 (m, 1H), 2.30-2.36 (m, 1H), 2.23-2.29 (m, 1H), 2.12-
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2.20 (m, 1H), 2.07 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 178.8, 176.8, 171.1, 133.1, 131.8, 
129.0, 128.6, 128.1, 126.5, 62.6, 42.6, 40.2, 32.8, 30.2, 24.5, 21.0; IR (film, cm-1): 3039, 2954, 
2931, 2852, 1730, 1709, 1597, 1498, 1385, 1244, 1192, 1171, 1041; HRMS (ESI) m/z calc’d for 
C18H19NO4Na [M + Na]+: 336.1212, found 336.1214. 
 
tert-butyldimethyl(pent-4-en-1-yloxy)silane: A 50 mL round bottom flask 
was charged with penten-1-ol (Sigma-Aldrich, 0.861 g, 10.0 mmol, 1.0 equiv) and dissolved in 
DCM (10 mL, 1.0 M). The reaction was then charged sequentially with tert-Butyldimethylsilyl 
chloride (1.80 g, 12.0 mmol, 1.0 equiv), imidazole (1.02 g, 15.0 mmol, 1.50 equiv), and DMAP 
(61.0 mg, 0.50 mmol, 0.05 equiv), and allowed to stir for 1 hr. The reaction slurry was then 
filtered through a silica plug, eluting with 1% EtOAc/hexanes, and concentrated in vacuo, to 
afford the title compound as a clear oil (1.991 g, 9.94 mmol, 99% yield). 
 This compound has been reported previously.114   1H NMR (500 MHz, CDCl3) δ 5.82 
(ddt, J = 17.0, 10.0, 6.5 Hz, 1H), 4.94-5.04 (m, 2H), 3.62 (t, J = 6.5 Hz, 2H), 2.10 (q, J = 7.0 Hz, 
2H), 1.58-1.64 (m, 2H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 138.6, 114.5, 
62.5, 32.0, 30.1, 25.9, 18.3, -5.3.  
 
 (±)-(3aS,4S,7aR)-4-(((tert-butyldimethylsilyl)oxy)methyl)-2-phenyl-
3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione [41]: t-
butyldimethyl(pent-4-en-1-yloxy)silane (60.1 mg, 0.30 mmol, 1.0 equiv) and 
N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv) were reacted using the general procedure. 
Purification by flash chromatography (15% EtOAc/hexanes) produced adduct 41 as a tan solid. 
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Run 1 (83.2 mg, 0.224 mmol, 75% yield); Run 2 (84.9 mg, 0.229 mmol, 76% yield). The product 
was isolated in >20:1 d.r. by 1H NMR for both experiments. Average: 76% yield. 
 1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 7.36 (t, J = 7.5 Hz, 1H), 7.20-7.22 
(m, 2H), 6.01 (ddd, J = 9.0, 6.5, 3.0 Hz, 1H), 5.89 (dt, J = 9.5, 3.5 Hz, 1H), 4.17 (dd, J = 10.0, 
7.0 Hz, 1H), 3.98 (dd, J = 10.0, 7.5 Hz, 1H), 3.41 (dd, J = 9.3, 6.5 Hz, 1H), 3.31 (dt, J = 2.0, 9.0 
Hz, 1H), 2.80 (ddd, J = 16.0, 6.5, 2.5 Hz, 1H), 2.58-2.62 (m, 1H), 2.27-2.33 (m, 1H), 0.90 (s, 
9H), 0.09 (s, 3H), 0.08 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 179.1, 177.0, 132.0, 130.8, 129.0, 
128.5, 127.7, 126.5, 63.1, 40.8, 39.9, 39.0, 25.9, 24.7, 18.3, -5.3, -5.4; IR (film, cm-1): 3041, 
2954, 2929, 2885, 2856, 1711, 1498, 1471, 1383, 1254, 1188, 1167, 1090, 837; HRMS (ESI) m/z 
calc’d for C21H30NO3Si [M + H]+: 372.1995, found 372.1999. 
 
 (but-3-en-1-yloxy)(tert-butyl)dimethylsilane: A 50 mL round bottom flask 
was charged with buten-1-ol (Sigma-Aldrich, 0.7211 g, 10.0 mmol, 1.0 equiv) and dissolved in 
DCM (10 mL, 1.0 M). The reaction was then charged sequentially with tert-Butyldimethylsilyl 
chloride (1.80 g, 12.0 mmol, 1.0 equiv), imidazole (1.02 g, 15.0 mmol, 1.50 equiv), and DMAP 
(61.0 mg, 0.50 mmol, 0.05 equiv), and allowed to stir for 1 hr. The reaction slurry was then 
filtered through a silica plug, eluting with 1% EtOAc/hexanes, and concentrated in vacuo, to 
afford the title compound as a clear oil (1.572 g, 8.43 mmol, 84% yield). 
 This compound has been reported previously.115 1H NMR (500 MHz, CDCl3) δ 5.82 (ddt, 
J = 17.5, 10.5, 7.0 Hz, 1H), 5.00-5.09 (m, 2H), 3.66 (t, J = 7.0 Hz, 2H), 2.28 (app qt, J = 7.0, 1.0 
Hz, 2H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 135.4, 116.3, 62.8, 37.5, 
25.9, 18.3, -5.3. 
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 (±)-(3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-2-phenyl-3a,4,7,7a-
tetrahydro-1H-isoindole-1,3(2H)-dione [42]: (but-3-en-1-yloxy)(tert-
butyl)dimethylsilane (55.9 mg, 0.30 mmol, 1.0 equiv) and N-phenylmaleimide (51.9 mg, 0.30 
mmol, 1.0 equiv) were reacted using the general procedure. Purification by flash 
chromatography (20% EtOAc/hexanes) produced adduct 42 as a white solid. Run 1 (54.7 mg, 
0.153 mmol, 51% yield); Run 2 (55.6 mg, 0.156 mmol, 52% yield). The product was isolated in 
>20:1 d.r. by 1H NMR for both experiments. Average: 52% yield. X-ray quality crystals could 
be obtained by recrystallizing the product in hot hexanes/minimal DCM, followed by sitting at 
4°C for 24 hr. 
 1H NMR (500 MHz, CDCl3) δ 7.45 (t, J = 7.5 Hz, 2H), 7.33-7.37 (m, 3H), 6.11-6.19 (m, 
2H), 4.78 (t, J = 4.5 Hz, 1H), 3.20 (ddd, J = 19.5, 10.0, 8.0 Hz, 1H), 3.06 (dd, J = 10.0, 4.0 Hz, 
1H), 2.62-2.74 (m, 2H), 0.79 (s, 9H), 0.03 (s, 3H), 0.01 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
179.3, 176.0, 132.1, 131.3, 130.6, 128.9, 128.2, 126.2, 64.1, 47.0, 36.8, 25.6, 22.0, 17.9, -4.5, -
4.9; IR (film, cm-1): 2947, 2926, 2895, 2854,1778, 1711, 1498, 1389, 1254, 1198, 1180, 1163, 
1049, 999; HRMS (ESI) m/z calc’d for C20H27NO3SiNa [M + Na]+: 380.1658, found 380.1657. 
 
tert-butyldimethyl((4-methylpent-4-en-1-yl)oxy)silane: A flame-dried 100 
mL round bottom flask was charged with LAH (1.013 g, 26.7 mmol, 1.90 equiv), suspended in 
Et2O (14 mL, 1 M), and cooled to 0°C. Ethyl 4-methyl-4-pentenoate (Sigma-Aldrich, 2.00 g, 
14.06 mmol, 1.0 equiv) was syringed into rxn slowly. The reaction was allowed to stir at 0°C for 
1.5 hr, at which time it was diluted with Et2O and quenched SLOWLY with H2O (10 mL), 
followed by 1M HCl (10 mL). The layers were separated and the aqueous layer was extracted 
with Et2O (2 x 15 mL). The combined organic layers were dried over MgSO4, filtered, and 
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concentrated cold in vacuo. The resulting primary alcohol was sufficiently pure, and was taken 
on crude to the next reaction. 
 A 100 mL round bottom flask was charged with the crude primary alcohol (1.408 g, 
14.06 mmol, 1.0 equiv) and dissolved in DCM (14 mL, 1.0 M). The reaction was then charged 
sequentially with tert-Butyldimethylsilyl chloride (2.532 g, 16.80 mmol, 1.2 equiv), imidazole 
(1.436 g, 21.1 mmol, 1.50 equiv), and DMAP (86.0 mg, 0.703 mmol, 0.05 equiv), and allowed to 
stir for 3 hr. The reaction slurry was then filtered through a silica plug, eluting with 1% 
EtOAc/hexanes, and concentrated in vacuo, to afford the title compound as a light yellow oil 
(2.8891 g, 13.5 mmol, 96% yield over 2 steps). 
 This compound has been reported previously.116 1H NMR (500 MHz, CDCl3) δ 4.70 (s, 
1H), 4.68 (s, 1H), 3.61 (t, J = 6.5 Hz, 2H), 2.05 (t, J = 7.5 Hz, 2H), 1.72 (s, 3H), 1.64-1.67 (m, 
2H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 145.5, 109.8, 62.8, 34.0, 30.8, 
25.9, 22.5, 18.3, -5.3. 
 
 (±)-(3aS,4S,7aR)-4-(((tert-butyldimethylsilyl)oxy)methyl)-6-methyl-2-
phenyl-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione [43]: t-
butyldimethyl((4-methylpent-4-en-1-yl)oxy)silane (64.3 mg, 0.30 mmol, 1.0 
equiv) and N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv) were reacted using the general 
procedure. Purification by flash chromatography (15% EtOAc/hexanes) produced adduct 43 as a 
clear oil. Run 1 (57.8 mg, 0.150 mmol, 50% yield); Run 2 (63.8 mg, 0.166 mmol, 55% yield). 
The product was isolated in >20:1 d.r. by 1H NMR for both experiments. Average: 53% yield. 
 1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.8 Hz, 2H), 7.36 (t, J = 7.5 Hz, 1H), 7.18-7.20 
(m, 2H), 5.50 (s, 1H), 4.12 (dd, J = 10.0, 7.0 Hz, 1H), 3.92 (dd, J = 10.0, 7.0 Hz, 1H), 3.36 (dd, J 
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= 9.0, 6.0 Hz, 1H), 3.30 (dt, J = 2.5, 9.0 Hz, 1H), 2.65 (dd, J = 15.0, 2.3 Hz, 1H), 2.55-2.57 (m, 
1H), 2.32 (dd, J = 15.5, 7.5 Hz, 1H), 1.80 (s, 3H), 0.90 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 179.1, 177.1, 136.6, 132.0, 129.0, 128.5, 126.5, 123.1, 63.3, 40.9, 
40.2, 39.6, 29.8, 26.0, 23.2, 18.4, -5.3, -5.4; IR (film, cm-1): 3066, 3037, 2954, 2929, 2883, 2856, 
1711, 1599, 1500, 1471, 1441, 1383, 1254, 1184, 1109, 1090, 839; HRMS (ESI) m/z calc’d for 
C22H32NO3Si [M + H]+: 386.2151, found 386.2146. 
 
2-(pent-4-en-1-yl)isoindoline-1,3-dione: A flame-dried 50 mL round 
bottom flask was charged with triphenylphosphine (1.42 g, 5.40 mmol, 1.0 
equiv) and THF (10.8 mL, 0.5 M), and cooled to 0°C. DIAD (Sigma-Aldrich, 1.06 mL, 5.40 
mmol, 1.0 equiv) was then syringed into the rxn dropwise, resulting in a white slurry which was 
stirred for 5 min. 4-penten-1-ol (0.55 mL, 5.40 mmol, 1.0 equiv) was then syringed into the 
reaction mixture and allowed to stir for 5 min, at which time phthalimide (0.794 g, 5.40 mmol, 
1.0 equiv) was added to the reaction and let stir for 12 hr at room temperature. The resulting 
yellow solution was concentrated in vacuo and purified directly using flash chromatography 
(15% EtOAc/hexanes), affording 2-(pent-4-en-1-yl)isoindoline-1,3-dione as a clear oil (0.957 g, 
4.445 mmol, 82% yield). 
 This compound has been reported previously.117 1H NMR (500 MHz, CDCl3) δ 7.84 (dd, 
J = 5.5, 3.0 Hz, 2H), 7.70 (dd, J = 5.5, 3.0 Hz, 2H), 5.81 (ddt, J = 17.0, 10.5, 7.0 Hz, 1H), 5.05 
(dq, J = 17.5, 1.5 Hz, 1H), 4.97 (dd, J = 10.5, 1.5 Hz, 1H), 3.69 (t, J = 7.5 Hz, 2H), 2.11 (dq, J = 
1.5, 7.5 Hz, 2H), 1.78 (pent., J = 7.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 168.4, 137.2, 
133.8, 132.1, 123.1, 115.2, 37.5, 30.9, 27.6. 
 
N
O
O
 124 
 (±)-2-(((3aS,4S,7aR)-1,3-dioxo-2-phenyl-2,3,3a,4,7,7a-hexahydro-1H-
isoindol-4-yl)methyl)isoindoline-1,3-dione [44]: 2-(pent-4-en-1-
yl)isoindoline-1,3-dione (64.6 mg, 0.30 mmol, 1.0 equiv) and N-
phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv) were reacted using the general procedure, 
except 5 mL of 2% MeOH/CH2Cl2 was used to elute the product from a short silica plug. 
Purification by flash chromatography (1% MeOH/CH2Cl2) produced adduct 44 as a white solid. 
This material could be further purified by recrystallizing from hot EtOAc. Run 1 (91.1 mg, 0.236 
mmol, 79% yield); Run 2 (100.2 mg, 0.259 mmol, 86% yield). The product was isolated in >20:1 
d.r. by 1H NMR for both experiments. Average: 83% yield. X-ray quality crystals could be 
obtained by recrystallizing the product in refluxing acetone, followed by sitting at r.t. for 24 hr. 
 1H NMR (500 MHz, CDCl3) δ 7.86 (dd, J = 5.5, 3.5 Hz, 2H), 7.73 (dd, J = 5.5, 3.0 Hz, 
2H), 7.46 (t, J = 7.5 Hz, 2H), 7.39 (t, J = 7.5 Hz, 1H), 7.23-7.25 (m, 2H), 6.06 (dt, J = 9.0, 3.0 
Hz, 1H), 6.00 (ddd, J = 10.0, 6.5, 3.0 Hz, 1H), 4.46 (dd, J = 14.0, 10.5 Hz, 1H), 4.15 (dd, J = 
14.0, 3.5 Hz, 1H), 3.48 (dd, J = 9.0, 6.0 Hz, 1H), 3.36 (dt, J = 1.5, 9.0 Hz, 1H), 2.80-2.86 (m, 
2H), 2.15-2.21 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 178.6, 176.6, 168.5, 134.0, 131.9, 131.7, 
131.2, 129.1, 128.8, 128.6, 126.5, 123.3, 42.7, 40.3, 39.7, 36.0, 24.6; IR (film, cm-1): 3066, 3047, 
2951, 2854, 1770, 1709, 1496, 1389, 1365, 1190, 1174, 1066, 1045, 968; HRMS (ESI) m/z 
calc’d for C23H18N2O4Na [M + Na]+: 409.1164, found 409.1162. 
 
(+)-(R)-tert-butyl((1-((4-methoxybenzyl)oxy)hex-5-en-2-
yl)oxy)dimethylsilane: This product was prepared as described 
previously.118 
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 1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 5.82 
(ddt, J = 16.5, 10.0, 6.5 Hz, 1H), 5.00 (dq, J = 17.0, 1.5 Hz, 1H), 4.94 (dq, J = 10.5, 2.0 Hz, 1H), 
4.45 (d, J = 2.0 Hz, 2H), 3.80-3.84 (m, 1H), 3.81 (s, 3H), 3.38 (dd, J = 9.5, 5.5 Hz, 1H), 3.33 (dd, 
J = 9.5, 5.5 Hz, 1H), 2.11-2.18 (m, 1H), 2.02-2.09 (m, 1H), 1.61-1.68 (m, 1H), 1.49-1.57 (m, 
1H), 0.88 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H); [α]D23 = +15.7o (c = 1.17, CHCl3). Literature value 
for the enantiomer of the title compound: [α]D23 = -14.1o (c = 1.17, CHCl3). 
 
 (3a,4,7a)-4-((R)-1-((tert-butyldimethylsilyl)oxy)-2-
((4-methoxybenzyl)oxy)ethyl)-2-phenyl-3a,4,7,7a-
tetrahydro-1H-isoindole-1,3(2H)-dione [45]: (+)-(R)-
tert-butyl((1-((4-methoxybenzyl)oxy)hex-5-en-2-yl)oxy)dimethylsilane (105.2 mg, 0.30 mmol, 
1.0 equiv) and N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv) were reacted using the 
general procedure. 1H NMR analysis of the crude reaction showed a diastereofacial selectivity of 
1.4:1 d.r., (both diastereomers being endo products). Purification by flash chromatography (16% 
EtOAc/hexanes) produced the major diastereomer [(+)-45] as a clear oil (rf = 0.30) and the 
minor diastereomer [(-)-45] as a white solid (rf = 0.19). Run 1 (major diastereomer: 77.1 mg, 
0.148 mmol; minor diastereomer: 53.9 mg, 0.103 mmol, 84% combined yield); Run 2 (major 
diastereomer: 77.7 mg, 0.149 mmol; minor diastereomer: 55.5 mg, 0.106 mmol, 85% combined 
yield). Both diastereomers were isolated in >20:1 endo:exo by 1H NMR. Average: 84% yield, 
>99% ee for both diastereomers. 
 Major Diastereomer [(+)-45]: 1H NMR (500 MHz, CDCl3) δ 7.43 (t, J = 7.5 Hz, 2H), 
7.35 (t, J = 8.0 Hz, 1H), 7.23 (d, J = 8.5 Hz, 2H), 7.16-7.18 (m, 2H), 6.86 (d, J = 8.5 Hz, 2H), 
5.96 (ddd, J = 9.5, 7.0, 3.0 Hz, 1H), 5.87 (dt, J = 9.0, 3.5 Hz, 1H), 4.65 (dt, J = 11.0, 3.5 Hz, 1H), 
N
O
O
Ph
H
H
TBSO
H
OPMB
N
O
O
Ph
H
H
TBSO
H
OPMB
+
 126 
4.45 (q, J = 12.0 Hz, 2H), 3.81 (s, 3H), 3.65 (dd, J = 9.0, 5.5 Hz, 1H), 3.57 (dd, J = 10.5, 3.0 Hz, 
1H), 3.50 (dd, J = 10.0, 4.0 Hz, 1H), 3.30 (dt, J = 1.5, 9.0 Hz, 1H), 2.78 (dd, J = 14.5, 6.5 Hz, 
1H), 2.53-2.55 (m, 1H), 2.24-2.29 (m, 1H), 0.90 (s, 9H), 0.14 (s, 3H), 0.13 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 179.2, 177.3, 159.1, 131.9, 130.7, 130.2, 129.2, 129.1, 128.5, 127.5, 126.6, 
113.6, 73.3, 72.9, 70.5, 55.2, 40.7, 40.6, 40.3, 26.1, 25.6, 18.3, -4.4, -4.7; IR (film, cm-1): 3045, 
2954, 2929, 2900, 2854, 1711, 1612, 1514, 1462, 1383, 1248, 1171, 1095, 833; HRMS (ESI) m/z 
calc’d for C30H39NO5SiNa [M + Na]+: 544.2495, found 544.2497; [α]D23 = +83.1o (c = 1.17, 
CHCl3). 
 Minor Diastereomer [(-)-45]:  1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 
7.36 (t, J = 7.5 Hz, 1H), 7.29 (d, J = 8.5 Hz, 2H), 7.17-7.19 (m, 2H), 6.89 (d, J = 8.5 Hz, 2H), 
6.05 (dt, J = 9.0, 3.5 Hz, 1H), 5.96 (ddd, J = 10.0, 7.0, 3.5 Hz, 1H), 4.60 (d, J = 12.0 Hz, 1H), 
4.50 (d, J = 11.5 Hz, 1H), 4.47 (dt, J = 10.0, 2.5 Hz, 1H), 3.96 (dd, J = 11.0, 2.5 Hz, 1H), 3.81 
(s, 3H), 3.67 (dd, J = 11.0, 2.5 Hz, 1H), 3.32 (dd, J = 9.0, 6.0 Hz, 1H), 3.26 (dt, J = 1.5, 9.0 Hz, 
1H), 2.76 (dd, J = 15.0, 7.5 Hz, 1H), 2.67-2.70 (m, 1H), 2.22-2.28 (m, 1H), 0.89 (s, 9H), 0.08 (s, 
3H), 0.06 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 179.1, 177.7, 159.2, 132.8, 131.9, 130.4, 
129.4, 129.0, 128.6, 126.6, 126.5, 113.7, 73.2, 71.8, 71.6, 55.3, 41.3, 40.9, 39.6, 25.9, 24.8, 18.1, 
-4.0, -4.7; IR (film, cm-1): 3047, 2954, 2929, 2900, 2856, 1774, 1711, 1612, 1514, 1500, 1464, 
1250, 1182, 1119, 1088, 1034, 991, 833, 777; HRMS (ESI) m/z calc’d for C30H39NO5SiNa [M + 
Na]+: 544.2495, found 544.2489; [α]D23 = -32.9o (c = 1.17, CHCl3). 
Determination of enantiomeric purity.  Racemic material [(±)-(R)-tert-butyl((1-((4-
methoxybenzyl)oxy)hex-5-en-2-yl)oxy)dimethylsilane →  (±)-45 major and (±)-45 minor] was 
independently synthesized using an analogous route from rac-glycidol.  
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Major Diastereomer: both enantiomers were separated by chiral HPLC (Chiralcel OD-H, 5/95 i-
PrOH/hexanes, 1.0 mL/min @ 30°C), tR = 6.8, 7.6 min.  Major enantiomer for (+)-45, tR = 6.8 
min. 
Minor Diastereomer: both enantiomers were separated by chiral HPLC (Chiralcel OD-H, 3/97 i-
PrOH/hexanes, 1.0 mL/min @ 30°C), tR = 13.7, 14.7 min.  Major enantiomer for (-)-45, tR = 13.7 
min.  
 
8-nitrooct-1-ene: A flame-dried 50 mL round bottom flask was charged with 
NaNO2 (0.453 g, 6.57 mmol, 1.1 equiv) and DMF (13.0 mL, 0.46 M). 8-bromo-1-octene (Sigma-
Aldrich, 1.0 mL, 5.98 mmol, 1.0 equiv) was then syringed into the reaction suspension and 
allowed to stir at r.t. for 4 hrs, at which time the reaction was quenched with H2O (20 mL) and 
diluted with Et2O (15 mL). The layers were separated and the organic layer was washed with 
H2O (2 x 20 mL), dried over MgSO4, filtered, and   concentrated in vacuo. The crude product 
was purified through flash chromatography (5% Et2O/hexanes), affording 8-nitrooct-1-ene as a 
yellow oil (0.546 g, 3.474 mmol, 58% yield). 
 1H NMR (500 MHz, CDCl3) δ 5.79 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H), 4.93-5.02 (m, 2H), 
4.38 (t, J = 7.0, Hz, 2H), 1.98-2.07 (m, 4H), 1.24-1.54 (m, 6H). 
 
 (±)-(3aS,4S,7aR)-4-(4-nitrobutyl)-2-phenyl-3a,4,7,7a-tetrahydro-1H-
isoindole-1,3(2H)-dione [46]: 8-nitrooct-1-ene (47.2 mg, 0.30 mmol, 1.0 
equiv) and N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv) were reacted 
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using the general procedure. Purification by flash chromatography (35% EtOAc/hexanes) 
produced adduct 46 as a pale orange oil (65.8 mg, 0.200 mmol, 67% yield). The product was 
isolated in >20:1 d.r. by 1H NMR. 
 1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 7.37 (t, J = 7.5 Hz, 1H), 7.19 (d, J 
= 7.5 Hz, 2H), 6.00 (ddd, J = 9.5, 6.5, 3.0 Hz, 1H), 5.82 (dt, J = 9.0, 3.5 Hz, 1H), 4.43 (t, J = 7.0 
Hz, 2H), 3.26-3.32 (m, 2H), 2.83 (ddd, J = 15.0, 7.0, 1.5 Hz, 1H), 2.32-2.39 (m, 1H), 2.21-2.26 
(m, 1H), 2.09 (pent., J = 7.0 Hz, 2H), 1.97-2.04 (m, 1H), 1.80-1.88 (m, 1H), 1.51-1.69 (m, 2H). 
13C NMR (125 MHz, CDCl3) δ 178.8, 176.8, 133.4, 131.8, 129.0, 128.5, 127.9, 126.4, 75.4, 42.6, 
40.3, 36.0, 30.3, 27.3, 24.7, 24.5; IR (film, cm-1): 3037, 2947, 2931, 2860, 1774, 1707, 1596, 
1549, 1498, 1438, 1385, 1192; HRMS (ESI) m/z calc’d for C18H20N2O4Na [M + Na]+: 351.1321, 
found 351.1320. 
 
 (±)-(3R,4S)-3-(but-3-en-1-yl)-1,4-diphenylazetidin-2-one: The title 
compound was prepared following a modified procedure.119 A flame-dried 15 
mL round bottom flask was charged with 5-hexenoic acid (Sigma-Aldrich, 0.45 mL, 3.78 mmol, 
1.0 equiv), DCM (1.89 mL, 2.0 M), and oxalyl chloride (0.36 mL, 4.17 mmol, 1.1 equiv), and 
allowed to stir at room temperature for 4 hr. The reaction was then concentrated in vacuo, 
redissolving in DCM (2 mL) several times to afford sufficiently pure 5-hexenoic acid chloride 
(0.399 g, 3.01 mmol). 
 A flame-dried 25 mL round bottom flask was charged with N-benzilideneaniline (Sigma-
Aldrich, 0.545 g, 3.01 mmol, 1.0 equiv), heptane (Sigma-Aldrich, 1.34 mL, 2.25 M), and 
tributylamine (Sigma-Aldrich, 1.43 mL, 6.02 mmol, 2.0 equiv), then topped with a condenser 
and heated to 45°C to dissolve the N-benzilideneaniline. A solution of 5-hexenoic acid chloride 
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(0.399 g, 3.01 mmol, 1.0 equiv) in toluene (0.67 mL, 4.5 M) was then cannulated into the 
reaction flask, and the reaction was let stir at 45°C for 4 hr, and 80°C for 12 hr. The reaction was 
then diluted with EtOAc (5 mL) and quenched with 1M HCl (3 mL). The layers were separated, 
and the organic layer was washed with 1M HCl (3 x 10 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The crude product was purified through three recrystallizations from hot 
hexanes to afford (±)-(3R,4S)-3-(but-3-en-1-yl)-1,4-diphenylazetidin-2-one in >20:1 d.r. (anti) as 
a white solid (0.145 g, 0.523 mmol, 17% yield over 2-steps). 
 1H NMR (500 MHz, CDCl3) δ 7.31-7.39 (m, 5H), 7.22-7.29 (m, 4H), 7.03 (t, J = 7.0, 
1H), 5.79 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H), 4.98 (dd, J = 17.0, 10.0 Hz, 2H), 4.68 (d, J = 2.5 Hz, 
1H), 3.13 (ddd, J = 8.5, 6.0, 2.5 Hz, 1H), 2.28 (q, J = 7.0 Hz, 2H), 2.03-2.10 (m, 1H), 1.91-1.99 
(m, 1H). 13C NMR (125 MHz, CDCl3) δ 167.7, 137.9, 137.7, 137.1, 129.1, 129.0, 128.4, 125.8, 
123.7, 116.9, 115.8, 61.2, 59.9, 31.2, 28.2; IR (film, cm-1): 3070, 3032, 3003, 2978, 2924, 2856, 
1745, 1641, 1599, 1500, 1456, 1383, 1354, 1146, 1115, 916; HRMS (ESI) m/z calc’d for 
C19H20NO [M + H]+: 278.1545, found 278.1540. 
 
 (±)-(3aS,4S,7aR)-4-((3,4)-2-oxo-1,4-diphenylazetidin-3-yl)-
2-phenyl-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione 
[47]: (±)-(3R,4S)-3-(but-3-en-1-yl)-1,4-diphenylazetidin-2-one 
(83.2 mg, 0.30 mmol, 1.0 equiv) and N-phenylmaleimide (51.9 
mg, 0.30 mmol, 1.0 equiv) were reacted using the general procedure, except 5 mL of 2% 
MeOH/CH2Cl2 was used to elute the product from a short silica plug. 1H NMR analysis of the 
crude reaction showed a diastereofacial selectivity of 1.28:1 d.r., (both diastereomers being endo 
products). Purification by flash chromatography (2% MeOH/CH2Cl2) produced the major 
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diastereomer 47 as a white solid (rf = 0.53) and the minor diastereomer 47 as a beige solid (rf = 
0.38). Run 1 (major diastereomer: 46.5 mg, 0.104 mmol; minor diastereomer: 36.6 mg, 0.082 
mmol, 62% combined yield); Run 2 (major diastereomer: 50.5 mg, 0.113 mmol; minor 
diastereomer: 39.5 mg, 0.088 mmol, 67% combined yield). Both diastereomers were isolated in 
>20:1 endo:exo by 1H NMR. Average: 65% yield. 
Major Diastereomer: This compound has been reported previously.120 1H NMR 
(500 MHz, CDCl3) δ 7.29-7.42 (m, 10H), 7.23-7.26 (m, 2H), 7.16-7.18 (m, 
2H), 7.04 (t, J = 7.5 Hz, 1H), 6.11 (ddd, J = 10.0, 7.0, 3.5 Hz, 1H), 5.86 (dt, J = 
9.0, 3.0 Hz, 1H), 4.74 (d, J = 2.5 Hz, 1H), 4.19 (dd, J = 12.0, 2.5 Hz, 1H), 3.93 
(dd, J = 9.0, 5.5 Hz, 1H), 3.35 (dt, J = 1.0, 9.0 Hz, 1H), 2.90-2.96 (m, 1H), 2.88 (dd, J = 15.5, 7.0 
Hz, 1H), 2.28-2.33 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 178.5, 176.6, 166.5, 137.5, 137.4, 
131.7, 130.5, 129.5, 129.3, 129.0 (2 peaks), 128.7, 128.6, 126.4, 126.1, 123.9, 117.0, 61.4, 59.6, 
41.9, 39.9, 37.4, 25.1. 
Minor Diastereomer: This compound has been reported previously as a 
mixture with the major diastereomer.100 1H NMR (500 MHz, CDCl3) δ 7.29-
7.41 (m, 10H), 7.24 (t, J = 7.5 Hz, 2H), 7.15-7.17 (m, 2H), 7.03 (t, J = 7.5 Hz, 
1H), 6.32 (dt, J = 9.0, 3.0 Hz, 1H), 6.10 (ddd, J = 9.5, 6.0, 3.0 Hz, 1H), 4.86 (d, 
J = 2.5 Hz, 1H), 4.08 (dd, J = 10.5, 2.0 Hz, 1H), 3.40 (dd, J = 9.0, 6.0 Hz, 1H), 3.36 (dt, J = 2.0, 
9.0 Hz, 1H), 2.95-2.97 (m, 1H), 2.87 (ddd, J = 15.5, 6.0, 1.5 Hz, 1H), 2.28-2.33 (m, 1H). 13C 
NMR (125 MHz, CDCl3) δ 178.4, 175.9, 166.6, 137.5, 137.0, 131.7, 130.0, 129.1, 129.0 (2 
peaks), 128.6 (3 peaks), 126.5, 126.2, 123.9, 117.0, 60.6, 59.5, 41.9, 39.8, 36.6, 24.5. 
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2-(pent-4-en-1-yl)-1,3-dioxane: A flame-dried 100 mL round bottom flask was 
charged with THF (34.0 mL, 0.15 M) and bromoethyl-1,3-dioxane (TCI-
America, 1.0 g, 5.123 mmol, 1.0 equiv). A solution of allylmagnesium chloride (2 M in THF, 
10.25 mL, 20.04 mmol, 4.0 equiv) was then added dropwise via syringe. The reaction was heated 
to reflux briefly (~10 min.) and then allowed to cool to room temperature and stir overnight. The 
reaction was then slowly quenched with sat’d NH4Cl solution (50 ml) and diluted with Et2O (150 
mL).  The layers were separated and the aqueous layer was extracted with Et2O (3 x 50 mL).  
The combined organics were then washed with H2O (2 x 15 mL), dried over MgSO4, filtered, 
and concetrated in vacuo. The crude product was purified through flash chromatography (10% 
EtOAc/hexanes) to afford 2-(pent-4-en-1-yl)-1,3-dioxane as a clear oil (0.793 g, 5.08 mmol, 99% 
yield).  
 1H NMR (400 MHz, CDCl3) δ 5.79 (ddt, J = 16.8, 10.0, 6.8 Hz, 1H), 5.00 (dd, J = 17.2, 
1.6 Hz, 1H), 4.94 (dd, J = 10.0, 1.2 Hz, 1H), 4.52 (t, J = 5.2 Hz, 1H), 4.10 (dd, J = 10.8, 4.8 Hz, 
2H), 3.76 (dt, J = 2.4, 12.4 Hz, 2H), 2.03-2.12 (m, 3H), 1.57-1.63 (m, 2H) 1.45-1.52 (m, 2H), 
1.34 (d pent, J = 13.2, 1.2 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 138.4, 114.6, 102.1, 66.8, 
34.6, 33.4, 25.8, 23.1; IR (film, cm-1): 3076, 2954, 2927, 2850, 2731, 2657, 1641, 1460, 1431, 
1404, 1379, 1286, 1244, 1146, 1084, 995, 910; HRMS (EI) m/z calc’d for C9H15O2 [M - H]+: 
155.10721, found 155.10588. 
 
 (±)-(3aS,4S,7aR)-4-((1,3-dioxan-2-yl)methyl)-2-methyl-3a,4,7,7a-
tetrahydro-1H-isoindole-1,3(2H)-dione [48]: 2-(pent-4-en-1-yl)-1,3-
dioxane (46.8 mg, 0.30 mmol, 1.0 equiv) and N-methylmaleimide (33.3 mg, 
0.30 mmol, 1.0 equiv) were reacted using the general procedure. Purification by flash 
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chromatography (50% EtOAc/hexanes) produced adduct 48 as a white solid. Run 1 (52.8 mg, 
0.199 mmol, 66% yield); Run 2 (55.9 mg, 0.211 mmol, 70% yield). The product was isolated in 
>20:1 d.r. by 1H NMR for both experiments. Average: 68% yield. 
 1H NMR (500 MHz, CDCl3) δ 5.85 (ddd, J = 9.5, 6.5, 3.5 Hz, 1H), 5.76 (dt, J = 9.0, 3.0 
Hz, 1H), 4.79 (t, J = 5.5 Hz, 1H), 4.10-4.13 (m, 2H), 3.78 (dddd, J = 12.5, 12.5, 5.5, 2.5 Hz, 2H), 
3.11-3.13 (m, 2H), 2.90 (s, 3H), 2.68 (dd, J = 15.0, 7.0 Hz, 1H), 2.53-2.56 (m, 1H), 2.30 (ddd, J 
= 14.0, 7.5, 5.0 Hz, 1H), 2.03-2.19 (m, 3H), 1.35 (dt, J = 13.5, 1.0 Hz, 1H). 13C NMR (125 MHz, 
CDCl3) δ 180.0, 178.1, 133.8, 127.2, 100.7, 66.9 (2 peaks), 42.9, 40.2, 36.3, 31.0, 25.8, 24.6, 
24.2; IR (film, cm-1): 3037, 2962, 2929, 2852, 2735, 1772, 1693, 1435, 1383, 1286, 1142, 1095, 
1018, 1001; HRMS (ESI) m/z calc’d for C14H19NO4Na [M + Na]+: 288.1212, found 288.1216. 
 
3-(hex-5-en-1-yl)cyclopent-2-enone: A flame-dried 50 mL round bottom 
flask was charged with Mg0 turnings (199.3 mg, 8.20 mmol, 2.3 equiv) and 
THF (4.24 mL). A solution of 6-bromo-1-hexene (Sigma-Aldrich, 0.756 g, 4.63 mmol, 1.30 
equiv) in THF (4.24 mL) was cannulated into the Mg suspension, and the reaction was topped 
with a condenser and heated to 60°C for 15 min, then cooled to 0°C. Once 0°C was achieved, a 
solution of 3-methoxy-2-cyclopenten-1-one (Sigma-Aldrich, 0.400 g, 3.56 mmol, 1.0 equiv) in 
THF (2.12 mL) was cannulated into Grignard reaction dropwise. The reaction flask was then 
topped with a condenser and heated to 60°C for 2 hr, resulting in a color change from dark 
brown to bright red to black. Upon completion, the reaction was cooled to 0°C and excess 
Grignard was quenched slowly with sat’d NH4Cl (~3 mL). A 10% HCl(aq) solution (20 mL) was 
then added, and the reaction was allowed to react for an additional 30 min. This solution was 
then extracted with Et2O (2 x 20 mL), and the combined organic layers were washed with H2O (1 
O
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x 20 mL), sat’d NaCl (1 x 20 mL), dried over MgSO4, filtered, and concentrated in vacuo. The 
crude product was purified through flash chromatography (25% EtOAc/hexanes) to afford 3-
(hex-5-en-1-yl)cyclopent-2-enone as a clear oil (0.447 g, 2.72 mmol, 76% yield). 
 This compound has been reported previously.121 1H NMR (500 MHz, CDCl3) δ 5.93-5.94 
(m, 1H), 5.78 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 5.00 (dd, J = 17.0, 1.5 Hz, 1H), 4.95 (dd, J = 
10.0, 1.0 Hz, 1H), 2.57-2.57 (m, 2H), 2.38-2.42 (m, 4H), 2.08 (q, J = 7.0 Hz, 2H), 1.59 (app 
pent, J = 7.5 Hz, 2H), 1.44 (app pent, J = 7.5 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 210.1, 
182.9, 138.2, 129.4, 114.7, 35.2, 33.3, 33.2, 31.4, 28.4, 26.4. 
 
 (±)-(3aR,4R,7aS)-4-(2-(3-oxocyclopent-1-en-1-yl)ethyl)-2-phenyl-3a,4,7,7a-
tetrahydro-1H-isoindole-1,3(2H)-dione [49]: 3-(hex-5-en-1-yl)cyclopent-2-
enone (49.3 mg, 0.30 mmol, 1.0 equiv) and N-phenylmaleimide (51.9 mg, 0.30 
mmol, 1.0 equiv) were reacted using the general procedure. Purification by flash 
chromatography (75% EtOAc/hexanes) produced adduct 49 as a beige solid. This solid could be 
recrystallized in refluxing 80% EtOAc/hexanes followed by sitting at -20°C. Run 1 (68.9 mg, 
0.206 mmol, 69% yield); Run 2 (68.2 mg, 0.203 mmol, 68% yield). The product was isolated in 
>20:1 d.r. by 1H NMR for both experiments. Average: 68% yield. 
 1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 7.37 (t, J = 7.5 Hz, 1H), 7.19-7.20 
(m, 2H), 6.04 (ddd, J = 9.5, 6.5, 3.0 Hz, 1H), 6.01 (d, J = 1.5 Hz, 1H), 5.85 (dt, J = 9.0, 3.0 Hz, 
1H), 3.28-3.34 (m, 2H), 2.85 (dd, J = 15.5, 7.0 Hz, 1H), 2.57-2.71 (m, 4H), 2.39-2.43 (m, 3H), 
2.22-2.31 (m, 2H), 2.05-2.13 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 209.8, 181.8, 178.7, 176.7, 
133.0, 131.7, 129.8, 129.0, 128.6, 128.3, 126.4, 42.5, 40.2, 35.7, 35.2, 31.7, 31.4, 28.6, 24.5; IR 
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(film, cm-1): 3035, 2953, 2916, 2848, 1774, 1705, 1676, 1614, 1498, 1439, 1385, 1186; HRMS 
(ESI) m/z calc’d for C21H21NO3Na [M + Na]+: 358.1419, found 358.1414. 
 
 
Dehydrogenative Diels-Alder Maleimide Scope for Figure 35 
 
 (±)-2-((3aS,4S,7aR)-2-(4-methoxyphenyl)-1,3-dioxo-
2,3,3a,4,7,7a-hexahydro-1H-isoindol-4-yl)ethyl acetate [50]: 
Acetic Acid 5-hexen-1-yl ester 34 (42.6 mg, 0.30 mmol, 1.0 equiv) 
and N-(4-methoxyphenyl)maleimide (Princeton BioMolecular Research, Inc., 60.9 mg, 0.30 
mmol, 1.0 equiv) were reacted using the general procedure. Purification by flash 
chromatography (40% EtOAc/hexanes) produced adduct 50 as a yellow solid (74.8 mg, 0.218 
mmol, 73% yield). The product was isolated in >20:1 d.r. by 1H NMR. 
 1H NMR (500 MHz, CDCl3) δ 7.10 (d, J = 9.5 Hz, 2H), 6.94 (d, J = 9.0 Hz, 2H), 6.01 
(ddd, J = 9.5, 6.5, 3.0 Hz, 1H), 5.85 (dt, J = 9.5, 3.5 Hz, 1H), 4.35 (ddd, J = 11.5, 7.0, 6.5 Hz, 
1H), 4.23 (ddd, J = 11.5, 6.5, 5.0 Hz, 1H), 3.81 (s, 3H), 3.28-3.30 (m, 2H), 2.83 (dd, J = 15.0, 7.0 
Hz, 1H), 2.47-2.51 (m, 1H), 2.28-2.35 (m, 1H), 2.23-2.27 (m, 1H), 2.12-2.20 (m, 1H), 2.07 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 179.0, 177.0, 171.1, 159.4, 133.0, 128.1, 127.6, 124.4, 
114.3, 62.6, 55.4, 42.5, 40.2, 32.8, 30.2, 24.5, 21.0; IR (film, cm-1): 2952, 2849, 1736, 1706, 
1609, 1514, 1389, 1249, 1192, 1167, 1033, 829; HRMS (ESI) m/z calc’d for C19H21NO5Na [M + 
Na]+: 366.1317, found 366.1316. 
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 (±)-2-((3aS,4S,7aR)-2-(4-fluorophenyl)-1,3-dioxo-2,3,3a,4,7,7a-
hexahydro-1H-isoindol-4-yl)ethyl acetate [51]: Acetic Acid 5-hexen-
1-yl ester 34 (42.6 mg, 0.30 mmol, 1.0 equiv) and N-(4-
fluorophenyl)maleimide (Oakwood Products, Inc., 57.3 mg, 0.30 mmol, 1.0 equiv) were reacted 
using the general procedure. Purification by flash chromatography (35% EtOAc/hexanes) 
produced adduct 51 as a pale yellow oil (75.2 mg, 0.227 mmol, 76% yield). The product was 
isolated in >20:1 d.r. by 1H NMR. 
 1H NMR (500 MHz, CDCl3) δ 7.17-7.20 (m, 2H), 7.11-7.14 (m, 2H), 6.02 (ddd, J = 10.0, 
6.5, 3.0 Hz, 1H), 5.85 (dt, J = 9.0, 3.5 Hz, 1H), 4.36 (ddd, J = 11.0, 7.0, 6.0 Hz, 1H), 4.23 (ddd, J 
= 11.5, 6.5, 5.0 Hz, 1H), 3.30-3.34 (m, 2H), 2.83 (dd, J = 15.0, 7.5 Hz, 1H), 2.48-2.51 (m, 1H), 
2.23-2.35 (m, 2H), 2.11-2.20 (m, 1H), 2.07 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 178.7, 176.7, 
171.1, 163.1, 161.1, 133.1, 128.3, 128.2, 128.1, 127.7, 127.6, 116.1, 115.9, 62.5, 42.6, 40.2, 32.8, 
30.1, 24.5, 21.0; IR (film, cm-1): 3041, 2960, 2921, 2856, 1736, 1709, 1604, 1511, 1389, 1235, 
1191, 1170, 1039, 834; HRMS (ESI) m/z calc’d for C18H18NO4FNa [M + Na]+: 354.1118, found 
354.1120. 
 
 (±)-2-((3aS,4S,7aR)-2-(4-acetylphenyl)-1,3-dioxo-2,3,3a,4,7,7a-
hexahydro-1H-isoindol-4-yl)ethyl acetate [52]: Acetic Acid 5-
hexen-1-yl ester 34 (42.6 mg, 0.30 mmol, 1.0 equiv) and N-(4-
acetylphenyl)maleimide (Alfa Aesar, 64.5 mg, 0.30 mmol, 1.0 equiv) were reacted using the 
general procedure. Purification by flash chromatography (45% EtOAc/hexanes) produced adduct 
52 as a pale yellow oil (80.3 mg, 0.226 mmol, 75% yield). The product was isolated in >20:1 
d.r. by 1H NMR. 
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 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.5 Hz, 2H), 6.03 
(ddd, J = 10.0, 7.0, 3.5 Hz, 1H), 5.87 (dt, J = 9.0, 3.5 Hz, 1H), 4.36 (ddd, J = 11.5, 7.0, 6.5 Hz, 
1H), 4.23 (ddd, J = 12.0, 6.5, 6.0 Hz, 1H), 3.33-3.37 (m, 2H), 2.84 (dd, J = 15.5, 7.0 Hz, 1H), 
2.61 (s, 3H), 2.48-2.52 (m, 1H), 2.22-2.36 (m, 2H), 2.12-2.20 (m, 1H), 2.07 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 196.9, 178.3, 176.4, 171.0, 136.6, 135.8, 133.1, 129.0, 128.1, 126.4, 62.5, 
42.7, 40.3, 32.8, 30.1, 26.6, 24.5, 21.0; IR (film, cm-1): 2964, 2921, 2857, 1736, 1710, 1686, 
1604, 1510, 1381, 1265, 1244, 1185, 1166, 1041, 959; HRMS (ESI) m/z calc’d for C20H21NO5Na 
[M + Na]+: 378.1317, found 378.1317. 
 
 (±)-2-((3aS,4S,7aR)-2-(4-bromophenyl)-1,3-dioxo-2,3,3a,4,7,7a-
hexahydro-1H-isoindol-4-yl)ethyl acetate [53]: Acetic Acid 5-
hexen-1-yl ester 34 (42.6 mg, 0.30 mmol, 1.0 equiv) and N-(4-
bromophenyl)maleimide (Alfa Aesar, 75.6 mg, 0.30 mmol, 1.0 equiv) were reacted using the 
general procedure. Purification by flash chromatography (35% EtOAc/hexanes) produced adduct 
53 as an orange solid (71.9 mg, 0.183 mmol, 61% yield). The product was isolated in >20:1 d.r. 
by 1H NMR. 
 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8.5 Hz, 2H), 7.11 (d, J = 8.5 Hz, 2H), 6.01 
(ddd, J = 10.0, 7.0, 3.5 Hz, 1H), 5.85 (dt, J = 9.0, 3.5 Hz, 1H), 4.36 (ddd, J = 11.5, 7.0, 5.5 Hz, 
1H), 4.23 (ddd, J = 11.0, 6.5, 5.0 Hz, 1H), 3.29-3.33 (m, 2H), 2.83 (dd, J = 15.0, 7.0 Hz, 1H), 
2.46-2.52 (m, 1H), 2.23-2.35 (m, 2H), 2.11-2.18 (m, 1H), 2.07 (s, 3H). 13C NMR (125 MHz, 
CDCl3) δ 178.4, 176.4, 171.0, 133.1, 132.1, 130.7, 128.1, 127.9, 122.3, 62.5, 42.6, 40.3, 32.8, 
30.1, 24.5, 21.0; IR (film, cm-1): 3039, 2960, 2848, 1896, 1777, 1740, 1705, 1492, 1442, 1386, 
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1247, 1188, 1169, 1070, 1039, 1013, 915, 821, 723; HRMS (ESI) m/z calc’d for C18H18NO4BrNa 
[M + Na]+: 414.0317, found 414.0315. 
 
 (±)-2-((3aS,4S,7aR)-2-methyl-1,3-dioxo-2,3,3a,4,7,7a-hexahydro-1H-
isoindol-4-yl)ethyl acetate [54]: Acetic Acid 5-hexen-1-yl ester 34 (42.6 
mg, 0.30 mmol, 1.0 equiv) and N-methylmaleimide (33.3 mg, 0.30 mmol, 
1.0 equiv) were reacted using the general procedure. Purification by flash chromatography (40% 
EtOAc/hexanes) produced adduct 54 as a pale yellow oil. Run 1 (53.2 mg, 0.212 mmol, 71% 
yield); Run 2 (52.4 mg, 0.209 mmol, 70% yield). The product was isolated in >20:1 d.r. by 1H 
NMR for both experiments. Average: 70% yield. 
 1H NMR (500 MHz, CDCl3) δ 5.90 (ddd, J = 9.5, 6.5, 3.0 Hz, 1H), 5.74 (dt, J = 9.0, 3.0 
Hz, 1H), 4.32 (ddd, J = 11.0, 6.0, 6.0 Hz, 1H), 4.21 (ddd, J = 11.5, 6.0, 6.0 Hz, 1H), 3.12-3.16 
(m, 2H), 2.91 (s, 3H), 2.73 (dd, J = 15.0, 7.0 Hz, 1H), 2.38-2.40 (m, 1H), 2.26-2.31 (m, 1H), 
2.06-2.17 (m, 2H), 2.06 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 179.8, 177.8, 171.0, 132.9, 
128.0, 62.6, 42.6, 40.2, 32.5, 30.2, 24.7, 24.2, 20.9; IR (film, cm-1): 3035, 2954, 2852, 1770, 
1736, 1695, 1437, 1385, 1286, 1242, 1134, 1105, 1043; HRMS (ESI) m/z calc’d for 
C13H17NO4Na [M + Na]+: 274.1055, found 274.1060. 
 
N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-2,2,2-
trifluoroacetamide: A flame-dried 25 mL round bottom flask was charged 
with N-(2-aminoethyl)maleimide trifluoroacetate salt (Sigma-Aldrich, 0.150 
g, 0.590 mmol, 1.0 equiv), CH2Cl2 (1.18 mL, 0.5 M), and NEt3 (0.246 mL, 1.77 mmol, 3.0 
equiv). Trifluoroacetic anhydride (0.10 mL, 0.708 mmol, 1.2 equiv) was then syringed into the 
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reaction and allowed to stir at r.t. for 40 min, at which time the reaction was quenched with H2O 
(5 mL) and satd. NaHCO3 (5 mL) and diluted with CH2Cl2 (10 mL). The layers were separated 
and the organic layer was washed with H2O (2 x 20 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The crude product was purified through flash chromatography (2% 
MeOH/ CH2Cl2), affording the title compound as a white solid (83.1 mg, 0.352 mmol, 60% 
yield). 
 1H NMR (500 MHz, CDCl3) δ 6.97 (br s, 1H), 6.77 (s, 2H), 3.79 (t, J = 5.5 Hz, 2H), 3.58 
(q, J = 5.5, Hz, 2H). 
 
 (±)-2-((3aS,4S,7aR)-1,3-dioxo-2-(2-(2,2,2-
trifluoroacetamido)ethyl)-2,3,3a,4,7,7a-hexahydro-1H-isoindol-4-
yl)ethyl acetate [55]: Acetic Acid 5-hexen-1-yl ester 34 (42.6 mg, 
0.30 mmol, 1.0 equiv) and N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-2,2,2-
trifluoroacetamide (70.8 mg, 0.30 mmol, 1.0 equiv) were reacted using the general procedure. 
Purification by flash chromatography (50% EtOAc/hexanes) produced adduct 55 as a pale 
yellow oil (80.3 mg, 0.213 mmol, 71% yield). The product was isolated in >20:1 d.r. by 1H 
NMR. 
 1H NMR (500 MHz, CDCl3) δ 6.91 (br s, 1H), 5.91 (ddd, J = 10.0, 7.0, 3.5 Hz, 1H), 5.75 
(dt, J = 9.0, 3.5 Hz, 1H), 4.32 (ddd, J = 11.5, 7.0, 5.5 Hz, 1H), 4.21 (ddd, J = 11.0, 6.5, 5.5 Hz, 
1H), 3.72 (dd, J = 7.5, 5.5 Hz, 2H), 3.51 (q, J = 5.5 Hz, 2H), 3.17-3.21 (m, 2H), 2.73 (dd, J = 
15.0, 7.0 Hz, 1H), 2.38-2.42 (m, 1H), 2.23-2.30 (m, 1H), 2.08-2.20 (m, 2H), 2.07 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 180.2, 178.2, 171.1, 157.6, 157.3, 133.0, 128.0, 116.7, 114.4, 62.5, 
42.6, 40.2, 39.1, 37.3, 32.6, 30.1, 24.3, 20.9; IR (film, cm-1): 3333, 3100, 2955, 2857, 1726, 
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1702, 1561, 1439, 1403, 1366, 1245, 1212, 1185, 1045; HRMS (ESI) m/z calc’d for 
C16H19N2O5F3Na [M + Na]+: 399.1144, found 399.1141. 
 
2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl 2,6-difluorobenzoate: A 
25 mL round bottom flask was charged with N-(2-hydroxyethyl)maleimide 
(Strem, 0.100 g, 0.708 mmol, 1.0 equiv), CH2Cl2 (0.94 mL, 0.75 M), and NEt3 (0.246 mL, 1.77 
mmol, 2.5 equiv). 2,6-difluorobenzoyl choride (Sigma-Aldrich, 0.177 mL, 1.42 mmol, 2.0 equiv) 
was then syringed into the reaction dropwise and allowed to stir at r.t. for 10 min, at which time 
the reaction was quenched with H2O (5 mL) and diluted with CH2Cl2 (10 mL). The layers were 
separated and the organic layer was washed with satd. NH4Cl (2 x 20 mL), dried over MgSO4, 
filtered, and concentrated in vacuo. The crude product was purified through flash 
chromatography (35% EtOAc/hexanes), affording the title compound as a white solid (173 mg, 
0.615 mmol, 87% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.38-7.44 (m, 1H), 6.93 (t, J = 8.5 Hz, 2H), 6.73 (s, 2H), 
4.52 (t, J = 5.5 Hz, 2H), 3.93 (t, J = 5.5, Hz, 2H). 
 
 (±)-2-((3aS,4S,7aR)-4-(2-acetoxyethyl)-1,3-dioxo-3a,4,7,7a-
tetrahydro-1H-isoindol-2(3H)-yl)ethyl 2,6-difluorobenzoate 
[56]: Acetic Acid 5-hexen-1-yl ester 34 (42.6 mg, 0.30 mmol, 1.0 
equiv) and 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl 2,6-difluorobenzoate (84.4 mg, 0.30 
mmol, 1.0 equiv) were reacted using the general procedure. Purification by flash 
chromatography (40% EtOAc/hexanes) produced adduct 56 as a pale yellow oil (85.0 mg, 0.202 
mmol, 67% yield). The product was isolated in >20:1 d.r. by 1H NMR. 
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 1H NMR (500 MHz, CDCl3) δ 7.39-7.45 (m, 1H), 6.94 (t, J = 8.0 Hz, 2H), 5.86 (ddd, J = 
10.0, 6.5, 3.0 Hz, 1H), 5.68 (dt, J = 9.0, 3.5 Hz, 1H), 4.42-4.51 (m, 2H), 4.29 (ddd, J = 11.0, 6.5, 
6.0 Hz, 1H), 4.18 (ddd, J = 11.5, 6.0, 5.5 Hz, 1H), 3.80-3.88 (m, 2H), 3.14-3.19 (m, 2H), 2.71 
(dd, J = 15.5, 7.0 Hz, 1H), 2.37-2.40 (m, 1H), 2.21-2.28 (m, 1H), 2.12-2.18 (m, 1H), 2.01-2.09 
(m, 1H), 2.05 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 179.3, 177.4, 171.0, 161.8 (2 peaks), 
161.1, 159.8, 159.7, 133.1 (2 peaks), 133.0, 132.8, 127.9, 112.1 (2 peaks), 112.0, 111.9, 62.6, 
61.7, 42.4, 40.0, 37.3, 32.4, 30.0, 24.1, 20.9; IR (film, cm-1): 3047, 2956, 2875, 2848, 1736, 
1703, 1636, 1595, 1471, 1431, 1402, 1365, 1335, 1290, 1261, 1115, 1016; HRMS (ESI) m/z 
calc’d for C21H21NO6F2Na [M + Na]+: 444.1235, found 444.1235. 
 
Intramolecular Dehydrogenative Diels-Alder Reactions for Figure 36 
 
 (E)-ethyl 4-(benzyl(pent-4-en-1-yl)amino)-4-oxobut-2-enoate [57]: 
A 25 mL round bottom flask was charged sequentially with 5-bromo-
1-pentene (Sigma-Aldrich, 0.275 mL, 2.32 mmol, 1.0 equiv), benzylamine (Sigma-Aldrich, 2.5 
mL, 23.2 mmol, 10.0 equiv), and K2CO3 (0.32 g, 2.32 mmol, 1.0 equiv), and the reaction was 
heated at 45°C for 3.5 hr. The reaction was then diluted with Et2O (5 mL) and H2O (10 mL), and 
the layers were separated. The organic layer was then washed with dilute NH4Cl (3 x 20 mL) in 
order to remove excess benzylamine, dried over MgSO4, filtered, and concentrated in vacuo. The 
crude benzyl pentenamine product was sufficiently pure and taken onto the next step without 
purification. 
 The benzyl pentenamine product (2.32 mmol, 1.0 equiv) was dissolved in DCM (3.6 mL) 
and pyridine (0.24 mL, 3.02 mmol, 1.3 equiv) and cooled to 0°C. A solution of ethyl fumaroyl 
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chloride (Sigma-Aldrich, 0.49 mL, 3.02 mmol, 1.3 equiv) in DCM (1.0 mL) was then syringed 
dropwise into the reaction, resulting in a dark red solution that was stirred at room temperature 
for 3 hr. The reaction was then diluted with DCM (10 mL), and quenched slowly with H2O (15 
mL) and satd NaHCO3 (15 mL). The layers were separated and the organic layer was washed 
with satd NaHCO3 (1 x 20 mL), H2O (1 x 20 mL), dried over MgSO4, filtered, and concentrated 
in vacuo. The crude product was purified through flash chromatography (25% EtOAc/hexanes) 
to afford the title compound (57) as a clear oil (0.685 g, 2.27 mmol, 98% yield over 2 steps). 
 1H NMR (500 MHz, CDCl3, asterisk denotes minor rotomer peaks) δ 7.24-7.43 (m, 5H), 
7.17 (d, J = 7.0 Hz, 1H), 6.90 (d, J = 15.0 Hz, 1H), 6.85* (d, J = 15.0 Hz, 1H), 5.70-5.81 (m, 
1H), 4.95- 5.04 (m, 2H), 4.68 (s, 2H), 4.62* (s, 2H), 4.27 (d, J = 7.0 Hz, 2H), 4.21* (d, J = 7.5 
Hz, 2H), 3.42* (app t, J = 7.5 Hz, 2H), 3.31 (app t, J = 7.5 Hz, 2H), 2.04 (pent, J = 6.5 Hz, 2H), 
1.67 (app sextet, J = 7.0 Hz, 2H), 1.33 (t, J = 7.0 Hz, 3H), 1.28* (t, J = 7.0 Hz, 3H). 
 
 (±)-(3aS,4S,7aR)-ethyl 2-benzyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1H-
isoindole-4-carboxylate [59]: A ½ dram borosilicate vial was charged 
sequentially with Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 catalyst 39 (15.9 mg, 
0.03 mmol, 0.10 equiv), 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv), and p-nitrobenzoic acid 
(5.01 mg, 0.03 mmol, 0.10 equiv). Acrylamide 57 (90.4 mg, 0.30 mmol, 1.0 equiv) was then 
added to the ½ dram vial, and the reaction was immediately dissolved in DCE (0.24 mL, 1.25 
M). The resulting dark red reaction mixture was charged with a stir bar, capped with a  eflon-
lined cap, and suspended in an oil bath at 45°C for 48 hr. Upon completion, the dark red reaction 
mixture was filtered through a short silica plug, eluting with ~5 mL EtOAc and concentrated in 
vacuo at 25°C (~25 torr) to afford a dark red crude oil. A small aliquot of this mixture was added 
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to a NMR tube and diluted with CDCl3. 1H NMR analysis of the crude product showed a 4:1 
trans:cis selectivity. After analysis, the sample was returned to the crude mixture and the solvent 
was removed. Purification by flash chromatography (50% Et2O/hexanes) produced 
hydroisoindoline 59 as a clear oil (53.6 mg, 0.179 mmol, 60% yield). The product was isolated 
with 4:1 d.r. by 1H NMR. 
 1H NMR (500 MHz, CDCl3) Major diastereomer: δ 7.30-7.33 (m, 2H), 7.25-7.28 (m, 
1H), 7.21 (d, J = 7.0 Hz, 2H), 5.75-5.78 (m, 1H), 5.68 (dq, J = 10.0, 3.0 Hz, 1H), 4.48 (d, J = 
14.5 Hz, 1H), 4.39 (d, J = 14.5 Hz, 1H), 4.21-4.34 (m, 2H), 3.25 (dd, J = 9.0, 6.0 Hz, 1H), 2.97 
(t, J = 10.0 Hz, 1H), 2.77-2.83 (m, 1H), 2.45-2.61 (m, 3H), 2.33-2.41 (m, 1H), 1.34 (t, J = 7.0 
Hz, 3H). Minor diastereomer (diagnostic): δ 7.16 (d, J = 7.0 Hz, 2H), 5.78-5.82 (m, 1H), 5.47-
5.51 (m, 1H), 4.55 (d, J = 15.0 Hz, 1H), 4.16 (dq, J = 2.0, 7.5 Hz, 2H), 3.45 (dd, J = 9.5, 7.5 Hz, 
1H), 2.89 (dd, J = 9.5, 1.5 Hz, 1H), 2.25-2.30 (m, 1H), 1.25 (t, J = 7.5 Hz, 3H).  13C NMR (125 
MHz, CDCl3, asterisk denotes minor diastereomer peaks) δ 174.4, 174.1*, 173.8*, 172.8, 136.6, 
136.2*, 128.6, 128.5*, 128.1, 128.0, 127.7*, 127.5, 127.4*, 127.3*, 127.1*, 125.2, 60.8, 60.7*, 
51.1*, 49.0, 47.2, 46.4, 42.3*, 40.6, 38.6, 37.1*, 30.4, 30.4*, 23.3*, 14.2; IR (film, cm-1): 3062, 
3028, 2980, 2933, 2912, 2966, 1732, 1699, 1496, 1454, 1421, 1306, 1252, 1180, 1119, 1097, 
1030; HRMS (ESI) m/z calc’d for C18H22NO3 [M + H]+: 300.1600, found 300.1598. 
 
deca-1,9-dien-3-one [58]: A flame-dried 50 mL round bottom flask was 
charged with Mg0 turnings (142.0 mg, 5.87 mmol, 1.3 equiv) and Et2O (3.01 mL). A solution of 
7-bromo-1-heptene (Sigma-Aldrich, 0.688 mL, 4.52 mmol, 1.0 equiv) in Et2O (3.01 mL) was 
syringed into the Mg suspension over 30 min. The reaction was then cooled to -10°C and freshly 
distilled acrolein (Sigma-Aldrich, 0.422 mL, 6.32 mmol, 1.4 equiv) was syringed into the 
O
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Grignard reaction dropwise over 30 min. Upon completion, the reaction was quenched slowly at 
-10°C with sat’d NH4Cl (~3 mL), and diluted with Et2O (10 mL) and H2O (10 mL). The layers 
were separated and the aqueous layer was extracted with Et2O (2 x 20 mL). The combined 
organic layers were then washed with H2O (1 x 20 mL), sat’d NaCl (1 x 20 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. The crude product was purified through flash 
chromatography (20% EtOAc/hexanes) to afford deca-1,9-dien-3-ol as a clear oil (0.402 g, 2.60 
mmol, 58% yield). 
 A 50 mL round bottom flask was charged with deca-1,9-dien-3-ol (0.285 g, 1.85 mmol, 
1.0 equiv) and acetone (5.6 mL, 0.33 M), and the solution was cooled to 0°C. This alcohol 
solution was then titrated with Jones’ reagent (4 M) until the red color persisted, and allowed to 
stir for 10 min. The red reaction solution was then quenched with iPrOH until a green color 
persisted, and let warm to rt. The reaction was diluted with DCM (10 mL) and H2O (10 mL) was 
added to dissolve the green solids. The layers were separated and the aqueous layer was 
extracted with DCM (2 x 40 mL). The combined organic layers were then washed with satd 
NaHCO3 (1 x 40 mL), sat’d NaCl (1 x 40 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. The crude product was then filtered through a short silica plug with 100% DCM to afford 
deca-1,9-dien-3-one (58) as a clear oil (0.268 g, 1.76 mmol, 95% yield). 
 1H NMR (500 MHz, CDCl3) δ 6.35 (dd, J = 17.5, 10.5 Hz, 1H), 6.21 (dd, J = 17.5, 1.0 
Hz, 1H), 5.81 (d, J = 10.5 Hz, 1H), 5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H), 4.99 (dd, J = 17.0, 1.5 
Hz, 1H), 4.94 (d, J = 10.0 Hz, 1H), 2.58 (t, J = 7.5 Hz, 2H), 2.05 (q, J = 7.5 Hz, 2H), 1.63 (pent, 
J = 7.5 Hz, 2H), 1.38-1.63 (m, 2H), 1.30-1.36 (m, 2H). 
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(±)-(4aR,8aS)-2,3,4,4a,8,8a-hexahydronaphthalen-1(7H)-one [60]: A ½ dram 
borosilicate vial was charged sequentially with Pd[1,2-
bis(benzylsulfinyl)ethane](OAc)2 catalyst 39 (15.9 mg, 0.03 mmol, 0.10 equiv), 2,6-Me2BQ 
(57.2 mg, 0.42 mmol, 1.4 equiv), and p-nitrobenzoic acid (5.01 mg, 0.03 mmol, 0.10 equiv). 
Deca-1,9-dien-3-one 58 (45.6 mg, 0.30 mmol, 1.0 equiv) was then added to the ½ dram vial, and 
the reaction was immediately dissolved in DCE (0.20 mL, 1.50 M). The resulting dark red 
reaction mixture was charged with a stir bar, capped with a Teflon-lined cap, and suspended in 
an oil bath at 45°C for 48 hr. Upon completion, the dark red reaction mixture was filtered 
through a short silica plug, eluting with ~5 mL EtOAc and concentrated in vacuo at 0°C (~25 
torr) to afford a dark red crude oil. A small aliquot of this mixture was added to a NMR tube and 
diluted with CDCl3. 1H NMR analysis of the crude product showed a 16:1 cis:trans selectivity. 
After analysis, the sample was returned to the crude mixture and the solvent was removed. 
Purification by flash chromatography (4% EtOAc/hexanes) produced cis-decalin 60 as a clear oil 
(27.4 mg, 0.182 mmol, 61% yield). The product was isolated with 16:1 d.r. by 1H NMR. 
 This compound has been reported previously.106 1H NMR (500 MHz, CDCl3): δ 5.71 (dq, 
J = 10.5, 2.5 Hz, 1H), 5.51 (dq, J = 10.0, 2.5 Hz, 1H), 2.66-2.72 (m, 1H), 2.49-2.52 (m, 1H), 
2.34-2.39 (m, 1H), 2.22-2.27 (m, 1H), 2.13-2.21 (m, 1H), 2.05-2.11 (m, 1H), 1.94-2.01 (m, 1H), 
1.67-1.88 (m, 4H), 1.48-1.54 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 213.2, 129.7, 128.4, 48.0, 
40.6, 37.2, 29.5, 23.3, 22.9, 22.2; IR (film, cm-1): 3016, 2927, 2864, 1705, 1444, 1431, 1317, 
1227, 1124, 1005; LRMS (EI) m/z calc’d for C10H14O [M]+: 150.1, found 150.1.  
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Dehydrogenative Diels-Alder Route to Hydroisoquinolines for Figure 37 
 
2,2,2-trichloroethyl benzyl(hex-5-en-1-yl)carbamate [61]: A 50 mL round 
bottom flask was charged sequentially with 6-bromo-1-hexene (Sigma-Aldrich, 
0.54 mL, 4.0 mmol, 1.0 equiv), benzylamine (Sigma-Aldrich, 4.4 mL, 40.0 mmol, 10.0 equiv), 
and K2CO3 (0.552 g, 4.0 mmol, 1.0 equiv), and the reaction was heated at 45°C for 4 hr. The 
reaction was then diluted with Et2O (20 mL) and H2O (20 mL), and the layers were separated. 
The organic layer was then washed with dilute NH4Cl (3 x 40 mL) in order to remove excess 
benzylamine, dried over MgSO4, filtered, and concentrated in vacuo. The crude benzyl 
hexenamine product was sufficiently pure and taken onto the next step without purification. 
 The crude benzyl hexenamine product (4.0 mmol, 1.0 equiv) was dissolved in DCM (8.0 
mL, 0.5 M) and pyridine (0.42 mL, 5.21 mmol, 1.3 equiv) and cooled to 0°C. 2,2,2-
trichloroethylchloroformate (Sigma-Aldrich, 0.72 mL, 5.21 mmol, 1.3 equiv) was then syringed 
dropwise into the reaction, resulting in a yellow slurry which was stirred at room temperature for 
12 hr. The resulting dark green reaction was then quenched slowly with H2O (15 mL) and satd 
NaHCO3 (15 mL). The layers were separated and the organic layer was washed with satd 
NaHCO3 (1 x 40 mL), H2O (1 x 40 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The crude product was purified through flash chromatography (5% Et2O/pentane) to afford the 
title compound (61) as a clear oil (1.254 g, 3.44 mmol, 86% yield over 2 steps). 
 1H NMR (500 MHz, CDCl3) δ 7.27-7.35 (m, 5H), 5.76 (ddt, J = 15.5, 10.0, 5.0 Hz, 1H), 
4.98 (d, J = 17.0 Hz, 1H), 4.94 (d, J = 10.0 Hz, 1H), 4.81 (d, J = 10.5 Hz, 2H), 4.54 (d, J = 12.0 
Hz, 2H), 3.25-3.31 (m, 2H), 2.04 (pent, J = 7.5 Hz, 2H), 1.56-1.62 (m, 2H), 1.33-1.41 (m, 2H); 
13C NMR (mixture of rotomers, 125 MHz, CDCl3) δ 154.9, 154.2, 138.3 (2 peaks), 137.2, 128.6, 
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127.7, 127.5, 127.5 (3 peaks), 114.7, 95.7, 95.6, 75.1 (2 peaks), 50.8, 50.1, 47.0, 46.4, 33.3 (2 
peaks), 27.4, 26.7, 25.9, 25.8; IR (film, cm-1): 3068, 3032, 2974, 2933, 2862, 1720, 1641, 1471, 
1454, 1425, 1360, 1252, 1225, 1132, 1063; HRMS (EI) m/z calc’d for C16H20Cl3NO2Na [M + 
Na]+: 386.0457, found 386.0459. 
 
 (±)-2,2,2-trichloroethyl benzyl(2-((3aS,4S,7aR)-1,3-dioxo-2-phenyl-
2,3,3a,4,7,7a-hexahydro-1H-isoindol-4-yl)ethyl)carbamate [62]: Olefin 61 
(109.4 mg, 0.30 mmol, 1.0 equiv) and N-phenylmaleimide (51.9 mg, 0.30 
mmol, 1.0 equiv) were reacted using the general procedure. Purification by flash 
chromatography (55% Et2O/pentane) produced adduct 62 as a light yellow oil. Run 1 (111.8 mg, 
0.209 mmol, 70% yield); Run 2 (120.9 mg, 0.226 mmol, 75% yield). The product was isolated in 
>20:1 d.r. by 1H NMR for both experiments. Average: 73% yield. 
 1H NMR (1:1 mixture of rotomers, 500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 4H), 7.27-
7.39 (m, 12H), 7.19 (d, J = 8.0 Hz, 4H), 5.97-6.00 (m, 2H), 5.79-5.82 (m, 2H), 4.72-4.87 (m, 
6H), 4.48 (d, J = 15.5 Hz, 1H), 4.42 (d, J = 15.5 Hz, 1H), 3.65 (pent, J = 7.0 Hz, 1H), 3.54-3.60 
(m, 1H), 3.33-3.42 (m, 3H), 3.25 (t, J = 9.0 Hz, 2H), 3.16 (dd, J = 9.0, 6.0 Hz, 1H), 2.81 (dd, J = 
15.0, 7.0 Hz, 2H), 2.26-2.33 (m, 4H), 2.05-2.19 (m, 4H). 13C NMR (1:1 mixture of rotomers, 125 
MHz, CDCl3) δ 178.8, 178.7, 176.9, 176.6, 154.9, 154.5, 137.1, 137.0, 133.3, 133.0, 131.8 (2 
peaks), 129.0, 128.6 (2 peaks), 128.5, 128.2, 128.0, 127.9, 127.6 (3 peaks), 126.4 (2 peaks), 95.7, 
95.6, 75.1 (2 peaks), 50.7, 49.9, 45.3, 45.0, 42.8, 42.3, 40.2 (2 peaks), 33.5, 33.4, 29.4, 28.7, 
24.5, 24.4; IR (film, cm-1): 3064, 3035, 2953, 2850, 1774, 1709, 1599, 1496, 1471, 1454, 1425, 
1385, 1267, 1207, 1128, 1061; HRMS (ESI) m/z calc’d for C26H25Cl3N2O4Na [M + Na]+: 
557.0778, found 557.0787. 
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 (±)-(4aS,8R,8aS)-2-benzyl-1-oxo-N-phenyl-1,2,3,4,4a,7,8,8a-
octahydroisoquinoline-8-carboxamide [63]: A 10 mL round bottom flask was 
charged with adduct 62 (47.5 mg, 0.0886 mmol, 1.0 equiv), THF (1.82 mL, 0.049 
M), glacial AcOH (0.20 mL, 0.44 M), and zinc dust (Sigma-Aldrich <10 micron, 106.8 mg, 1.63 
mmol, 18.4 equiv), and allowed to stir at room temperature for 1 hr. The reaction was then 
filtered through a celite plug to remove excess Zn, washing with DCM, and concentrated in 
vacuo. The concentrate was then re-dissolved in DCM and washed with 5% K2CO3 (1 x 10 mL). 
The aqueous layer was extracted with DCM (3 x 15 mL), and the combined organic layers were 
dried over MgSO4, filtered, and concentrated in vacuo. The crude benzylamine adduct was 
sufficiently pure, and taken onto the next step without purification. 
 The crude benzylamine adduct (0.0886 mmol) was dissolved in toluene (1.82 mL, 
0.049M) in a 25 mL round bottom flask, and the reaction was heated to 80°C for 2.5 hr. The 
toluene was then removed in vacuo, and the crude product was purified through flash 
chromatography (1.5% MeOH/CH2Cl2) to afford octahydroisoquinoline-8-carboxamide (63) as a 
white solid (27.8 mg, 0.077 mmol, 87% yield over 2 steps). This material could be further 
purified through recrystallization from 50% EtOAc/hexanes. 
 This compound has been reported previously.107 1H NMR (500 MHz, CDCl3) δ 10.89 (br 
s, 1H), 7.63 (d, J = 7.5 Hz, 2H), 7.25-7.32 (m, 5H), 7.17 (d, J = 6.5 Hz, 2H), 7.06 (t, J = 7.5 Hz, 
1H), 5.91 (ddd, J = 9.5, 6.0, 3.0 Hz, 1H), 5.57 (dd, J = 10.0, 1.5 Hz, 1H), 4.78 (d, J = 15.0 Hz, 
1H), 4.48 (d, J = 15.0 Hz, 1H), 3.23 (dd, J = 5.0, 2.0 Hz, 1H), 3.13 (dd, J = 9.0, 4.0 Hz, 2H), 2.95 
(t, J = 6.5 Hz, 1H), 2.85 (br s, 1H), 2.48-2.51 (m, 2H), 1.94-2.00 (m, 1H), 1.80-1.85 (m, 1H). 13C 
NMR (125 MHz, CDCl3) δ 172.4, 171.3, 138.9, 136.5, 129.2, 128.7, 128.6, 128.0, 127.6, 127.4, 
123.6, 119.9, 50.6, 44.3, 42.4, 36.1, 27.2, 26.5; IR (film, cm-1): 3319, 3197, 3132, 3062, 3026, 
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2927, 2868, 1668, 1631, 1599, 1543, 1496, 1441,1356, 1325, 1252, 1194, 1080, 910; HRMS 
(ESI) m/z calc’d for C23H25N2O2 [M + H]+: 361.1916, found 361.1909. 
 
 
Dehydrogenative Diels-Alder Route to Isoindoloquinolines for Figure 38 
 
N-(3,4-dimethoxy)phenethyl maleimide [65]: This product was 
prepared as described previously.122 
 1H NMR (500 MHz, CDCl3) δ 6.71-6.79 (m, 3H), 6.66 (s, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 
3.75 (t, J = 7.5 Hz, 2H), 2.85 (t, J = 7.5 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 170.5, 148.8, 
147.7, 134.0, 130.2, 120.8, 111.8, 111.2, 55.8 (2 peaks), 39.1, 34.0. 
 
 (±)-Methyl 3-((3aS,4S,7aR)-2-(3,4-dimethoxyphenethyl)-1,3-
dioxo-2,3,3a,4,7,7a-hexahydro-1H-isoindol-4-yl)propanoate 
[66]: Methyl 6-heptenoate 64 (Sigma-Aldrich, 42.7 mg, 0.30 
mmol, 1.0 equiv) and 3,4-dimethoxyphenethyl maleimide 65 (78.4 mg, 0.30 mmol, 1.0 equiv) 
were reacted using the general procedure. Purification by flash chromatography (50% 
EtOAc/hexanes) produced adduct 66 as a pale yellow oil. Run 1 (81.7 mg, 0.204 mmol, 68% 
yield); Run 2 (89.1 mg, 0.222 mmol, 74% yield). The product was isolated in >20:1 d.r. by 1H 
NMR for both experiments. Average: 71% yield. 
 1H NMR (500 MHz, CDCl3) δ 6.77 (d, J = 9.0 Hz, 1H), 6.71 (d, J = 6.5 Hz, 2H), 5.79 
(ddd, J = 10.0, 7.0 Hz, 3.5 Hz, 1H), 5.60 (dt, J = 9.5, 3.0 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 3.69 
(s, 3H), 3.66 (t, J = 7.5 Hz, 2H), 3.03-3.08 (m, 2H), 2.76 (t, J = 7.5 Hz, 2H), 2.66 (dd, J = 15.0, 
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7.0 Hz, 1H), 2.46-2.57 (m, 2H), 2.26-2.28 (m, 1H), 2.15-2.22 (m, 1H), 2.01-2.11 (m, 2H). 13C 
NMR (125 MHz, CDCl3) δ 179.5, 177.4, 173.6, 148.7, 147.6, 132.7, 130.1, 127.7, 120.8, 111.9, 
111.0, 55.8 (2 peaks), 51.6, 42.2, 40.1, 39.7, 35.0, 33.0, 32.1, 26.3, 24.1; IR (film, cm-1): 3033, 
2993, 2951, 2837, 1770, 1736, 1695, 1591, 1516, 1441, 1402, 1360, 1263, 1238, 1153, 1028; 
HRMS (ESI) m/z calc’d for C22H27NO6Na [M + Na]+: 424.1736, found 424.1734. 
 
 (±)-methyl 3-((1R,3aS,4R,7aR)-2-(3,4-dimethoxyphenethyl)-1-
hydroxy-3-oxooctahydro-1H-isoindol-4-yl)propanoate [67]: A 10 
mL round bottom flask was charged with adduct 66 (61.9 mg, 0.154 
mmol, 1.0 equiv), H2 purged MeOH (1.93 mL, 0.08 M), and 30% 
Pd/C (Sigma-Aldrich, 12.5 mg). The reaction was topped with a H2 balloon and allowed to stir 
for 2 hr. The reaction was then filtered through a celite plug, washing with EtOAc, and 
concentrated in vacuo to afford the hexahydrophthalimide product. This crude material was 
taken onto the next step.  
 The site-selective mono-reduction of the imide to form hydroxylactam 67 was achieved 
using a modified procedure.109 The crude hexahydrophthalimide product (0.154 mmol) was 
dissolved in absolute EtOH (1.54 mL, 0.10 M), and the reaction was cooled to 0°C. NaBH4 (46.6 
mg, 1.23 mmol, 8.0 equiv) was added to the reaction in one portion, and allowed to dissolve (~ 5 
min). The mixture was stirred at 0°C while 1 drop of a 2 M solution of H2SO4 in EtOH was 
added every 10 min and monitored by TLC. After 40 min (4 drops of 2 M H2SO4 in EtOH) the 
reaction was quenched slowly at 0°C with sat’d. NH4Cl (5 mL) and diluted with DCM (5 mL). 
The mixture was allowed to warm to room temperature, and H2O was added until the solution 
clarified. The layers were separated and the aqueous layer was extracted with DCM (3 x 15 mL). 
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The combined organic layers were washed with sat’d. NaHCO3, dried over MgSO4, filtered, and 
concentrated in vacuo to afford the crude hydroxylactam 67 as a single isomer. This material was 
taken onto the next step without purification. 
 1H NMR (500 MHz, CDCl3) δ 6.74-6.80 (m, 3H), 4.86 (dd, J = 10.5, 5.0 Hz, 1H), 3.86 (s, 
3H), 3.85 (s, 3H), 3.66 (s, 3H), 3.55 (dt, J = 13.5, 7.5 Hz, 1H), 3.39-3.45 (m, 1H), 2.80-2.88 (m, 
2H), 2.37-2.45 (m, 3H), 2.26-2.33 (m, 2H), 1.93-2.06 (m, 1H), 1.97 (br d, J = 10.5 Hz, 1H), 
1.74-1.80 (m, 1H), 1.45-1.65 (m, 3H), 1.15-1.23 (m, 1H), 1.07 (dq, J = 2.5, 12.5 Hz, 1H), 0.93 
(dq, J = 4.0, 13.0 Hz, 1H). 
 
 (±)-Methyl 3-((8aS,9R,12aR,12bR)-2,3-dimethoxy-8-oxo-
5,6,8,8a,9,10,11,12,12a,12b-decahydroisoindolo[1,2-
a]isoquinolin-9-yl)propanoate [68]: The N-acyliminium ion 
cyclization of hydroxylactam 67 was achieved using a modified procedure.123 A flame-dried 25 
mL round bottom flask was charged with the crude hydroxylactam 67 (0.154) and toluene (1.71 
mL, 0.09 M). 10-camphorsulfonic acid (53.6 mg, 0.231 mmol, 1.5 equiv) was added to the 
reaction in one portion, and the mixture was heated to 80°C for 1.5 hr. The reaction was then 
cooled, diluted with DCM (5 mL), and quenched with satd NaHCO3. The layers were separated 
and the aqueous layer was extracted with DCM (3 x 10 mL). The combined organic layers were 
dried over MgSO4, filtered, and concentrated in vacuo. The crude product was purified through 
flash chromatography (65% EtOAc/hexanes) to afford isoindoloquinoline 68 as a white solid 
(42.1 mg, 0.109 mmol, 71% yield over 3 steps). X-ray quality crystals could be obtained by 
recrystallizing the product in hot hexanes/minimal EtOAc, followed by sitting at 4°C for 12 hr. 
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 1H NMR (500 MHz, CDCl3) δ 6.67 (s, 1H), 6.58 (s, 1H), 4.26 (ddd, J = 12.0, 6.0, 2.0 Hz, 
1H), 4.20 (s, 1H), 3.89 (s, 3H), 3.85 (s, 3H), 3.62 (s, 3H), 3.05 (dt, J = 4.5, 12.0 Hz, 1H), 2.95-
3.02 (m, 1H), 2.22-2.55 (m, 6H), 1.92-2.01 (m, 2H), 1.80 (dt, J = 13.0, 3.5 Hz, 1H), 1.50-1.68 
(m, 3H), 1.36 (app tq, J = 3.0, 12.5 Hz, 1H), 1.13-1.21 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 
175.2, 174.3, 148.0, 147.6, 127.5, 127.1, 112.0, 107.8, 62.0, 56.0, 55.8, 51.4, 43.4, 39.1, 38.5, 
36.2, 32.0, 29.2, 28.9, 27.7, 27.2, 24.0; IR (film, cm-1): 2929, 2854, 1734, 1685, 1610, 1516, 
1450, 1416, 1360, 1329, 1259, 1227, 1165, 1107, 1012, 874; HRMS (ESI) m/z calc’d for 
C22H29NO5Na [M + Na]+: 410.1943, found 410.1938. 
 
Diene Isomerization Studies for Figure 39 
 
 (Z)-1,3-hexadiene [69]: A 1 dram borosilicate vial was charged with 1,3-
hexadiene (Sigma-Aldrich, 3.3:1 Z:E isomeric mixture as determined by 1H NMR 
analysis, 0.9469 g, 11.527 mmol, 1.0 equiv), DCE (0.53 mL, 21.7 M), and N-phenylmaleimide 
(0.485 g, 2.80 mmol, 0.243 equiv). The reaction suspension was charged with a stir bar, capped 
with a teflon-lined cap, and suspended in an oil bath at 45°C bath for 3 hr, resulting in a clear 
yellow solution. A small aliquot of this solution was added to a NMR tube and diluted with 
CDCl3. 1H NMR analysis showed only (Z)-1,3-hexadiene (69) and Diels-Alder product (70). The 
(Z)-1,3-hexadiene product was isolated from the reaction mixture using a Kugelrohr distillation 
apparatus (80°C, 760 torr.) to afford the title compound 69 (0.370 g, 4.508 mmol, 51% yield, 
>50:1 Z:E by 1H NMR) as a 21.3 M solution in DCE. This solution of (Z)-1,3-hexadiene was 
then used for the following crossover isomerization study. 
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 1H NMR (400 MHz, CDCl3) δ 6.64 (dt, J = 16.8, 10.0 Hz, 1H), 5.97 (t, J = 10.8 Hz, 1H), 
5.46 (dt, J = 10.8, 7.6 Hz, 1H), 5.18 (d, J = 16.8 Hz, 1H), 5.08 (d, J = 10.0 Hz, 1H), 2.20 (app 
dpent, J = 1.6, 7.6 Hz, 2H), 1.00 (t, J = 7.6 Hz, 3H). 
 
 (±)-(3aS,4S,7aR)-4-ethyl-2-phenyl-3a,4,7,7a-tetrahydro-1H-isoindole-
1,3(2H)-dione [70]: A ½ dram borosilicate vial was charged sequentially with 
Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 catalyst 39 (15.9 mg, 0.03 mmol, 0.10 
equiv), N-phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv), 2,6-Me2BQ (40.8 mg, 0.30 mmol, 
1.0 equiv), and p-nitrobenzoic acid (5.01 mg, 0.03 mmol, 0.10 equiv). Acetic Acid 5-hexen-1-yl 
ester (34) substrate (21.3 mg, 0.15 mmol, 0.5 equiv) and (Z)-1,3-hexadiene 69 (12.3 mg, 0.15 
mmol, 0.5 equiv) were then added to the ½ dram vial, and the reaction was immediately 
dissolved in DCE (0.3 mL, 1.0 M). The resulting dark red reaction mixture was charged with a 
stir bar, capped with a teflon-lined cap, and suspended in an oil bath at 45°C bath for 48 hr. 
Upon completion, the dark red reaction mixture was filtered through a short silica plug, eluting 
with ~5 mL EtOAc, and concentrated in vacuo at 25°C (~25 torr) to afford a dark red crude oil. 
A small aliquot of this mixture was added to a NMR tube and diluted with CDCl3. 1H NMR 
analysis of the crude product showed a ~1:1 40:70 ratio, both with >20:1 d.r. After analysis, the 
sample was returned to the crude mixture and the solvent was removed. The crude product was 
purified through flash chromatography (25% EtOAc/hexanes to 40% EtOAc/hexanes, SiO2, 20 x 
160 mm) to furnish the isomerization/Diels-Alder product 70 (26.6 mg, 0.104 mmol, 69% yield) 
and the dehydrogenation/Diels-Alder product 40 (29.9 mg, 0.954 mmol, 64% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.44 (t, J = 7.5 Hz, 2H), 7.36 (t, J = 7.5 Hz, 1H), 7.20 (dd, 
J = 9.0, 1.5 Hz, 2H), 5.98 (ddd, J = 9.5, 6.0, 3.5 Hz, 1H), 5.88 (dt, J = 9.5, 3.5 Hz, 1H), 3.27-3.31 
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(m, 2H), 2.80 (ddd, J = 15.5, 6.5 Hz, 1H), 2.22-2.29 (m, 2H), 1.92-2.01 (m, 1H), 1.76-1.85 (m, 
1H), 1.08 (t, J = 7.5 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 179.1, 176.9, 133.9, 131.9, 129.0, 
128.4, 127.3, 126.5, 42.8, 40.4, 38.1, 24.4, 24.1, 12.6; IR (film, cm-1): 3037, 2962, 2933, 2906, 
2873, 1774, 1709, 1597, 1498, 1456, 1444, 1383, 1190, 1169, 862, 754, 692; HRMS (ESI) m/z 
calc’d for C16H17NO2Na [M + Na]+: 278.1157, found 278.1154. Note: The structure and relative 
stereochemistry of isomerization/Diels-Alder product 70 was confirmed through independent 
synthesis, involving the Diels-Alder reaction between (E)-1,3-hexadiene and N-
phenylmaleimide. 
 
Figure 42. Pd(II)-catalyzed Diene Isomerization Study 
(Z)-1,3-diene
(1.0 equiv.)
Me
N
O
O
Ph
H
H
Me
cat 39
(10 mol%)
Me
(E)-1,3-diene
Isomerization
46% 
yield
69 (+/-)-70
NPM+
 
a) Conditions: 39 (10 mol%), NPM (1.0 equiv.), 2,6Me2BQ (1.0 equiv.), p-
NO2BzOH (10 mol%), DCE (1M), 45oC, 48 hr. Cycloadduct 70 isolated as 
a single diastereomer. 
 
 
Pd(II)-catalyzed Diene isomerization study: A ½ dram borosilicate vial was charged sequentially 
with Pd[1,2-bis(benzylsulfinyl)ethane](OAc)2 catalyst 39 (15.9 mg, 0.03 mmol, 0.10 equiv), N-
phenylmaleimide (51.9 mg, 0.30 mmol, 1.0 equiv), 2,6-Me2BQ (40.8 mg, 0.30 mmol, 1.0 equiv), 
and p-nitrobenzoic acid (5.01 mg, 0.03 mmol, 0.10 equiv). (Z)-1,3-hexadiene 69 (24.6 mg, 0.30 
mmol, 1.0 equiv) was then added to the ½ dram vial, and the reaction was immediately dissolved 
in DCE (0.3 mL, 1.0 M). The resulting dark red reaction mixture was charged with a stir bar, 
capped with a teflon-lined cap, and suspended in an oil bath at 45°C bath for 48 hr. Upon 
completion, the dark red reaction mixture was filtered through a short silica plug, eluting with ~5 
mL EtOAc, and concentrated in vacuo at 25°C (~25 torr) to afford a dark red crude oil. A small 
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aliquot of this mixture was added to a NMR tube and diluted with CDCl3. 1H NMR analysis of 
the crude product showed a >20:1 d.r. of endo adduct 70. After analysis, the sample was returned 
to the crude mixture and the solvent was removed. The crude product was purified through flash 
chromatography (20% EtOAc/hexanes, SiO2, 20 x 160 mm) to furnish the isomerization/Diels-
Alder product 70 (35.2 mg, 0.138 mmol, 46% yield). Note: Following the same procedure, 
except without Pd(II) catalyst 39, the (Z)-diene 69 was fully recovered. 
 
 
 
 
 
 
X-ray Crystal Structural Data for Figures 34 and 38 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 42 – Deposition number: CCDC 816037 
 
(Note: This crystal sample solved in a centrosymmetric space group and therefore both 
enantiomers exist in the crystal.)  
 
Table.  Crystal data and structure refinement for ba60las. 
Identification code  ba60las 
Empirical formula  C20 H27 N O3 Si 
Formula weight  357.52 
Temperature  193(2) K 
Wavelength  0.71073 Å 
N
O
O
Ph
H
H
OTBS
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Crystal system  Monoclinic 
Space group  P2(1)/c   
Unit cell dimensions a = 16.0358(8) Å a= 90°. 
 b = 8.2776(5) Å b= 107.358(3)°. 
 c = 15.5407(9) Å g = 90°. 
Volume 1968.90(19) Å3 
Z 4 
Density (calculated) 1.206 Mg/m3 
Absorption coefficient 0.137 mm-1 
F(000) 768 
Crystal size 0.333 x 0.288 x 0.233 mm3 
Theta range for data collection 2.66 to 25.40°. 
Index ranges -19<=h<=19, -9<=k<=9, -18<=l<=18 
Reflections collected 33510 
Independent reflections 3620 [R(int) = 0.0647] 
Completeness to theta = 25.40° 100.0 %  
Absorption correction Integration 
Max. and min. transmission 0.9842 and 0.9695 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3620 / 0 / 232 
Goodness-of-fit on F2 1.032 
Final R indices [I>2sigma(I)] R1 = 0.0387, wR2 = 0.0951 
R indices (all data) R1 = 0.0527, wR2 = 0.1031 
Largest diff. peak and hole         0.257 and -0.308 e.Å-3 
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Compound 44 – Deposition 
number: CCDC 816038 
 
(Note: Four molecules are present in the unit cell. Two molecules of the same enantiomer exist 
within an asymmetric unit. This crystal sample solved in a centrosymmetric space group and 
therefore both enantiomers exist in the crystal.)  
 
Table.  Crystal data and structure refinement for ba61las. 
Identification code  ba61las 
Empirical formula  C23 H18 N2 O4 
Formula weight  386.39 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1    
Unit cell dimensions a = 7.7991(6) Å a= 76.317(4)°. 
 b = 12.1515(10) Å b= 89.530(5)°. 
 c = 21.4998(16) Å g = 72.349(4)°. 
Volume 1882.1(3) Å3 
Z 4 
Density (calculated) 1.364 Mg/m3 
Absorption coefficient 0.095 mm-1 
F(000) 808 
Crystal size 0.518 x 0.293 x 0.163 mm3 
Theta range for data collection 1.81 to 25.51°. 
Index ranges -9<=h<=9, -14<=k<=14, -25<=l<=25 
Reflections collected 33098 
Independent reflections 6957 [R(int) = 0.0714] 
N
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Completeness to theta = 25.51° 99.1 %  
Absorption correction Integration 
Max. and min. transmission 0.9913 and 0.9684 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6957 / 0 / 523 
Goodness-of-fit on F2 1.013 
Final R indices [I>2sigma(I)] R1 = 0.0440, wR2 = 0.0915 
R indices (all data) R1 = 0.0814, wR2 = 0.1059 
Largest diff. peak and hole         0.148 and -0.219 e.Å-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound 68 – Deposition number: CCDC 816035 
 
(Note: This crystal sample solved in a centrosymmetric space group and therefore both 
enantiomers exist in the crystal. The enantiomer shown was arbitrarily selected as the 2nd 
structure in the crystal, and thus the atom numbering starts at C23, O6, N2.) 
 
 
Table.  Crystal data and structure refinement for ba87kas. 
Identification code  ba87kas 
Empirical formula  C22 H29 N O5 
Formula weight  387.46 
Temperature  193(2) K 
Wavelength  0.71073 Å 
N
O
MeO
OMe
O
OMe
H
HH
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Crystal system  Triclinic 
Space group  P -1    
Unit cell dimensions a = 10.4545(8) Å a= 88.953(5)°. 
 b = 13.0186(10) Å b= 75.935(5)°. 
 c = 15.2390(13) Å g = 86.647(5)°. 
Volume 2008.4(3) Å3 
Z 4 
Density (calculated) 1.281 Mg/m3 
Absorption coefficient 0.090 mm-1 
F(000) 832 
Crystal size 0.342 x 0.194 x 0.091 mm3 
Theta range for data collection 1.57 to 25.44°. 
Index ranges -12<=h<=12, -15<=k<=15, -18<=l<=18 
Reflections collected 32558 
Independent reflections 7343 [R(int) = 0.0795] 
Completeness to theta = 25.44° 98.7 %  
Absorption correction Integration 
Max. and min. transmission 0.9932 and 0.9712 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7343 / 0 / 511 
Goodness-of-fit on F2 1.010 
Final R indices [I>2sigma(I)] R1 = 0.0505, wR2 = 0.0968 
R indices (all data) R1 = 0.1097, wR2 = 0.1165 
Largest diff. peak and hole                                         0.234 and -0.198 e.Å-3 
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